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Histone post-translational modifications modulate chromatin structure and 
function either by directly altering the intrinsic physical properties of the 
chromatin fiber or by nucleating the recruitment and activity of a host of trans-
acting nuclear factors. Histone ubiquitylation is one class of histone PTMs where 
the 76 amino acid protein, ubiquitin, is ligated to the ε-nitrogen of a lysine amino 
acid residue within the histone substrate. 36 unique ubiquitin sites across the 4 
canonical histones have been annotated, with 7 of these sites associated with 
chromatin-templated processes. One such modification, the ubiquitylation of 
Histone H2B at lysine 120  (H2B-Ub) is enriched at the 5’ end of active genes 
and has been implicated in transcriptional elongation and chromatin 
conformation, interacting with over 90 trans-acting nuclear factors. Further, it is 
additionally responsible for the regulation of H3K4 and H3K79 methylations, 
through the direct stimulation of methyltransferase activity specific to the 
installation of these marks. Interested in the surface features on ubiquitin 
required for H2B-Ub stimulation of the human H3K79 methyltransferase, hDot1L, 
we developed a strategy for the site-specific chemical ligation of ubiquitin to pre-
assembled mononucleosomes to greatly expedite structure activity studies of 
ubiquitin in a nucleosome context. Accordingly, we synthesized a library of H2B-
ligated ubiquitin alanine mutant nucleosomes and tested their ability to stimulate 
hDot1L-mediated H3K79 methylation. A functional hotspot on Ub that is required 
for the stimulation of hDot1L activity in vitro was identified. We additionally 
investigated the structural implication of this functional hotspot in the context of 
nucleosomes and nucleosomal array compaction. Both nucleosomal structural 
and H2B-Ub-induced impairment of chromatin fiber compaction was not affected 
by this functional surface. Lastly, this functional hotspot was further tested with 
the yeast H3 methyltransferases, yDot1 and ySet1C. Surprisingly, this functional 
surface was dispensable for yDot1-mediated H3K79 methylation both in vivo and 
in vitro. Further insights into yDot1-mediated H3K79 methylation was obtained 
through an alanine scan of the Ub surface in the context of the nucleosome. 
Interestingly, the hDot1L hotspot within ubiquitin was found to be important for 
the regulation of ySet1-mediated H3K4 methylation. Collectively, these data 
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Chapter 1. Introduction 
 
1.1. Introduction 
Deoxyribonucleic acid (DNA) is the carrier of genetic information from which all 
life as we know it is based. Encoded by the nucleobases of DNA, genes are 
functional units that are transcribed into ribonucleic acid (RNA), and may be 
subsequently translated into proteins.1, 2 Considering the essentiality of this for all 
of life’s processes, organisms have evolved complex mechanisms for the 
spatiotemporal regulation of their genes. With the sequencing of the human 
genome, and the recent Encyclopedia of DNA Elements (ENCODE) project that 
has served to functionally annotate DNA elements, we have progressed far 
beyond the simple idea that DNA contains genes and have begun to disentangle 
the structures and mechanisms behind how genetic information is utilized and 
propagated.  
 
It is clear that DNA sequence alone is not sufficient to explain certain phenotypic 
or transcriptional phenomena; rather it’s the integration of multiple different inputs 
that determines the transcriptional fate of a gene. This was first observed in 
1930, as Position Effect Variegation (PEV), where the translocation of a gene 
resulted in its variable expression between cells with otherwise identical DNA 
sequences.3, 4 This has also been demonstrated in processes such as X-
chromosome inactivation and in multicellular development.5 In order to 
understand gene function we must consider the context in which DNA exists. 
 2 
This is the study of epigenetics, which herein, will be narrowly defined as the 
study of gene function that is not directly attributed to DNA sequence alone. 
 
1.2. Chromatin Structure and Function 
In eukaryotes, DNA is segregated into the nucleus of a cell where it exists in 
chromosomes, or DNA polymers (human chromosomes are between 50 and 250 
megabases) stored in the form of the nucleoprotein complex known as 
chromatin. During interphase, the nuclear structure resembles a fractal globular 
state where chromosomes occupy discrete chromosomal territories (Figure 
1.1a).7 Gene-rich chromosome domains localize towards the center of the 
nucleus and gene poor areas to the nuclear periphery.6, 7 Recently, proximity-
based DNA ligation technologies coupled to bioinformatic analysis of annotated 
DNA elements (discerned through epigenomic methods, such as Chromatin 
Immunoprecipitation followed by massively parallel DNA sequencing  (ChIP-seq)) 
have markedly enhanced the resolution to which we can explore the large-scale 
organization of chromatin.7-9 Accordingly, we have learned from these studies 
that macro-chromatin structure correlates well with finer chromatin elements 
(discussed further below) suggesting that the spatial organization of the nucleus 
may either influence or be a consequence of gene function.  
 
The fundamental repeating unit of chromatin, at the 100 base pair (bp) scale, is 
the nucleosome. The nucleosome consists of a ~146 bp DNA duplex wrapped 
around a histone octamer composed of two copies each of histone H2A, histone 
 3 
H2B, histone H3, and histone H4 (Figure 1.1b).10 Atomic resolution crystal 
structures of the nucleosome reveal that DNA is wrapped in 1.65 turns of a left-
handed super helix around the histone octamer in which two H3/H4 dimers form 
a tetramer and associate with individual H2A/H2B dimers on either side of the 
nucleosome face.11 Histones possess a canonical alpha-helical histone fold, 
which forms the structural scaffolding of the octamer core, and a basic N-terminal 
tail protruding out from the nucleosome (Figure 1.1b).  
 
Intervening DNA connects nucleosomes and their genomic positions have been 
mapped to base pair resolution using ChIP-Seq as well as Micrococcal Nuclease 
(MNase) digestion. Accordingly, nucleosomes are repeated throughout the 
genome about every 160 to 240 bp and nucleosome positioning is determined 
through both DNA sequence-dependent and epigenetic mechanisms (Figure 
1.1c).12-14 Nucleosomes have been shown to condense into higher order 
structures in vivo, stabilized by inter-nucleosomal interactions and, in some 
contexts, through the help of additional proteins (e.g. linker histone H1 and 
Heterochomatin Protein 1 (HP1).15-17 In vitro studies reveal that contiguous 
nucleosome arrays fold into regular local structures 30 nm in diameter (so-called 
30 nm fibers).18 However the intricacies of higher order chromatin folding in vivo 













Figure 1.1. Chromatin structure and organization. (a) Chromatin is organized 
hierarchically where at a nuclear level chromosomes occupy distinct territories (left 
panel). On the megabase scale chromosomes divide into euchromatin (green line, 
middle panel) and heterochromatin (grey line, middle panel), which can be further 
divided into TADs (green line, right panel). TADs display discreet functional elements 
(functional elements correspond to Table 1.1 colors and elements identified in Figure 
1.1d). (b) The structure of the nucleosome (PBD accession code: 1KX5).  The N-
terminal histone tails protrude out from the nucleosome core. H2A (yellow) H2B (red) 
H3 (blue) H4 (green) DNA (grey). (c) Nucleosomes show different levels of 
compaction and are dispersed along the genomic DNA (grey line). (d) The seven 
major classes of chromatin. Heterochromatin (repressed, gray box) is separated from 
euchromatin typically through CTCF enriched elements (turquoise box). Enhancers 
(orange/yellow box) typically interact with promotes (light red box) in trans, which lie 
adjacent to TSS (red box) and transcribed regions (green box). 
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Chromatin can be divided into euchromatin and heterochromatin based on 
regions of high and low gene transcription, respectively. Euchromatin is generally 
less compact than heterochromatin15 and one way to subdivide euchromatin is 
into six categories that serve to explain many functional transcriptional elements 
of chromatin (Figure 1.1d, Table 1.1).9 The transcribed (T) state of chromatin 
includes genomic regions that contain transcribed genes. The Transcriptional 
Start Site  (TSS) state is proximally upstream of the T state where gene 
transcription is initiated. The Promoter Flanking (PF) state surrounds the TSS 
state and contains chromatin elements that aid in transcription, including 
Transcription Factor (TF) recognition motifs. Both Enhancer (E) and Weak 
Enhancer (WE) elements function in similar ways to the PF, however are distal to 
their corresponding TSS region. Lastly, the CCCTC binding factor (CTCF) state 
is enriched in insulator elements, which serve to sequester enhancer regions 
from non-cognate TSS regions. Conversely, heterochromatin or the Repressed 
(R) state is generally associated with transcriptionally silent regions of the 
genome, which is more nucleosome dense. Heterochromatic regions include 
inactive genes, telomeres, and tandem repeat DNA.15 Heterochromatin can be 
further subdivided into functionally distinct types of chromatin that is either 
transcriptional inactive or transcriptionally repressed.20 
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Table 1.1. The seven major classes of chromatin. This table was reproduced from 
Consortium, and Bernistein et al 2012.9 Chromatin classes were determined from 
integrative analysis of elements identified from the ENCODE project. The colors of the 
chromatin classes correspond to those used in Figure 1.1d. 
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regulatory 
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Enriched for RNA 






At a 100 kilobase scale, euchromatin and heterochromatin organize into distinct 
topologically associated domains (TADs). 8 TADs are defined as regions of DNA 
that are separated by characteristic boundary elements and where DNA-DNA 
interactions in-cis are predominant. Since gene transcription is coordinated within 
TADs more so than between TADs –this is not to say gene transcription between 
TADs is not coordinated- it is posited that TADs contain primarily autonomous 
gene regulatory networks with relatively little inter-TAD associations.8 TADs are 
postulated to be hardwired features of chromosomes and are invariant across 
cell-types. However, whether a TAD is euchromatic or heterochromatic is cell-
type dependent.  
 
On a megabase scale, groups of adjacent TADs organize into two distinct 
alternating chromatin states, known as open and closed chromatin.7 Open and 
closed chromatin states correspond to groups of euchromatic TADs and 
heterochromatic TADs, respectively. These different chromatin compartments 
preferentially self-associate; that is, open chromatin preferentially associates with 
other open chromatin regions, whereas closed chromatin prefers to associate 
with other closed chromatin domains, creating functionally distinct compartments 
within the nucleus.7  
 
1.2.1. Chromatin Regulation 
Chromatin architecture does not offer up mechanistic principles for the 
organization and regulation of chromatin; it is merely descriptive. Fortunately, 
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much work has focused on the regulation of chromatin structure and function and 
how this relates to the many trans-acting factors that bind to and often modify the 
chromatin template. Based on this ever expanding body of knowledge, we now 
know that several biochemical inputs impinge on chromatin to regulate the 
activity of DNA-templated process such as transcription, principally: (i) DNA 
sequence-specific chromatin binders; (ii) non-coding RNA; (iii) histone variants; 
and modification of the (iv) DNA and (v) histones.  
 
DNA sequence-dependent binding of proteins to specific chromatin elements is a 
firmly established mode of regulation. This is exemplified through the DNA 
sequence specific recognition of transcription factor proteins such as GCN4 and 
NF-Y (Figure 1.2a).21, 22 Transcription factors activate gene transcription and 
represent ~8% of protein coding genes in the human genome. Other chromatin 
binders, such as the insulator CTCF, also recognize DNA in a sequence-specific 
manner as an integral part of their function.23     
 
RNA has been shown to play both a sequence-dependent and sequence-
independent role in chromatin regulation. Comprising about 60% of genomic 
coding regions in mammals, RNA has been shown to both recruit and compete 
away specific factors to/from chromatin.24 Although the true extent of RNA 
regulation of chromatin is unknown, mechanisms in which RNA regulates 
chromatin include: (i) RNA interference; (ii) competition with endogenous RNAs; 
(iii) direct RNA binding of chromatin modifiers such as the PRC2 complex; and 
 9 
(iv) RNA-DNA interactions both in-cis and in-trans as in the case of XIST in X-
chromosome inactivation (Figure 1.2b).25-27  
 
Nucleosome composition is additionally adjusted through the incorporation of 
histones variants into the nucleosome. In addition to the 4 canonical histones 
there are over 20 reported histone variants, which are specific to different 
chromatin regions and cell-types (Figure 1.2c).28, 29 For example H2A.Z, a variant 
of H2A, localizes to gene promoters where it plays a specific role in nucleosomal 
stability and gene transcription.28 Further, H2AZ.2.2, a spliced isoform of H2A.Z.2 
is specifically enriched in the brain and serves to further destabilize 
nucleosomes.28  
 
Covalent modification of chromatin has emerged as a central component of 
epigenetic regulation (Figure 1.2c). Both the DNA template and the histone spool 
around which the nucleic acid is packaged are subject to dynamic chemical 
modification, the former through methylation on the 5 position of the cytosine 
base (preferentially in CpG sequences) and latter through the introduction of 
manifold post-translational modifications (PTMs).15 These DNA and protein 
modifications are faithfully propagated and maintained down cell lineages due to 














Figure 1.2. Mechanisms of chromatin regulation. (a) DNA sequence-dependent 
recognition of DNA by a transcription factor. (b) RNA recognition of DNA and tethering 
of RNA-binding protein. (c) Different ‘types’ of nucleosomes containing different 
histone variants (left nucleosome), and post-translational modifications (right 
nucleosome histone tail). Additionally, the cystosine bases of the DNA can be 
modified (orange DNA bases). 
 
mis-regulation of these enzymes is frequently associated with disease in 
humans, for example cancer, underlining the importance of the associated 
chromatin modifications in the regulation of nuclear processes.31 While DNA 
methylation is primarily associated with gene silencing and inactive chromatin 
generally, histone PTMs have been correlated with both euchromatin and 
heterochromatin states. Both DNA and histone modifications can function 
through the recruitment or repulsion of trans-acting chromatin binders – for 
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example, DNA methylation at CpG sequences can interfere with TF binding or 
can directly recruit transcriptional silencing factors through methyl-CpG binding 
domains.15 As noted in the following sections, histone PTMs (which are the focus 
of this thesis research) provide an amazingly diverse set of ‘ingredients’ for the 
regulation of chromatin. 
 
1.2.2. Histone post-translation modifications 
Histone PTMs are site-specific covalent modifications that are attached to the 
amino acid side chains of the histone proteins. Modification sites number in the 
hundreds with many sites showing multiple types of PTMs.15 Over 15 
chemotypes of histone PTMs, or ‘marks’, have been annotated across the 4 
canonical histones.32, 33 PTMs vary in chemical complexity and composition and 
include: phosphorylation (ph), acetylation (ac), methylation (me), ubiquitylation 
(Ub), crotonylation, citrullination, SUMOylation, ADP ribosylation, and proline 
isomerization. Furthermore, a subset of these modifications can exist in multiple 
states (e.g. lysine can be mono-methylated (me1), di-methylated (me2) or tri-
methylated (me3)). Histone PTMs are dynamic and are installed and removed by 
a subset of chromatin modifiers. 
 
A recent mass spectrometry study identified 708 unique post-translationally 
modified histones indicative of a complex combinatorial nucleosomal PTM 
landscape.34 Yet another layer of complexity is given by the possibility of 
asymmetric nucleosome modification in vivo, as each nucleosome contains two 
copies of each canonical histone that can contain very different PTM patterns.35 
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However, while nucleosomes contain multiple histone PTMs, their combinatorial 
co-occurrence is remarkably segregated as groups of histone PTMs co-occupy 
with one another.36, 37 Broadly, histone PTMs can be grouped as either active, i.e. 
associated with euchromatin, or repressive, i.e. associated with heterochromatin, 
marks. It is hypothesized that the combinatorial nature of histone PTMs 
constitute a histone code, a code that is read out by chromatin binders and  
modifiers to bring about distinct downstream effects.30  
 
1.2.3.  Functions of histone post-translational modifications 
 
Figure 1.3. The regulation of chromatin by histone PTMs. (a) Histone PTMs 
modulate DNA/histone and histone/histone interactions altering chromatin structure. (b) 
Histone PTMs directly recruit chromatin binders (c) Histone PTMs directly block 
chromatin binders through disruption of protein/chromatin interaction surfaces.  
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Histone PTMs play a role in nucleosome dynamics including processes in which 
nucleosomes are translocated, unwrapped, evicted or replaced. Neutralization of 
the positive charge of lysine upon acetylation, and potentially less well-
understood acylations such as crotonylation, suggests a direct physical 
mechanism for how this is achieved; namely through the disruption of DNA-
histone and histone-histone interactions (Figure 1.3a). Similarly, phosphorylation, 
which installs a negative charge to an otherwise neutrally charged amino acid 
residue, has been described to interfere with nucleosome wrapping, making 
chromatin more accessible to DNase I in vitro.38 In addition, many histone PTMs 
exist on the surface of the nucleosome proximal to histone-DNA contacts and are 
thought to function by altering intra-nucleosome dynamics.39, 40 For example, the 
acetylation of H3K115 and the phosphorylation of H3K118 modifications are 
adjacent to the nucleosomal DNA and alter nucleosome dynamics.38, 41, 42 
 
In addition to directly affecting chromatin compaction, PTMs can regulate 
chromatin structure and function through more subtle trans-acting mechanisms. 
The readout of histone modifications, such as acetyl lysine, methyl lysine, methyl 
arginine, and phospho serine, by a variety of specific protein modules, or histone 
PTM binders, has been well documented.43, 44 For example, structural studies 
have demonstrated that the protein 53BP1 specifically recognizes H4K20me2 
through its tandem Tudor domain, an interaction integral for recruitment of 53BP1 
to sites of DNA damage.45 Other marks affect nucleosome dynamics upon 
recruitment of histone PTM binders. H3K9me3 has been shown to recruit HP1, 
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thereby inducing heterochromatin formation (Figure 1.3b).46 Additionally, 
H3K36me recruits chromatin remodelers, enzymes responsible for the 
translocation of nucleosomes along the DNA, as well as deacetylases 
highlighting that histone PTMs have the capacity to recruit both chromatin 
binders and modifiers. Conversely, histone PTMs can actively inhibit binding of 
certain chromatin modifiers and binders (Figure 1.3c). This has been shown for 
the Inhibitor of Growth Protein 2 (ING2) Plant Homeo Domain (PHD) finger, 
which recognizes H3K4me3 with a low micromolar affinity. However, in the 
presence of H3K4me3 and either H3R2me or H3T3ph a ~20-fold decrease in 
binding affinity is observed.47 Accordingly, histone PTMs (or patterns of histone 
PTMs) have the ability to recruit both chromatin modifiers and binders, initiating 
further chromatin-templated processes. 
 
1.2.4.  Chromatin Complexes  
Analogous to how nucleosomes contain multiple histone PTMs and histone 
variants, many chromatin-modifying complexes contain multiple histone PTM 
binding domains and are post-translationally modified. For example, the 
chromatin remodeler SWI/SNF complex, an 11-subunit complex comprising 
multi-histone PTM binding domains, is subjected to a host of post-translational 
modifications.48, 49 The combinatorial nature of histone PTM binder subunits, and 
the dynamic modification of these subunits, in chromatin complexes may serve to 
recognize chromatin both intra and inter-nucleosomally through spatio-temporal 
multivalent associations.50 This has profound implications for the regulation of 
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chromatin structure and function and thus understanding the mechanistic role 
that histone PTMs play in chromatin involves understanding both the mark as 
well as the context in which the mark is recognized and interpreted.  
 
1.2.5.  Histone Ubiquitylation  
Ubiquitylation refers to the covalent attachment of the small (76 amino acids) 
globular protein Ub, typically to the ε-nitrogen of a lysine residue in a target 
protein substrate51, 52. Ub is a highly conserved protein (96% sequence homology 
between yeast and human) indicating the protein is under strong evolutionary 
pressure to retain its surface features. Ub is also a highly stable protein existing 
in micromolar concentrations inside the cell where it functions both as a signal for 
protein degradation, as well as in the regulation of protein-protein interactions, 
modulation of protein activity, and protein localization.53 Proteolytic processes 
have been shown to mainly involve UbK48 poly-ubiquitylated substrates (all 
seven lysines in ubiquitin can themselves be ubiquitylated to generate polymers). 
Conversely, non-proteolytic processes are thought to occur through other poly-
ubiquitin linkages and through mono-ubiquitylation. Ub has been shown to play a 
role in numerous biological processes and in the context of the nucleus these 
include gene regulation and DNA damage repair.54  
 
Protein ubiquitylation is achieved via a three-enzyme cascade that ultimately 
results in the formation of an isopeptide linkage between the C-terminus of Ub 
and the ε-NH2 of a lysine within the substrate. In this reaction cascade, the C-
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terminus of Ub is activated in an ATP-dependent reaction by an Ub activating 
enzyme (E1), transferred to an ubiquitin conjugating enzyme (E2) that then 
associates with an Ub protein ligase (E3) before ligation to its substrate. In 
humans, 2 different non-specific E1 enzymes have been identified.55 By contrast, 
the numbers of E2 and E3 ligases in humans are in the dozens and hundreds, 
respectively, and ultimately substrate specificity in the ubiquitylation system 
arises from the particular E2/E3 combination used.56 Importantly, the 
ubiquitylation mark is reversible and can be removed from a given protein via 
dedicated de-ubiquitylating enzymes (DUBs) making ubiquitylation a dynamic 
reversible modification.57  
 
Thirty-six ubiquitylation sites have been annotated in the 4 canonical human 
histones using proteomics methods.58 Of these sites, 7 histone ubiquitylations 
have been validated and characterized further.59-62 By far the two best-studied 
chromatin ubiquitylation marks occur on histone H2A at lysine 119 (H2AK119-
Ub) and histone H2B at lysine 120 (herein referred to simply as H2B-Ub).60 To 
the first approximation, H2AK119-Ub and H2B-Ub have opposing effects on 
chromatin regulation, at least as it pertains to the regulation of transcription.63 
H2AK119-Ub comprises about 5 to 15% of the total pool of H2A in higher 
eukaryotes and is, in fact, the most abundant histone ubiquitylation mark in 
higher eukaryotes, although the modification is surprisingly absent in yeast.64 
H2AK119-Ub is primarily associated with transcriptional silencing, but has also 
been linked to DNA damage repair.54 By contrast, H2B-Ub, which is the major 
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focus of this thesis work, is linked to regions of active transcription, but as 
detailed in the following section, has been linked to many processes.  
 
1.3.  H2BK120 ubiquitylation  
H2B-Ub has been known for over 40 years and is one of the most studied 
histone ubiquitylations.60 The H2B-Ub modification is conserved from yeast to 
humans where it comprises  ~10% and ~1%, of the total H2B in cells, 
respectively. 65, 66 On a molecular level, H2B-Ub is associated with euchromatin 
and found mainly towards the 5’ end of gene bodies and within intron-exon 
boundaries of highly expressed skipped exons as well as chromatin boundaries 
in higher eukaryotes. 67-70 H2B-Ub has been implicated in almost every molecular 
process ascribed to chromatin with over 90 H2B-Ub interacting factors 
identified.71, 72 Processes involving H2B-Ub include: (i) the regulation of 
transcription elongation,73-75 (ii) RNA processing and DNA replication,76-78 (iii) 
DNA damage response and repair,79-82 (iv) nucleosome positioning,83 (v) 
chromatin segregation,84 and  (vi) the maintenance of chromatin boundaries.68, 70  
 
The ubiquitylation machinery responsible for the generation of H2B-Ub is well 
characterized and is conserved from yeast to humans.85-89 Rad6A and Rad6B in 
humans (Rad6 in yeast) are the E2 conjugating enzymes for H2B-Ub with Rad6A 
being in much greater abundance than Rad6B (also of note, these E2 enzymes 
are 95% homologous).86, 87 Interestingly, in yeast, efficient H2B ubiquitylation 
requires Rad6 S120 phosphorylation which highlights that H2B-Ub, itself, is 
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regulated through post-translational modifications.85, 90 RNF20 and RNF40 form 
the H2B-Ub E3 complex (referred herein as hBre1), which has been suggested 
to exist as a tetramer containing RNF20/RNF20 and RNF40/RNF40 pairs (in 
yeast the complex is a homo-tetrameric Bre1 complex). 85, 86 In yeast, Rad6/Bre1 
form a higher-order complex with the Large 1 protein, which is thought to 
regulate both the association of Rad6/Bre1 in gene bodies as well as Ubp8, a 
H2B-Ub specific DUB.88, 91  
 
In yeast, both Ubp8 and Ubp10 have been reported to deubiquitylate H2B-Ub.73, 
92-94 These DUBs act on distinct pools of H2B-Ub, Ubp8 is responsible for 
targeting active chromatin near the TSS and Ubp10 within the gene body.69 Ubp8 
is a member of the Spt-Ada-Gcn5-Acetyl transferase (SAGA) complex, which is 
best known for its histone acetyltransferase activity encoded by the integral 
subunit Gcn5.95, 96 The SAGA complex in humans has been shown to contain the 
Ubp8 homolog, USP22, which is thought to be the main H2B-Ub deubiquitylase 
in humans.97 Less is known about Ubp10, however it’s thought to be associated 
with telomeric silencing.69, 94, 98-100 In humans, exon specific DUBs have been 
reported and many more H2B-UB specific DUBs have been proposed.101-104 
Moreover, the requirement for efficient ubiquitylation/deubiquitylation of H2B-Ub 
for optimal transcription has led to the hypothesis that H2B-Ub is transient and 




1.3.1. H2B-Ub role in transcription elongation 
A growing body of work has focused on the role of H2B-Ub in transcription 
elongation.  In transcription, RNA Pol II transcribes DNA to RNA in a multi-step 
fashion, a process that requires many components such as activators and co- 
activators for proper function. The role of H2B-Ub in transcription has been 
established by the observation that the ubiquitin conjugating enzymes specific for 
H2B-Ub, Bre1 and Rad6, co-localize with the elongating form of RNA Pol II 
(Figure 1.4). 85, 86 Partial depletion of RNF20 in humans or yBre1 in yeast 
 
Figure 1.4. The role of H2B-Ub in transcriptional elongation. The H2B-Ub 
conjugation machinery localizes with RNA Pol II through association with the PAF 
complex serving to ubiquitylate H2B during transcription. Rad6S120ph is essential for 
efficient ubiquitylation (The letter P denotes a site of phosphoylation implicated in this 
pathway). The FACT complex recognizes H2B-Ub facilitating nucleosomal reassembly, 
potentially through its interactions with chromatin remodelers. COMPASS and Dot1 
methylate H3K4 and H3K79 in the presence of H2B-Ub during transcription and are 
associated with the PAF complex and the S2/S5ph CTD of RNA Pol II, respectively. 
Further, the Ubp8 containing SAGA complex follows the RNA Pol lI complex and 




reduces H2B-Ub levels, thereby up- or downregulating different subsets of 
genes.69, 106 In biochemically-reconstituted systems, localization of the H2B-Ub 
conjugation machinery involves recruitment of Bre1 through interactions with the 
subunit hPAF1 (or yPAF1 in yeast) of the RNA Polymerase II Associated Factor 
(PAF) complex, and the subsequent recruitment of Rad6 through interactions 
with Bre1 (Figure 1.4).85 Further, it has been shown in vitro that transcription is 
required for efficient H2B ubiquitylation.86 Since the presence of H2B-Ub did not 
alter the rate of transcription in this system, it was proposed that H2B-Ub might 
function in transcriptional steps not observable in such a well-defined but 
simplified system.86  
 
H2B-Ub has been suggested to play a role in nucleosome reassembly in the 
wake of RNA Pol II passage through its functional association with the Facilitates 
Chromatin Transcription (FACT) complex. FACT is a heterodimer protein 
complex containing the subunits Spt16 and SSRP1. It is believed to enhance 
‘nucleosome breathing’, thereby stabilizing the open configuration of 
nucleosomes and facilitating RNA Pol II passage.107-109 H2B-Ub and Spt16 have 
been shown to functionally interact and affect chromatin structure through 
transcription-coupled effects in yeast.110 This functional association is most likely 
through a physical interaction between the PAF complex and both Bre1 and the 
FACT complex, although recently a direct physical interaction between Bre1 and 
the FACT complex has been reported (Figure 1.4).74, 111-113 Additionally, H2B-Ub 
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has been associated with other histone chaperones/remodelers such as CHD1, 
which has been shown to physically interact with FACT, and SWI/SNF.71, 111, 114 
 
1.3.2. H2B-Ub affects chromatin structure and stability  
It has been proposed that H2B-Ub plays a structural role to facilitate 
transcription. The identification of functional interactions between H2B-Ub and 
various histone chaperones and chromatin remodelers is indicative of this 
activity. The effect of H2B-Ub on chromatin structure and stability has been 
examined from both a direct and an indirect perspective, using well-defined 
biochemical systems and in-vivo experiments. It has been shown that H2B-Ub 
has a role in regulating nucleosome occupancy levels and nucleosomal 
positioning –which could be due to functional interactions between H2B-Ub with 
histone chaperones/remodelers- in genic regions during transcription.83 The 
presence of H2B-Ub appears to correlate with more stable nucleosomes in cell 
extracts, as both H3 and H2B histones are more easily salt-extracted from yeast 
chromatin in the absence of H2B-Ub.115 Presumably, experiments of this type 
reflect both direct and indirect effects as H2B-Ub co-occupies with many factors 
responsible for altering chromatin structure and stability.68  
 
In well-defined reconstituted systems, H2B-Ub only modestly affects 
nucleosomal stability under equilibrium conditions.116 However, H2B-Ub impedes 
Mg2+ mediated compaction of well-defined nucleosomal arrays indicating that the 
modification can intrinsically affect chromatin structure.117 Further, this property 
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was attributed to specific effects of ubiquitin as this affect on chromatin 
compaction could not be reproduced with the structurally similar ubiquitin-like 
protein, Hub1.117 It remains to be seen whether this structural property of H2B-Ub 
significantly contributes to transcriptional regulation in vivo. 
 
1.3.3. H2B-Ub directly controls H3K4 and H3K79 methylations 
Apart from intrinsic effects, H2B-Ub plays a role in transcription through the 
trans-histone cross-talk between H2B-Ub and H3 methylation. It has been shown 
that H2B-Ub is critical for both H3K4 methylation and H3K79 methylation, 
through the stimulation of the dedicated H3K4 and H3K79 methyltransferases, 
Su(var)3-9, Enhancer of zeste, and Trx 1 (Set1) and Disruptor of Telomeric 
Silencing 1 (Dot1), respectively.86, 118, 119 In vivo, H2B-Ub has been shown to be 
dispensable for both monomethylation of these lysines (H3K4me1 and 
H3K79me1), but necessary for stimulating higher methylation states.120 In vitro 
studies using chemically reconstituted mono- and polynucleosomes, 
demonstrated that H2B-Ub enhances the kinetics and efficacy of all methylation 
states of H3K4 and H3K79.86, 121 This section will focus on what is known about 
the mechanistic details of the installation of these marks in relation to H2B-Ub.  
 
1.3.3.1. H2B-Ub directly regulates H3K4 methylation 
H3K4 methylation is implicated in transcriptional regulation with H3K4 tri-
methylation being associated with the TSS of virtually all active genes.122 It is 
postulated that H3K4me3 influences transcription primarily through the 
 23 
recruitment of transcriptional co-activators (H3K4 recognition domains number in 
the 20s)44. 122, 123 Surprisingly, given the aforementioned trans-histone cross-talk, 
this localization is in stark contrast to H2B-Ub, which is primarily found within 
active gene bodies (Figure 1.5).68, 124 H3K4me3 is known to correlate with 
transcriptional rates, co-occupy with RNA Pol II and histone acetylation; all 
indicative of gene transcription.124-127 H3K4me1/2 patterns differ significantly 
between yeast and humans and, in both organisms, have been hypothesized to 
have non-overlapping functions. Indeed, these different methylation states often 
occupy discrete chromatin regions.128 For example, in humans, enhancers are 
often marked with H3K4me1 whereas as already noted H3K4me3 localizes with 
the TSS of genes. 128   
 
In yeast, the dedicated H3K4 methyltransferase ySet1 contains the canonical Set 
catalytic domain observed in all known lysine methyltransferases, except for the 
H3K79 methyltransferase, Dot1. ySet1 exists in an 8 member protein complex, 
aptly named the Complex of Proteins Associated with Set1 (COMPASS) 
(hereafter referred to as ySet1C). This complex is required for proper H3K4 
methylation activity, as ySet1 is inactive on its own. In humans, there are six 
known H3K4 methyltransferase complexes.129 Two of these complexes have 
compositions similar to ySet1C, including polypeptides similar to ySet1 (hSet1A 
and hSet1B), and are known as the human COMPASS complexes (referred to 
herein collectively as hSet1C). The four other complexes that are known to 




Figure 1.5. Localization of H2B-Ub and related histone PTMs. Gene schematic 
including promotor (light red), TSS (red), and transcribed (green) regions (top panel). 
Simplified H2B-Ub/H3K4me3/H3K79me1/2/3 occupancy patterns determined by ChIP 
seq (bottom panel).130 H3K4me3 localizes to the TSS of genes whereas both H2B-Ub 
and H3K79me1/2/3 co-localize to the gene body and are bias to the 5’ end (vertical 
axis represents relative abundance, horizontal axis represents linear DNA segment). 
 
hSet1C is thought to be the primary H3K4me3 methyltransferase in mammalian 
cells as it is generally more active and less gene-specific than the other reported 
H3K4 methyltransferases, although all have been shown to have non-redundant 
roles.131  
 
Both ySet1C and hSet1C (collectively referred to as Set1C) are associated with 
transcriptional elongation through interactions with the PAF complex.132 It has 
been hypothesized that, analogous to Rad6/Bre1, ySet1C follows RNA Pol II 
during transcriptional elongation (Figure 1.4).64 It has been postulated that Rad6 
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and Bre1 play a role in this trans-histone cross talk through the direct 
ubiquitylation of the ySet1C containing subunit, Cps35/Swd2.133 However, in vitro 
studies with homogenously prepared H2B-Ub and recombinantly prepared Set1C 
have demonstrated a direct role for H2B-Ub in H3K4 methylation in the absence 
of RNA Pol II and Rad6/Bre1. 86 Nonetheless, the mechanistic details of how 
H2B-Ub directly stimulates Set1C-mediated H3K4 methylation, including how 
Set1C reads out H2B-Ub, remains inadequately understood.  
 
1.3.3.2. H2B-Ub directly regulates H3K79 methylation  
Analogous to Set1C, H2B-Ub can directly stimulate H3K79 methylation.118 
H3K79 methylation has been linked to transcription, cell cycle regulation, DNA 
damage/repair, and development, as well as the regulation of 
heterochromatin.134-137 H3K79 has been found to exhibit all 3 methylation states 
(me1, me2, and me3) in yeast, although the existence of H3K79me3 in higher 
eukaryotes remains unclear. All H3K79 methylations correlate with actively 
transcribed regions of the genome, and in contrast to H3K4me3, co-occupy with 
H2B-Ub (~24% overlap between H3K79me3 and H2B-Ub in human embryonic 
carcinoma (NCCIT) cells) (Figure 1.5).68 H3K79me2 has been shown to exert a 
minimal impact on overall nucleosomal structure. Instead, H3K79me2 alters the 
electrostatic environment in the vicinity of H3K79me2, by adopting a distinct 
rotameric conformation, and exposing a hydrophobic cavity near H3K79me2.138 
Three chromatin modifiers have been postulated to interact with H3K79me2 
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chromatin however whether these interactions occur in vivo (or are through direct 
physical interaction) is a matter of much debate.45, 139-142 
 
H3K79 methylation is carried out solely by the methyltransferase Dot1 – note the 
human version of the enzyme is also referred to as Dot1-like (hDot1L). Knock-
down or deletion of Dot1 in human cell lines and yeast, respectively, leads to a 
loss of H3K79 methylation.130, 143 Dot1 is the only known histone lysine 
methyltransferase that contains a non-Set catalytic domain. Indeed, bioinformatic 
analysis indicates Dot1 is evolutionarily more similar to arginine 
methyltransferases.144 The crystal structures of the yDot1 and hDot1L catalytic 
domains have been solved and show a high degree of structural conservation 
(Figure 1.6a and b).145, 146 Interestingly, these crystal structures reveal a S-
adenosyl methionine (SAM), the methyl-donating co-factor, binding pocket in the 
interior of the catalytic core and a lysine binding channel that contains the H3K79 
methylation site. This is in contrast to Set domains, where SAM binds in a 
shallow pocket on the Set domain surface.129  
 
The conserved nature of the catalytic domain in the yeast and human versions of 
the enzyme notwithstanding, the two enzymes diverge in terms of their overall 
architectures and interacting partners. The yeast version of Dot1 is 582 amino 
acids in length with the catalytic domain located near the C-terminus of the 
protein (Figure 1.6a). By contrast the human enzyme is much larger, containing 
1739 amino acids, and has the catalytic domain located at the N-terminus. DNA 
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binding regions crucial to enzymatic activity have been identified in both yDot1 
and hDot1L, and localize to the N-terminus of the polypeptide and the C-terminus 
of the polypeptide, respectively (Figure 1.6a). 145 The reason for this 
rearrangement is unclear. Additional sequence motifs have been identified in the 
yeast enzyme that are required for H3K79 methylation (Figure 1.6a), namely; an 
acidic patch near the C-terminus that physically interacts with a basic patch in 
histone H4 (particularly H4 R17 and R19),121, 147 and a region spanning amino 
acids 101-140 that has been reported to physically interact with ubiquitin.148 The 
human enzyme also requires H2B-Ub and the same basic patch in H4 for its 
stimulation.121 However, the associated interaction motifs present in the yeast 
Dot1 are not conserved in hDot1L and so it remains unclear how the human 
enzyme engages ubiquitylated chromatin. 
 
Both the yeast and human Dot1 enzymes have been shown to interact with 
various other nuclear factors, besides chromatin. For instance, Cps35, a member 
of the COMPASS complex that is also ubiquitylated, has been shown to 
functionally interact with yDot1 and could serve to localize yDot1 to genic regions 
through ySet1C and the PAF complex (Figure 1.4).133 hDot1L has been shown to 
exist in protein complexes, albeit poorly characterized, that contain components 
critical in the Wnt development pathway, suggesting that in higher eukaryotes 
hDot1L plays a role in development.137, 149-151 hDot1L physically interacts with the 
phosphorylated (S2ph and S5ph) C-terminal domain (CTD) of RNA Pol II, with a 
basic region corresponding to residues 618 to 627 of hDot1L being required for  
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this interaction.130 Further, hDot1L co-localizes with RNA Pol II at TSSs, linking 
hDot1L and H3K79 methylation to transcription in humans. This led to the 
hypothesis, similar to the Csp35 example in yeast, that hDot1L follows RNA Pol II 













Figure 1.6. Comparison of yDot1 and hDot1L. (a) Schematic comparing the yDot1 
and hDot1L domain architectures. The catalytic domain (blue) is conserved between 
the two methyltransferase whereas the DNA binding domain (yellow) and the 
unstructured region it localizes to (red) is different in relation to the catalytic domain. 
(b) Crystal structure comparison of the yDot1 (purple, PBD code: 1U2Z) and hDot1L 
(gray, PBD code: 1NW3) catalytic cores show a conserved tertiary structure.  
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(Figure 1.4). Notably, the same study demonstrated that yDot1 does not interact 
with the CTD of RNA Pol Il.  
 
Importantly, biochemical studies have shown that hDot1L is capable of directly 
methylating H3K79 in the context of H2B-Ub containing nucleosomes, chromatin 
arrays, and chromatinized plasmids.118 Thus, the only strict requirement for 
H3K79 methylation by Dot1 is the presence of H2B-Ub – presumably the role of 
additional factors in vivo is to help regulate this activity in a spatial-temporal 
sense. Biochemical studies further reveal that the H2B-Ub/H3K79me crosstalk is 
intra-nucleosomal, non-cooperative i.e. one H3K79me to one H2B-Ub, and 
involves specific regions on the ubiquitin surface.117, 118, 121, 152 However, despite 
extensive biochemical study in well-defined H2B-Ub systems (discussed further 
in Chapter 3), it is still unclear how hDot1L functionally recognizes H2B-Ub. 
 
Figure 1.7. Potential mechanisms of intra-nucleosomal hDot1L regulation by 
H2B-Ub (a) In this scenario, Ub may impart an alternative nucleosome conformation 
that is required for H3K79 methylation. (b) hDot1L could additionally require H2B-Ub 
for correct postiioning on the nucleosomal surface. (c) H2B-Ub may allosterically  
regulate hDot1L as well. 
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Three non-mutually exclusive mechanistic models for how this could be achieved 
are: (i) H2B-Ub may allosterically alter the nucleosome and indirectly regulate 
H3K79 methylation, (ii) H2B-Ub could potentially directly interact with hDot1L and 
be required for correct hDot1L positioning and/or binding of the nucleosome, and 
(iii) H2B-Ub could additionally allosterically modify hDot1L leading to H3K79 
methylation (Figure 1.7). 
 
1.3.4. Role of H2B-Ub and hDot1L in cancer 
Cancer is increasingly being recognized as having an epigenetic component that 
contributes to tumor initiation and progression.31 Whole genome sequencing of 
numerous cancer cell lines has revealed persistent somatic mutations within a 
host of epigenetics regulators, including those that modulate histone PTMs.31, 153 
Given that the biochemical crosstalk between H2B-Ub and H3 lysine methylation 
is integral to both transcription and DNA damage repair, it should not be 
surprisingly then that mis-regulation of H2B-Ub and/or H3K79/H3K4me is 
intimately involved in human cancers.72 Aberrant levels of H2B-Ub have been 
shown to result from altered activities of Rad6/Bre1 and DUBs.72 This in turn 
leads to the disruption of proper chromatin function and gene expression patterns 
–specifically in proto-oncogenes- and increases genome instability; all processes 
that can lead to cancer.  
 
hDot1L has been implicated in the misregulation of chromatin resulting in mixed 
lineage leukemia.154 Specifically, 10% of childhood malignancies have been 
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attributed to translocation events of the MLL1 gene leading to the generation of 
MLL fusion proteins.129 Three of these fusion proteins, MLL-AF10, MLL-AF9, and 
MLL-ENL, interact with hDot1L and have been shown to exist in a functional 
complex with Dot1.155 hDot1L recruitment by MLL-AF10 has been shown to 
result in abnormal H3K79 methylation and to be essential –however not 
sufficient— for leukemogenesis. Aberrant H3K79 methylation leads to the mis-
regulation of HOX gene transcription, which is a hallmark of cancer. Importantly, 
inhibition of this enzyme using either knock-down or pharmacological methods 
dramatically slows disease progression in mouse leukemia models.72 
 
1.4. Semi-synthetic strategies to make histone PTMs  
Analysis of ubiquitylated chromatin in biochemically homogenous systems is 
critical to elucidate the role that histone ubiquitylation plays in chromatin biology. 
Although the purification of endogenous ubiquitylated histones is possible, it 
results in heterogeneous substrates (i.e. the isolated ubiquitylated histones will 
contain additional PTMs) obfuscating biochemical analysis.60, 156 Enzymatic 
ubiquitylation is also feasible, and has been demonstrated for H2BK34, 
H2BK120, and H2AK119.86, 157 However, this approach requires the isolation of 
the cognate E2/E3 enzymes and results in rather inefficient ubiquitylation. Due to 
the many shortcomings of the aforementioned methods, chemical methods for 
the incorporation of post-translationally modified histones have gained much 
traction in the last decade. The main advantage of chemical synthesis is 
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homogenous substrate preparation, thereby allowing for the precise biochemical 
analysis of both chromatin structure and function. 
 
1.4.1. Expressed protein ligation 
One invaluable method to generate histones containing specific PTMs is 
expressed protein ligation (EPL). This semi-synthesis strategy is based on native 
chemical ligation (NCL) but employs recombinant production of one or more of 
the polypeptides, making the synthesis of full-length proteins, such as histones, 
tractable. In this section, both NCL and EPL will be discussed and their 
applications to the preparation of chemically defined PTM-modified chromatin 
substrates, in particular ubiquitylation, will be explored.  
 
Solid-phase peptide synthesis (SPPS) has been employed to study histone 
acetylation as early as the 1970’s.158 In an early landmark study, the specificity of 
deacetylase enzymes, which are responsible for removing histone acetylation 
marks, was investigated with chemically synthesized peptides containing acetyl 
lysine.158 This peptide strategy has been applied to other histone PTMs where 
the PTM-containing amino acid derivative is chemically accessible, i.e. lysine 
acetylation, lysine methylation, serine/threonine/tyrosine phosphorylation etc.159 
Indeed, this approach has been taken to the point where combinatorial libraries 
of modified histone peptides have been generated and used to probe a number 
of biochemical questions such as the binding specificities of various chromatin 
modifiers.160 Although histone-derived peptides have proven useful, they have 
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obvious shortcomings when the process in question requires a more 
physiologically relevant substrate. For example, biochemical crosstalk pathways, 
such as the H2B-Ub – H3 methylation examples discussed above, can only be 
probed using nucleosome substrates.118 Thus, considerable efforts in recent 
years have focused on the generation of modified full-length histones and their 
subsequent reconstitution into physiologically relevant chromatin fragments. 
 
Arguably the most powerful route to modified histones employs the related NCL 
and EPL methods. Here, the target protein is assembled from a series of 
fragments, some of which contain the PTM of interest. NCL relies on the 
condensation in water of a peptide bearing a C-terminal thioester with a second 
peptide containing an N-terminal 1,2-amino thiol moiety (i.e. cysteine), resulting 
in a native peptide bond between the two peptides (Figure 1.8).161 If necessary 
this process can be conducted in an iterative fashion until the complete protein is 
assembled. When all the fragments are synthetic in origin the process is referred 
to as NCL (i.e. total synthesis), whereas when one or other of these building 
blocks is a recombinant polypeptide, the process is termed EPL (semi-
synthesis).162 Operationally, EPL is well suited to generating modified histones 
since many of the PTMs are located close to the N- or C-termini of the proteins. 
Thus, the target histone can be assembled from a suitable modified, typically 
short synthetic peptide and a longer recombinant fragment (Figure 1.8).162 
Histone ligation sites are typically chosen to be adjacent to an alanine residue so 





































































































































































































Figure 1.8. EPL applied to the semi-synthesis of histones. (a) The use of inteins 
affords a histone C-terminal thioester upon thiolysis with a small-molecule thiol (R-
SH). Histone PTMs are incorporated into a N-terminal cysteine-containing peptide via 
SPPS. Ligation of the peptide containing the desired PTM (hexagon) and recombinant 
histone thioester via NCL produces the native PTM-containing histone upon 
desulfurization of the cysteine used for ligation resulting in an native alanine at the 
ligation site. (b) Conversely a N-terminal cysteine containing recombinant histone 
fragment can be produced by proteoltic processing and ligated with a PTM-containing 
(star) synthetic peptide thioester. Subsequent desulfurization results in a native N-




histones) of the initial EPL produced construct results in the native histone with 
the PTM (or PTMs) of interest. In other words the entire process is traceless. 
Additional methods have also been developed to make internal PTMs accessible 
by using multi-piece ligation strategies.163 EPL has been applied to study histone 
PTMs and modified histones in many different contexts.159  
 
A key feature of the EPL technology is the use of autoprocessing proteins known 
as inteins that are involved in a protein editing process known protein splicing.162 
A detailed understanding of the mechanism of intein-mediated protein splicing 
has allowed the rational design of engineered inteins that can be used to install a 
C-terminal thioester into essentially any recombinant protein. Operationally, an 
intein fusion protein is expressed in a suitable cell host and, following purification, 
is exposed to a small molecule thiol to afford the desired protein thioester 
derivative, which can then be utilized for semi-synthesis (Figure 1.8a). 
Furthermore, a subset of inteins are naturally split and conduct splicing in trans 
and have proven more efficient for the generation of protein thioesters.164 
Accordingly, many inteins have been characterized and utilized for the 
generation of proteins containing C-terminal thioesters.165  
 
The first semi-synthesis of H2B-Ub employed the use of a three-piece EPL 
strategy (Figure 1.9a and b).118, 166 In this strategy, the peptide corresponding to 
H2B(117-125) was synthesized with a photolytically removable ligation auxiliary 
at H2BK120. Two recombinant thioester fragments, an Ub(1-75)-thioester and an  
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Figure 1.9. Semi-synthesis of ubiquitylated histones. (a) Schmatic of the 
preparation of ubiquitin. For EPL-based approaches Ub is prepared as a C-terminal 
thioester through the use of inteins followed by thiolysis with a small-molecule alkyl or 
aryl thiol (right panel). For disulfide conjugated ubiquitylation, aminoethanethiol is 
used for intien thiolysis (left panel). Aminoethanethiol subsequently undergoes a 
spontanous N to S acyl shift resulting in a C-terminal thiol. (b) Retrosynthetic analysis 
of the preparation of ubiquitylation histones using EPL. The larger histone fragement 
(grey) is prepared recombantly through the use of inteins and the peptide (blue) is 
synthesized by SPPS. R = CH2CH2SO3H; R’= CH2CH2CH2C(O)NH2CH3; R” = CH3 (c) 
Retrosynthetic analysis of the preparation of ubiquitylation histones using amber 
codon supression. The full-length histone (grey) is prepared recombinantly through 
amber codon suppression. R = CH2CH2SO3H (d) Retrosynthetic analysis of the 
preparation of ubiquitylation histones using asymeteric disulfide chemistry. A histone 
containing a cysteine mutation (grey) is recombnantly prepared, and subsquently 







H2B(1-116)-thioester, were prepared through thiolysis of the corresponding intein 
fusions. The Ub(1-75) thioester fragment was first ligated to the K120 position 
within the H2B(117-125) peptide and following photolytic removal of the ligation 
auxiliary and a cysteine protecting group, this intermediate was subsequently 
ligated to the H2B(1-116) thioester. This yielded native H2B-Ub upon 
desulfurization (Figure 1.9b and Figure 1.10a). The second generation EPL 
approach expedited the ligation of ubiquitin to the H2B(117-125) peptide in 
exchange for an UbG76A mutation upon desulfurization (Figure 1.10b).121 This 








































Figure 1.10. Comparison of H2B-Ub ligation junctions. (a) The native iso-peptide 
linkage between the ε-NH2 lysine and ubiquitin produced from the photo-auxiliary EPL 
synthesis. (b) A UbG76A mutation results when using an EPL approach that greatly 
expedites the synthesis of H2B-Ub (or an amber codon suppresion approach). (c) The 
ligation junction between H2B and Ub results in a disulfide bond when Ub-SH is ligated 
to H2BK120C. 
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homogeneous H2B-Ub. Variants of this semi-synthetic route have subsequently 
appeared in the literature, involving the use of different lysine analogs for the 
ubiquitin ligation step, as well as N-methylation of the isopeptide bond between 
ubiquitin and its substrate to prevent deubiquitylation in vivo.167-169  
 
1.4.2. Unnatural Amino Acid Mutagenesis 
Ribosomal methods for incorporating PTMs into histones site-specifically have 
also been reported.170, 171 This approach relies on the expansion of the genetic 
code by the appropriation of the amber stop codon (UAG) to insert an unnatural 
amino acid, such as an amino acid containing a PTM, during mRNA translation. 
The type of amino acid inserted is achieved using ‘orthogonal’ aminoacyl-tRNA 
synthetase-tRNA pairs that naturally, or have been evolved to, recognize the 
unnatural amino acid. This so-called ‘amber-suppression’ method has been 
employed to incorporate PTMs such as phosphorylation, acetylation, and 
methylation into recombinant histones.170, 172  
 
Although this method is not well suited for the direct incorporation of ubiquitin into 
a protein, strategies have been developed to incorporate amino acid analogs to 
facilitate EPL-based ubiquitylation through subsequent steps.173, 174 Specifically, 
thia-lysine analogs, containing a 1,2 amino thiol side chain, that are recognized 
by ‘orthogonal’ aminoacyl-tRNA synthetase-tRNA pairs can be incorporated into 
proteins, and subsequently ubiquitylated (Figure 1.9c and Figure 1.10b). This 
method alleviates the need for a multi-piece ligation as the full-length amino thiol-
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handle containing protein is recombinantly prepared. However, the yields of 
recombinant protein obtained by this amber-suppression method can be quite 
low compared to the semisynthetic method. Thus this method may be best suited 
for histone ubiquitylations that occur in the middle of the histone, and that are 
thus more difficult to obtain by semi-synthesis. 
 
1.4.3. Cysteine derivatization as a route to histone PTMs 
The derivatization of cysteine has been used to incorporate many PTM analogs 
into proteins including: glycosylation, prenylation, lysine methylation, 
ubiquitylation, and lysine acetylation.159 The chemical alkylation of cysteine 
containing histones was first demonstrated in the semi-synthesis of H3 and H4 
containing methyl lysine analogs.175 These methyl-lysine analogs could be read 
out by site-specific methyl lysine antibodies, as demonstrated for H3K9me1/2/3, 
H3K4me3, H3K79me2 and H4K20me3. Additionally it was shown that the 
chromatin structural protein, HP1, bound to an H3K9me2 methyl lysine analog 
containing histone similar to the native H3K9me2. Lysine acetylation, such as on 
H4K16, has also been mimicked using cysteine chemistry.176, 177 The H4K16ac 
analog was shown to be recognized by an anti-H4K16ac antibody and, when 
incorporated into nucleosomal arrays, displayed the expected chromatin 
decompaction behavior previously ascribed to the native modification.176  
 
Cysteine derivatization for the preparation of ubiquitylated histone proteins has 
also been reported.152, 178 This employs the use of disulfide chemistry and results 
in a non-native disulfide linkage between ubiquitin and its substrate. Specifically, 
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the linkage is 1 atom longer (~2.4 Å) when compared to the native iso-peptide 
linkage (Figure 1.10c). An intein-fusion strategy is used to generate a ubiquitin 
derivative containing a C-terminal thiol group, via thiolysis of the ubiquitin-intein 
construct with aminoethanethiol (Figure 1.9a).152, 178 This Ub-thiol derivative was 
then attached to a unique cysteine within the target protein, e.g. H2B bearing a 
K120C mutation, via a nucleophilic disulfide exchange reaction (Figure 1.9d).152 
178 Importantly, although the disulfide approach generates a non-native linkage 
that is slightly longer than the normal isopeptide bond, the resulting H2BssUb 
conjugate was found to be indistinguishable from the native H2B-Ub in terms of 
hDot1L stimulation.152 Thus, this simple route to ubiquitylated histones offers 
great promise in teasing apart the function of Ub in chromatin regulation. Indeed, 
this disulfide strategy has recently been used to install ubiquitin at H2AK15 
allowing for the determination that the DNA damage protein 53PB1 recognizes 
H2BK15-Ub through the hydrophobic patch on ubiquitin (I44).179  
 
 
1.5. Summary and conclusions 
Gene regulation is a multifaceted process that has been fine-tuned so as to rely 
on the integration of multiple genetic and epigenetic factors. The identification of 
histone PTMs as fundamental to this regulation necessitates a thorough 
investigation of the mechanisms by which they function. H2B-Ub is one such 
modification that has been identified in many major chromatin associated 
processes and is biomedically relevant.  Although semi-synthetic methods have 
allowed progress to be made in understanding the mechanistic details of H2B-
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Ub-related processes, many questions remain unanswered, particularly with 
respect to how H2B-Ub is being recognized in these processes.  
 
My thesis will focus on elucidation of the critical determinants governing Dot1 
recognition of Ub and apply what is learned from this study to ySet1C regulation 
and chromatin compaction. In Chapter 2, we will first explore a more efficient Ub 
ligation methodology to expedite the study of the H2B-Ub modification. With this 
improved methodology we will then investigate the structure activity relationship 
between hDot1L and H2B-Ub in Chapter 3, with a more detailed analysis of our 
results in Chapter 4. In Chapter 5, we will attempt to complement these 
mutagenesis studies from a structural perspective both in a nucleosomal and 
nucleosomal array context. Further, in Chapter 6 we will extend our findings to 
both ySet1 and yDot1. This thesis is rooted in the belief that, similar to the 
histone code, the molecular mechanistic contributions of individual histone PTMs 
can be discerned in well-defined systems and integrated into the biological 
framework in which they function. In the discussion I will put the findings of my 
thesis into a more biological context, as well as look forward to what lies ahead in 
the fascinating world of histone PTMs. 
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Chapter 2. Site-specific chemical ubiquitylation of the 
mononucleosome via an asymmetric disulfide approach 
 
2.1. Introduction 
Histone ubiquitylation has been implicated in multiple different chromatin-
templated processes.64, 71, 72 Although proteome-wide approaches have been 
invaluable in the identification of histone ubiquitylation sites and their associated 
interactome, in vitro studies with homogenously prepared substrates are crucial 
for the further characterization of ubiquitylated protein–protein interactions.58 This 
presents a significant challenge for synthetic chemists as a thorough 
investigation not only requires the synthesis of the ubiquitylated histone, but also 
ideally involves the synthesis of many ubiquitylated histone mutants in order to 
explore attendant structure-activity relationships (SAR).  
 
Over the past six years, semi-synthetic strategies for the homogenous 
preparation of site-specific ubiquitylated histones, has enabled the study of these 
modified histones in well-defined systems.118, 121, 152 Methodologies include the 
preparation of ubiquitylated histones containing a native isopeptide linkage as 
well as methodologies that introduce non-native linkages near the Ub ligation 
junction (see section 1.4 for a more detailed discussion) (Figure 1.10). The latter 
strategies circumvent the complexity of the first reported synthesis, as well as 
facilitate the preparation of ubiquitylated histones at internal sites. This has  
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Figure 2.1. Preparation of H2BssUb MNs from act-MNs. Scheme of the Ub-SH act-
MN ligation strategy. Site-specific ligation of Ub directly to the MN is achieved upon 
addition of Ub-SH (unmodified Ub shown in green, PDB 1UBQ3) to the act-MN (left 
panel) (wild-type MN shown, PDB 3LZ0). The H2B-Ub MN is modeled as a composite 
of Ub and MN structures (right panel). H2A (yellow), H2B (red), H3 (blue), H4 (green) 
are shown.  Insets: close-up of the act-MN and H2BssUb modifications. Note as each 
act-MN contains 2 copies of H2B-TNB the act-MN can be di-ubiquitylated. 
 
served to expedite the synthetic preparation of ubiquitylated histones as a trade 
off for non-native, but biochemically suitable, substrates.121, 152 However, despite 
these improvements, all synthetic routes to date for histone ubiquitylation involve 
multistep protocols and are performed at the histone level, taking weeks to 
prepare a single ubiquitylated construct. Further, once synthesized, these 
ubiquitylated constructs must be incorporated into mononucleosomes (MNs) 




We were motivated to develop a flexible strategy that would allow for the 
incorporation of Ub and Ub variants in a fast and facile way to enable SAR 
studies of the Ub surface in the context of H2BK120 ubiquitylation (H2B-Ub). In 
order to expedite the overall synthesis of H2B-Ub MNs and significantly reduce 
the amount of precious materials needed for reconstitution, we decided to test a 
strategy where H2B is ubiquitylated subsequent to the incorporation into MN 
substrates. We hypothesized that the site-specific ubiquitylation of H2B could be 
achieved within the context of the MN based on an asymmetric disulfide strategy 
that results in an Ub linkage to H2BK120C through a disulfide bond (H2BssUb) 
(Figure 2.1, Figure 1.10c). In this strategy, we envisioned the preparation of an 
activated MN (act-MN) that contains a cysteine activated with 5-thio-2-nitro-
benzoic acid (TNB) –in this case at H2BK120C (H2B-TNB). Upon addition of an 
Ub engineered with a C-terminal thiol (Ub-SH), this act-MN would undergo 
ubiquitylation to produce H2BssUb MNs (Figure 2.1).  
 
2.2.  The preparation of Ub-SH using ultra-fast splicing inteins 
Our laboratory previously reported a strategy for the preparation of Ub-SH for 
use in the site-specific ligation to histones activated with DTNP (see section 1.4.3 
for more details).152 In this strategy, Ub was cloned into the commercially 
available pTBX1 vector that contained the GyrA intein followed by a Chitin 
Binding domain (CBD). Following affinity purification on chitin beads, thiolysis 
with aminoethanethiol afforded the desired Ub-SH protein. Similar to the original 
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synthesis of H2B-Ub, this method was both low-yielding (2mg/L expression) and 
the preparation was on the time scale of weeks due to inefficient thiolysis and a 
time consuming purification procedure. Thus, we sought to take advantage of the 
newly characterized ultra-fast splicing inteins as well as the use of a 6xHis tag for 
greatly expedited protein affinity purification.165   
 
A plasmid containing residues 1-75 of Ub (i.e. lacking the final glycine of the 
native protein) followed by the ultrafast fused-Npu intein and a 6xHis tag (Ub-
Npu-His) was generated and expression of this fusion was optimized in E. coli 
BL21 cells. Additional optimization of both the affinity purification and subsequent 
thiolysis (with aminoethanethiol) steps was carried out, ultimately yielding Ub-SH 
in substantially improved amounts relative to the prior procedure (20 mg versus 2 
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Figure 2.2. Characterization of Ub-SH prepared via an Ub-NPU-His construct (a) 
C18 analytical RP-HPLC chromatogram of purified Ub-SH. (b) ESI-MS of purified Ub-
SH.  
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shortened to a few days from weeks due to these improvements in the 
purification and thiolysis steps. For example, the thiolysis step using the fused-
Npu intein was complete in 5 hours compared to incomplete thiolysis after 4 days 
with the GyrA intein. Using this improved procedure, Ub-SH was expressed, 
purified and lyophilized prior to use. The purity of Ub-SH was confirmed by 
Reversed Phase High-Performance Liquid Chromatography (RP-HPLC) and 
Electrospray Ionization Mass Spectrometry (ESI-MS) (Figure 2.2). 
 
2.3. Preparation of an activated H2BK120C MN  
We were next interested to see if we could prepare a MN containing the single 
lysine to cysteine mutant (H2BK120C) activated with TNB to yield an act-MN 
(Figure 2.3). Cysteine activation with 5,5'-dithiobis-(2-nitrobenzoic acid) (Di-TNB) 
has been reported, under non-denaturing conditions, which is why we pursued 
this strategy as opposed to what was previously employed to activate H2BK120C 
at the histone level.178 Further, we designed our protocol to include the activation 
step after histone octamer formation. The rationale behind this was to allow the 
H2BK120C-containing octamer to be prepared under reducing conditions to 
prevent the formation of H2B disulfide-linked dimers during the octamer 
reconstitution process. Moreover, this strategy would allow unreacted Di-TNB (or 
reacted TNB) to be removed concurrent upon dialysis of the modified octamers 
with DNA to form act-MNs, thus streamlining the process.  
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The desired H2BK120C containing histone octamer was reconstituted under 
reducing conditions, following dialysis of the purified recombinant core histones 
from a 7M Guanidine HCl containing buffer into a high salt buffer.180 Importantly, 
in order to achieve site specificity within the MN, H2BK120C was the only 
cysteine in any of the four histones employed in this study. As the only naturally 
occurring cysteine found within the four canonical core histones is H3C110, we 
used a H3C110S histone point mutant. H3C110 has been mutated previously in 
H2BssUb MNs without any adverse effects.152 More specifically, this amino acid 
residue is found in the globular octamer histone core and both a H3C110S and 































































Figure 2.3. The activiation of H2BK120C with Di-TNB. H2BK120C is activated in the 
presence of Di-TNB through a thiol exchange of cysteine with TNB (left panel). This 




Size exclusion chromatography was employed for purification of the octamer and 
was performed under non-reducing conditions. This ensured removal of the 
reducing agents used in the octamer assembly. The H2BK120C octamer was 
then concentrated and a Di-TNB containing buffer was added 1:1 to activate the 
octamer. Note, this protocol ensured that Di-TNB was present in large molar 
excess (10 mM) compared to the octamer (10-100 µM). Reaction progression 
could be visualized photometrically as Di-TNB reacts with free thiol to yield TNB, 
which has a strong absorbance at 412 nm (Figure 2.3). By this measure, the 
disulfide exchange reaction to yield the H2B-TNB containing histone octamer 
was deemed to be complete after 10 minutes. Act-MNs were then formed via the 
standard semi-gradual dialysis approach, where the ‘601’ strong positioning 153 
bp DNA sequence (601 DNA) was mixed with the H2B-TNB containing histone 
octamer and dialyzed from a high salt buffer into a low salt buffer. Act-MN 
formation was analyzed via native polyacrylamide gel electrophoresis (PAGE) 
followed by ethidium bromide staining to ensure properly formed MNs (vida 
infra). 
 
2.4. Ligation of Ub-SH to the act- MN  
We then proceeded to test whether the act-MNs were accessible to ligation with 
Ub-SH. The ligation reactions were performed at 55oC in order to enhance the 
kinetics of the conjugation. This temperature (for up to 3 hours) is commonly 
applied to MNs to correctly shift MN DNA to a homogenous position with respect 
to the octamer core.180 Further, to allow for small volumes, parallel sample 
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preparation (vide infra), and homogenous ligation conditions, we decided to 
optimize our reaction using PCR tubes in a PCR machine using a 20-fold excess 
of Ub-SH. 
 
Addition of Ub-SH to the act-MNs resulted in H2BssUb MNs as observed via gel 
shift by sodium dodecyl sulfate (SDS) PAGE followed by Coomassie staining and 
confirmed by mass spectrometry (Figure 2.4 a and b, respectively). A time 
course of this ligation was monitored via native PAGE followed by ethidium 
bromide staining (Figure 2.5a).  A mix of non-modified (non), mono-ubiquitylated 
(mono) and di-ubiquitylated (di) containing MNs were observed after one hour of 
ligation as each MN contains two copies of each histone (Figure 2.5a). These will 
 
Figure 2.4. SDS-PAGE analysis and mass spectrometry of H2BssUb after 
addition of Ub-SH to act-MNs. (a) SDS-PAGE gel of act-MNs before and after 
addition of Ub-SH visualized by coomassie staining. The appearance of a band that 
runs at the molecular weight of H2BssUb is present when Ub-SH is added to act-MNs 
(lane 3). (b) ESI-MS of purified H2BssUb after ligation to act- MNs.  
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be collectively referred to as Ub-SH act-MNs to indicate both the ~20-fold excess 
of Ub-SH present in trans and the heterogeneity of Ub modification (this is will be 
critical to differentiate H2BssUb prepared via on-nucleosomal ligations (Ub-SH 
act-MNs) to that of homogenously reconstituted H2BssUb MNs).  
 
Native PAGE gel bands (either non, mono, or di-Ub species) stained with 
ethidium bromide were quantified. Ub-SH act-MN gel bands were normalized to 
the total amount of Ub-SH act-MN (at the time of 60 min) to determine the 
absolute amount of each ubiquitylated species. This resulted in the calculation of 
the abundance of each type of MN (Ax, where x = non, mono, di) to the total 
amount of Ub-SH act-MN after 60 min: 
 
Anon = non/total60 , Amono = mono/total60 , Adi = di/total60 
 
Where non, mono, di = quantification of the respective gel band; 
total60 = non + mono + di at the time = 60 Ub-SH time point 
 
Note that the Ax value is normalized to the absolute abundance relative to Ub-SH 
act-MNs at T = 60 min and is thus a good way to compare ligations between 
samples. Further, the total abundance of H2BssUb MNs can be calculated by  
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Figure 2.5. Time course analysis of the Ub-SH act-MN conjugation reaction.  (a) 
Ub-SH act-MN ligations were monitored via native PAGE followed by ethidium bromide 
staining over the course of 1 hour. (b) The progress of the Ub-SH act-MN ligations was 
monitored by quantification of the gel bands in panel a using image J software. A 
stacked quantification of all three species (di, mono, non) is shown, relative to total MN 
abundance at t = 60 minutes (blue, yellow, and gray). The total H2BssUb abundance 
(green dotted line) is calculated to take into account that the mono-ubiquitylated MNs 
contains one copy of H2BK120C and one copy of H2BssUb. The reaction progressed to 
about 70% completion (total H2BssUb) over the course of 1 hour resulting in a mix of 





taking into account that the mono species contained one copy of H2BK120C and 
one copy of H2BssUb per MN: 
 
Total H2BssUb = Adi + (0.5 x Amono) 
 
Quantification of the time course revealed that the reaction went to 70% 
completion (total H2BssUb) resulting in approximately an equimolar ratio of di-
ubiquitylated to mono-ubiquitylated MNs (Amono and Adi values), as each MN 
contains two copies of H2B (Figure 2.5b). Under the reaction conditions, the 
reaction appeared to not progress any further after 1 hour and thus all further 
ligations –and quantifications- were performed at 1 hour.  
 
2.5. Note about terminology used throughout this thesis  
In an effort to simplify nomenclature, while remaining informative, we have 
adopted terminology to account for both the type of H2B-Ub ligation as well as 
whether the ligations were performed on the histone or MN level. The semi-
synthetic method utilized for ubiquitylation will be annotated by the use of H2B-
Ub and H2BssUb, which respectively indicates ubiquitylation via an EPL approach 
(that results in an UbG76A mutation), or an asymmetric disulfide approach 
(Figure 1.10b and c, respectively). The MN denotation will be directly preceded 
by either modified histones, e.g. H2B-Ub MN, or when necessary, to prevent 
ambiguity, unmodified histones, e.g. H2B MN to delineate what type of MN is 
being discussed and to indicate the homogeneity of the MN. Histone and MNs 
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will further be annotated to include species i.e. Xenopus laevis, Drosophila 
melanogaster, Saccharomyces cerevisiae, when appropriate e.g. xH2B, dH2B, 
yH2B respectively. Lastly, in the case of on-nucleosomal ubiquitylations, which 
results in heterogeneous MNs, Ub (or Ub variants) will be included for 
clarification and the MNs will be referred to as act-MNs, e.g. Ub-SH act-MNs. 
This will serve to further underscore that these MNs mixtures also contain a ~20-
fold excess of Ub-SH. All non-annotated substrates will assume the H2BK120 (or 
K120C) site of ubiquitylation and xMNs.  
 
2.6. hDot1L activity is stimulated by Ub-SH act-MNs 
Ultimately, we were interested in utilizing act-MNs to facilitate a SAR study of the 
Ub surface in regard to hDot1L activity. Consequently, it was critical to show that 
Ub-SH act-MNs were able to stimulate hDot1L activity similarly to those 
generated by previous reconstitution methods after histone ubiquitylation, i.e. 
H2BssUb MNs. Previous studies demonstrated that the presence of Ub in trans 
neither upregulated hDot1L activity towards H2B MNs or titrated hDot1L activity 
away from H2B-Ub MNs.118 Further, an analysis of MNs with different intra-
nucleosomal ratios of H2B-Ub to H2B revealed a lack of cooperatively within the 
MN for H2B-Ub stimulation of hDot1L-mediated H3K79 methylation (discussed in 
more detail in section 1.3.3.2).121 Accordingly, we reasoned hDot1L 
methyltransferase assays could be performed on Ub-SH act-MNs without further 






         
Figure 2.6. hDot1L methyltransferase assays on both act-MNs and MNs with Ub 
in cis and in trans. (a)  Coomassie stained SDS PAGE gel showing hDot1L(1-416) 
purified from BL21 cells. (b) 3H-SAM methyltransferase assays were performed on 
H2B MNs (lanes 1-3), H2BssUb MNs (lanes 4 and 6), and act-MNs (lanes 5 and 7) in 
the presence or absence of TNB or Ub-SH in trans (as indicated in panel b). MNs 
were visualized by native-PAGE followed by Sybr Gold staining (top panel), and 3H-
methyl incorporation was probed by fluorography (bottom panel). (c) Quantification of 
3H-methyl incorperation was performed by filter binding assays followed by liquid 
scintillation counting. 3H-methylation was observed in samples where Ub was present 
in the reaction in cis (Panels (b) and (c), lanes 4, 6, 7) and no additional stimulation 
was observed when Ub was added in trans (middle and bottom panels lane 4 versus 
lane 6). Error bars, s.e.m. (n = 3).  
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We chose to test the activity of hDot1L towards Ub-SH act-MNs and compare it 
to fully reconstituted H2BssUb MN substrates. Specifically, the catalytic domain of 
the H3K79 methyltransferase, hDot1L(1-416) (referred to herein as hDot1L), was 
utilized (Figure 2.6a). Using 3H-labeled S-Adenosyl-L-methionine (SAM) in the 
hDot1L methyltransferase assay, we found Ub-SH act-MN were able to activate 
hDot1L-mediated H3K79 methylation, and showed an expected 1:1 ratio of H2B-
Ub to H3K79 methylation as evidenced by the 2-fold difference in fluorography 
between the di-ubiquitylated and mono-ubiquitylated MNs species (Figure 2.6a, 
middle panel lane 7). No methylation was observed on non-modified act-MNs 
(Figure 2.6a and b, lane 5). Neither the presence of TNB in cis, i.e. H2B-TNB, 
nor Di-TNB/TNB in trans affected hDot1L-mediated H3K79 methylation, 
indicative of the null effect of TNB toward hDot1L activity (Figure 2.6a and b, 
lanes 2 and 5). Importantly, and consistent with previous reports, Ub-SH in trans 
did not affect hDot1L activity toward H2B MN or H2BssUb MNs either in the same 
reaction i.e. Ub-SH act-MNs, or in homogenously prepared i.e. H2B MNs and 
H2BssUb MNs samples (Figure 2.6a and b, lanes 3, 4 and 7). 
 
Moreover, to ensure the methylation reaction did not reach saturation on the time 
scale we were interested in, we performed a time course (Figure 2.7). We found 
that a time point of 15 min was optimal for our methyltransferase assays, i.e. the 
reaction had progressed significantly (and so could be easily monitored) but was 
far below saturation allowing meaningful comparisons to be made. We also 




    
Figure 2.7. hDot1L methyltransferase assays on MNs with Ub made from on-
nucleosomal ligations and on-histone reconstitutions. 3H-SAM methyltransferase 
assays were performed on H2B MNs (grey line, triangle), and H2BssUb MNs made 
either by on-histone reconstitution methods (H2BssUb, green line, square) or on-
nucleosomal ligations (Ub-SH act-MN, green dashed line, diamond). Quantification of 
methylation was performed by filter binding assays followed by liquid scintillation 
counting. By taking into account the extent of H2BssUb in Ub-SH act-MNs, a fully 
100% H2BssUb stimulation curve was estimated (thick green line). Error bars, s.e.m (n 





and estimated the amount of scintillation counts expected if these MNs contained 
100% H2BssUb (Figure 2.7, thick green line). This estimation was similar to the 
activity of hDot1L on H2BssUb MNs. Collectively, these assays demonstrated that 
Ub-SH act-MNs were substrates for hDot1L-mediated methylation and could be 
used to further probe this trans-histone pathway. 
 
2.7. Adaptability to other ubiquitylation sites on the MN  
An attractive feature of our strategy is that it should be easily adaptable to any 
accessible ubiquitylation site on the MN surface via the preparation of a cysteine 
mutant histone and its subsequent incorporation into an act-MN. This 
circumvents the need to design completely new ligation junctions and multiple 
histone expression constructs typical for the preparation of a new protein via EPL 
semi-synthesis.  
 
To test this concept we generated 4 different act-MNs containing the cysteine 
mutant histones (H2AK119C, H2BK116C, H2BK108C, and H3K79C) to compare 
to the H2BK120C act-MN ligation with Ub-SH. All ligation sites we employed are 
annotated sites of ubiquitylation in human histones, and map to different regions 
on the MN surface (Figure 2.8a).58 Upon Ub-SH ligation, it was apparent that all 
of these act-MNs were capable of being ubiquitylated although to different 
extents. H2BK116C, H2BK120C and H3K79C act-MNs showed comparable Ub-
SH ligation comprising 50-60% of total ligation sites (Figure 2.8a, lanes 3, 5 and 
6). H2BK108C and H2AK119C ligated to a lesser degree, 30% and 20% 
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respectively (Figure 2.8, lanes 2 and 4). Nonetheless, this ligation method 
worked for the attachment of Ub-SH to other regions of the act-MN surface and 
hence may be of practical use for accessing other histone ubiquitylations in a 
rapid, high throughput manner.  
 
Figure 2.8. Direct Ub-SH ligations to other single cysteine histone mutants after 
incorporation into nucleosomes.  Ub-SH was ligated to act-MN prepared with single 
cysteine histone mutants. (a) Histone cysteine ligate sites mapped to the MN surface (PDB 
3LZ0. (b) Act-MNs were visualized by native-PAGE followed by ethiduim bromide staining 
(top panel). Ub-SH act-MNs ubiquitylated species were quantified by normalizing the 
absolute amount of each species to the total amount observed for H2BK120C (bottom 
panel). The extent of the reaction was dependent on the ligation site, however all Ub-SH 




2.8. Summary and conclusions 
In this chapter we explored the use of site-specific asymmetric disulfide 
exchange as an approach to ubiquitylate pre-assembled MNs containing a TNB 
activated cysteine, where the TNB activation is performed on the octamer level. 
The approach is compatible with nucleosomal reconstitution protocols, and 
achieves regioselectivity by exploiting the ability to introduce a unique cysteine 
residue into recombinant chromatin. While several methods for the preparation of 
H2B-Ub substrates have already been described, the method described here is 
simple, fast and can potentially be used to study other histone ubiquitylations and 
their associated functions in a high throughput manner. As this method relies on 
the late stage diversification of the Ub substrate, systematic structure-activity 
analysis of the system becomes tractable, which is the focus of the next chapter.  
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Chapter 3. A 13-member ubiquitin alanine mutant library to 




The rapid synthesis of H2BssUb through the ligation of Ub-SH to act-MNs lends 
itself to SAR studies of the Ub surface in relation to H2B-Ub processes. In our 
initial validation of this technique, we tested the stimulation of hDot1L-mediated 
H3K79 methylation in the context of Ub-SH act-MNs. This showed that on-
nucleosome ligations are amenable to hDot1L methyltransferase assays and the 
stimulation of hDot1L activity is directly attributed to the formation of H2BssUb 
within the Ub-SH act-MN ligation mixtures. In this chapter we utilize Ub-SH act-
MN ligations combined with the creation of an Ub alanine mutant library for a 
comprehensive alanine scan of the ubiquitin surface to identify functional 
residues in hDot1L-mediated H3K79 methylation. 
 
Compared to smaller PTMs such as acetylation and methylation, Ub is 
‘information rich’ in that it alters the steric and electrostatic properties around its 
attachment site, as well as presenting a large surface area for the recruitment of 
binding factors. At 8.5 kDa, Ub is nearly as large as the histone to which it is 
linked (13.8 kDa in the case of H2B), increasing the MN surface by as much as 







Figure 3.1. Design of the ubiquitin surface mutant library. (a) Ubiquitin and 
Ubl sequence alignment. Ubiquitin, Nedd8, Hub1 and Smt3 were aligned using 
the Lalign multiple sequence server. Similar residues shared between all Ubl’s 
and ubiquitin are highlighted in red. Conserved residues between only ubiquitin 
and Nedd8 are outline in a green dashed box. The surface residues in ubiquitin 
that were mutated to alanine are shaded. The colors, and the numbers above, 
indicate the groupings in the 13 surface mutants. (b) Visual representation of the 
ubiquitin surface mutants mapped on to the ubiquitin structure (PDB 1UBQ3) in 
their respective color. Homologous regions between ubiquitin and Nedd8, but not 




Table 3.1 Alanine ubiquitin mutants. All alanine mutants are shown and colored as 
in Figure 3.1. Alanine mutations are bolded in each respective mutant.  
 
 
including the ubiquitylation of H2AK15, have revealed a canonical binding 
hotspot on ubiquitin involving a hydrophobic patch centered on L8/I44,53, 179 
however additional interaction surfaces, albeit not in a chromatin context, have 
been extensively characterized.182, 183  
 
Previously, using EPL synthesized H2B-Ub reconstituted into H2B-Ub MNs, it 
was shown that the mutation of the canonical hydrophobic patch in ubiquitin 
(L8/I44) to alanine did not affect hDot1L stimulation.121 A complementary study, 
using disulfide linked H2BssUb reconstituted MNs and involving the attachment of 
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ubiquitin like proteins (Ubls) to H2BK120C, revealed that ubiquitin functions in a 
residue specific manner.121, 152 Nedd8 stimulated hDot1L while two other Ubls, 
Smt3 and Hub1, did not. These Ubl proteins share the same tertiary structure, 
but have between 23-55% sequence identity to ubiquitin, leading us to 
hypothesize that a specific surface shared between ubiquitin and Nedd8 was 
critical for hDot1L-mediated H3K79 methylation (Figure 3.1a). However, the 
cumbersome H2B-Ub synthetic approaches used for these studies severely 
limited the type of study that could be performed on a reasonable time scale. 
Thus, enabled by our recently developed on-nucleosomal ligation technology, we 
undertook the first comprehensive SAR study on the H2B-Ub/H3K79me crosstalk 
phenomenon.  
 
3.2. Synthesis of a H2B-Ub mutant MN library 
We hypothesized that stimulation of hDot1L methyltransferase activity required a 
specific surface region on ubiquitin, i.e. a functional ‘hotspot’. To test this, the 
ubiquitin surface was subdivided into thirteen distinct patches, consisting of two 
to four solvent exposed residues, and each individual patch was mutated to 
alanine through site-directed mutagenesis (Figure 3.1). Note, one of these 
surface alanine mutants, Ub13, centered on the canonical L8/I44 binding hotspot, 
served as a internal positive control since it has been previously shown not to be 
involved in hDot1L stimulation.121  
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Preparation of the desired MN library began with the generation of the 
corresponding library of Ub mutants, each bearing a C-terminal thiol group to 
facilitate on-nucleosome ligation (Ubmut-SH). Each of these was prepared 
analogous to the wild-type Ub-SH (as detailed in Chapter 2), i.e. by thiolysis of an 
Ubmut-intein fusion protein followed by HPLC purification. All Ubmut-SH were well 
behaved throughout the purification process and displayed similar thiolysis rates 
and yields compared to Ub-SH. Ub2-SH, due to the mutation of the +2 amino 
acid to alanine, was additionally missing the initiator +1 methionine (Figure 3.2a 
and b). This was presumably due to N-terminal processing during expression. All 
Ubmut-SH proteins were characterized by ESI-MS and stored as lyophilized 
powders until use in ligation reactions (Figure 3.2). Typically, we obtained 20 
mgs of each purified Ubmut-SH protein from an initial 1 L E. coli expression 
system. 
 
With the set of purified Ub-SH proteins in hand, we moved to the parallel 
assembly of the corresponding MN library. This was carried out by on-
nucleosome ligation according to the conditions optimized in Chapter 2. All 
ligations, proceeded similarly to the wild-type Ub-SH ligation, with efficiencies 
between 0.51-0.71 as measured by total H2BssUb (Figure 3.3). The major 
exception to this was the Ub12-SH ligation, which proved sluggish and afforded 
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Figure 3.2. HPLC and Mass Spectrometry characterization of select Ub-SHs. (a) C18 
analytical RP-HPLC chromatogram of purified Ub2-SH. (b) ESI-MS of purified Ub2-SH. (c) 
C18 analytical RP-HPLC chromatogram of purified Ub7-SH. (d) ESI-MS of purified Ub7-




3.3. hDot1L methyltransferase assays with the Ub-SH act-MN library  
With our Ubmut-containing MN library in hand, we explored the Ub surface 
requirements needed to stimulate hDot1L-mediated H3K79 methylation. Note 
that since the presence of Ub-SH in trans has no effect on hDot1L stimulation 
(see Chapter 2, Figure 2.6), this initial screening experiment could be performed 




Figure 3.3. Analysis of Ub-SH and Ubmut-SH ligation to act-MNs. (a) MNs were 
visualized by native PAGE followed by ethidium bromide staining. (b) Quantification of 
ligation was performed by densitometry and adjusted relative to Ub-SH act-MNs. 
Abundance, ANon (grey box), AMono (yellow box), and ADi (blue box) are plotted for each 
Ubmut-SH. All ligations except for Ub2-SH and Ub12-SH were comparable to Ub-SH.  
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reactions, thereby expediting the entire SAR experiment. Accordingly, a series of 
3H-SAM hDot1L methyltransferase assays were carried out on the library with 
act-MNs and Ub-SH act-MNs used as negative and positive controls, 
respectively (Figure 3.4). Quantitative 3H-methyl incorporation, measured 
through scintillation counting, was adjusted to take the absolute values of 
H2BssUb (see section 2.4) into account termed Ubstim: 
 
Ubstim = CPM/(Total H2BssUb) 
Where CPM = counts per minute  
Ubstim is normalized so that Ubstim of Ub-SH act-MNs = 1 
 
Thus Ubstim was a measure of 3H-methyl incorporation per absolute abundance 
of each H2BssUb contained in each Ub-SH act-MN reaction. After adjusting for 
differences in Ub-SH act-MNs ubiquitylation it was evident that Ub7 and Ub12 
uniquely disrupted hDot1L-mediated H3K79 methylation while all other mutants, 
including the Ub13 mutant, showed activity comparable to that of wild type 
ubiquitin (Figure 3.4a, lane 2). Consistent with our initial hypothesis, the residues 
collectively mutated in Ub7 and Ub12 have 71% sequence identity to Nedd8, and 






Figure 3.4. Surface features on ubiquitin critical for hDot1L stimulation. (a) hDot1L 
activity on each of the Ub surface mutants, 1-13. MNs were visualized by native-PAGE 
followed by ethidium bromide staining (top panel), and 3H-methyl incorporation was 
probed by fluorography (middle panel). Quantification of methylation was performed by 
filter binding assays followed by liquid scintillation counting and adjusted to include the 
extent of Ub-SH ligation, termed Ubstim (bottom panel). Error bars, s.e.m (n = 6). 
Unmodified act-MNs and Ub-SH act-MNs were included as negative and positive 
controls, respectively. Only Ub7-SH act-MNs (yellow box) and Ub12-SH act-MNs (purple 
box) mutants led to a substantial reduction in hDot1L stimulation. The Ub13-SH act-MN 
mutant (orange box), centered on the canonical hydrophobic hotspot, did not lead to 
reduction in hDot1L activity, which is consistent with a previous study (see text). (b) 
Summary of alanine scanning results. Grey residues were tested and did not have an 
affect on hDot1L stimulation. Residues colored white were not tested. Ub13 (orange), 




3.4. Confirmation that Ub7 and Ub12 disrupt hDot1L activity 
To confirm the results of this initial screen, and for further validation of our on-
nucleosomal technology to probe SAR’s in a nucleosome context, we prepared 
H2BssUb MNs containing the Ub7 and Ub12 mutants via the standard 
asymmetric disulfide reconstitution protocol, which affords homogeneous 
substrates. These were subsequently incorporated into octamers and MNs using 
standard procedures (Figure 3.5a, top panel).180 Methyltransferase assays with 
hDot1L established that both mutants have reduced ability to activate the 
enzyme, with Ub12 having the most profound effect, again consistent with the 
initial screen (Figure 3.5a and b). Comparison of H2BssUb MNs 
methyltransferase results to that of Ub-SH MNs (through calculation of Ubstim for 
the homogenously prepared MNs), revealed that the methyltransferase assays 






Figure 3.5. Comparison of hDot1L activity on H2BssUb  and Ub-SH act-MNs. (a) The 
reduced ability of the Ub7 and Ub12 mutants to stimulate hDot1L compared to Ub was 
evaluated on fully reconstituted (i.e. homogeneous) H2BssUb MNs. MNs were visualized by 
native-PAGE followed by ethidium bromide staining (top panel), and 3H-methyl incorporation 
was probed by fluorography (middle panel). Quantification of methylation was performed by 
filter binding assays followed by liquid scintillation counting and reported in counts per minute. 
Error bars, s.e.m (n = 3). (b) Methyltransferase results from both fully reconstituted H2BssUb 
MN (all MNs indicated by H2BssUbmut label) and Ub-SH act-MNs (all MNs indicated with Ubmut-
SH label) are compared. Scintillation counts from panel a, were adjusted to include the extent 
of Ub-SH ligation, termed Ubstim and compared to data in Figure 3.4a (bottom panel, see text 
details). Error = s.e.m. (n = 3-6).  
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sequence, the residues mutated in Ub7 and Ub12 formed a contiguous patch 
near the C-terminus of ubiquitin (Figure 3.4b, yellow and purple patches).  
 
3.5. Summary and conclusions 
Collectively, in Chapters 2 and 3 we have demonstrated an efficient alanine 
scanning approach for SAR studies of histone ubiquitylations. This was applied 
to the study H2B-Ub in the context of hDot1L-mediated H3K79 methylation 
however this could easily be extended to the other annotated Ub sites within the 
octamer core or H2B-Ub functions (we’ll revisit this idea in Chapter 6). Using this 
approach we generated 13 unique Ubmut-SH act-MNs and tested their ability to 
stimulate of hDot1L activity. Ub7 and Ub12 were unable to upregulate hDot1L 
activity to comparable levels of Ub. This was further confirmed through the 
synthesis of H2BssUb7 and H2BssUb12 and the reconstitution of these constructs 
into MNs followed by hDot1L assays. As these residues are remarkably close in 
the tertiary structure of Ub, this chapter indicates that hDot1L functionally 
recognizes the Ub surface near the C-terminus of Ub. In Chapter 4 we will 
explore components of this patch further in order to identify the critical 





Chapter 4. Investigation of the critical surface on Ub required for 
hDot1L-mediated H3K79 methylation 
 
4.1. Introduction 
In the previous chapter we used an on-nucleosomal ligation approach and tested 
the capacity of a library of Ub-SH mutants to stimulate hDot1L activity in the 
context of Ub-SH act-MNs. Additionally, the results from this scan were validated 
through hDot1L methyltransferase assays on homogeneous H2BssUb7 MNs and 
H2BssUb12 MNs prepared using a multi-step reconstitution approach. In this 




Figure 4.1. The Ub12 mutated patch mapped onto the Ub structure. Structure of 
Ub (PDB 1UBQ3) with the LRLR patch highlighted in purple. Residues from the LRLR 
patch are shown as a stick representation whilst other residues are shown as 
spheres. Inset: Close-up of LRLR amino acid residues. 
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effect returning hDot1L activity to levels exhibited by unmodified H2B MNs. Ub12 
is a quadruple alanine mutant where the contiguous L71 R72 L73 R74 motif near 
the C-terminus of Ub has been mutated to alanine (Figure 4.1). This region is 
critical for Ub recognition by many identified E2/E3 ligases, displays structural 
plasticity, and has been implicated in many known Ub interactions.182-185 
Specifically, the last 6 amino acids of Ub (70-76) are directly involved in ~50% of 
Ub-protein interactions in all reported Ub-protein complex structures, however 
within these structures the conformation of Ub(70-76) is not conserved.183, 186 
Moreover, it has been found that all of these residues are essential for yeast 
viability. Ub engineered with any single alanine point mutant within the LRLR 
motif, as the sole Ub source in yeast, results in non-viable yeast strains.184 
Accordingly, we hypothesized that, due to the importance of this surface in other 
known Ub interactions as well as in vivo, the mutated residues contained within 
Ub12 comprise the functional surface of Ub recognized by hDot1L.  
 
In this chapter, we will investigate the critical determinants within the Ub12 patch 
responsible for reduced act-MN ligation capacity as well as hDot1L activity. We 
were interested in whether the effect of these mutations was specific for 
H2BK120C act-MN ligation and hDot1L activity –and thus potentially linked-, or a 
general property of Ub12-SH. This could be rationalized as LRLR being a 
conserved structure motif within Ub recognized by hDot1L and/or the MN or 
Ub12 ‘mis’-folding respectively. To gain insight into this we subdivided the LRLR 
motif and employed further mutagenesis to test both hDot1L activity as well as 
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ligation to the act-MN. Using these results we structurally characterized the Ub 
mutant that we believe contains the two most central residues on Ub for 
stimulation of hDot1L activity.  
 
4.2. The aberrant Ub12 ligation to act-MNs is not specific to H2BK120C 
MNs  
The Ub12-SH act-MN conjugation reaction was characterized further in an 
attempt to determine whether the slow ligation kinetics observed was specific to 
the H2BK120C attachment site or a general consequence of the Ub12 mutations. 
We reasoned that the proximity of the mutations in Ub12 to the H2B-Ub ligation 
junction could be responsible for this effect (these mutations are adjacent to the 
                       
Figure 4.2. Ub12-SH ligation kinetics toward the act-MN. Time course for the on-
nucleosome Ub-SH and Ub12-SH ligation to the act-MN. MNs at the indicated time 
points were visualized by ethidium bromide staining (top panels) and total H2BssUb 
and H2BssUb12 was calculated via densitometry (bottom panel). Error S.E.M. (n = 3).  
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C-terminal glycines of Ub). Further the mutated patch resulted in the C-terminal 
amino acid residue sequence of LVAAAAG instead of LVLRLRG, which could 
conceivably have major structural ramifications as the former is more non-polar. 
This non-polar mutated patch could either be occluded in the Ub12-SH structure 
or unable to interact with the highly charged MN surface explaining both the 





Figure 4.3. Ligation of Ub-SH and Ub12-SH to act-MNs containing different lysine 
to cysteine mutations. Ub-SH and Ub12-SH were ligated to multiple different act-MNs. 
MNs were visualized via native PAGE followed by ethidium bromide staining (top panel). 
Absolute abundance (Ax) (grey, yellow, and blue boxes) was calculated by densitometry. 
In all different act-MNs, Ub12-SH ligated to the act-MN less so than Ub-SH. 
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To explore this, we first performed a time course of the ligation of Ub12-SH to the 
act- MN to compare to that of Ub-SH act-MNs (Figure 4.2). As expected, the 
ligation of Ub12-SH to the act-MN was extremely slow at all tested time points 
(Figure 4.2). To determine whether this was specific for the H2BK120C act-MN 
or a general consequence of the Ub12-SH mutations we tested the ability of 
Ub12-SH to ligate to act-MNs at different ligation sites (Figure 4.3). Interestingly, 
we found that the slow reactivity of Ub12-SH was independent of the attachment 
site; the mutant had a reduced ability to ligate to all positions tested on the MN 
surface (Figure 4.3). Thus, the poor reactivity of Ub12-SH appeared to be an 
intrinsic feature of the Ub12-SH protein.  
 
4.3. H2BssUb12 prevents the stimulation of hDot1L activity through L71A 
and L73A amino acid residue mutations 
As the H2B-Ub ligation junction can be varied substantially with little effect on 
hDot1L-mediated H3K79 methylation,152 we reasoned we may be able to tease 
apart if the inability of H2BssUb12 to promote H3K79 methylation and the slowed 
ligation kinetics of this mutant were in some way linked. We chose to subdivide 
Ub12 into two individual mutants retaining either both arginines (Ub L71/73A, 
referred to herein as uLL) or both leucines (Ub Arg72/74A, referred to herein as 










Figure 4.4. The ligation of uRR-SH and uLL-SH to the act-MN and subsequent 
methyltransferase assays. (a) Ub12 was split into two alanine sub-mutants, uLL and 
uRR, and Ub-SH act-MN ligations were monitored by native PAGE and visualized by 
Sybr Gold staining DNA (top panel). Non, mono, and di ubiquitylated species were 
quantified and the absolute abundance (Gray, yellow, and blue boxes) was calculated. 
(b) 3H-SAM methyltransferase assays with uLL-SH and uRR act-MNs. MNs were 
visualized by Sybr Gold staining the DNA (top panel). 3Methyl- incorporation was 
visualized by fluorography. Two different exposures of 12 hours (top middle panel) and 
5 days (bottom middle panel) are shown. Ubstim was calculated based on filter binding 
assays followed by scintillation counting (bottom panel). (c) uRR (blue) and uLL (red) 
mutations mapped on to the ubiquitin surface (PBD 1UBQ3). 
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charge-based or hydrophobicity-based effect. The two Ub12-derived mutants 
were prepared, ligated to the act-MN and hDot1L methyltransferase assays were 
performed (Figure 4.4a and b). The uRR mutant showed a ligation defect similar 
to Ub12, but still promoted robust H3K79 methylation considering the extent of 
ligation of this mutant (Figure 4.4a and b lane 4). Specifically, uRR-SH ligated to 
the act-MN similar to Ub12-SH, with both ligations only showing a small fraction 
of the mono species and no di species, in contrast with what was observed for 
Ub-SH (Figure 4.4a, lanes 3 and 4 compared to lane 2). However, subsequent to 
hDot1L methyltransferase assays showed 3H-methyl incorporation for uRR-SH 
more so than Ub12-SH (Figure 4.4b, lanes 3 and 4). Conversely, the uLL mutant 
ligated to the MN to a similar extent as wild type Ub (Figure 4.4a, lanes 2 and 5). 
Surprisingly, considering the extent of uLL-SH ligation compared to uRR-SH, 
uLL-SH was unable to stimulate hDot1L-mediated H3K79 methylation (Figure 
4.4b, lane 5). Taken together, the R72/74A double mutation prevented ligation to 
the act-MN whilst the L71/73A double mutation was responsible for the inability 
of these mutants to stimulate hDot1L activity. Thus, the ligation deficiency of 
Ub12-SH and its inability to activate hDot1L activity are not linked.   
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4.4. uLL is unable to stimulate hDot1L in multiple contexts1 
 
We chose to characterize the uLL mutant further as it contributed to the bulk of 
the reduction in hDot1L stimulation compared to Ub and Ub12. We synthesized 
uLL with an isopeptide linkage to H2B (H2B-uLL), in order to determine whether 
the non-native conjugation chemistry used in the initial analysis (i.e. H2BssuLL in 
the context of uLL-SH act-MNs) had any combinatorial effect in this crosstalk. 
H2B-uLL was reconstituted into MNs and hDot1L activity was assayed  (Figure 
4.5, Figure 4.6a). Importantly, H2B-uLL was unable to stimulate hDot1L in the 
context of the MN in comparison to H2B-Ub, which was consistent with the 
                                            
 
1	  The H2B-Ub and H2B-uLL EPL-based histones were synthesized by Sam Pollock and 
full-length hDot1L was recombinantly prepared by Beat Fierz in Professor Tom Muir’s 
 
Figure 4.5. Characterization of H2B-uLL prepared via EPL. (a) C18 analytical RP-




                        
 
Figure 4.6. hDot1L methyltransferase assays with H2B-uLL containing MNs and 
chromatinized plasmids. (a) 3H-SAM methyltransferase assays were performed on 
MNs (visualized by Sybr Gold, top panel) using hDot1L(1-416). 3H-methyl 
incorporation was visualized by fluorography (middle panel). Quantification of 
methylation was performed by filter binding assays followed by liquid scintillation 
counting (bottom panel). Error bars, s.e.m (n = 3). (b) Coomassie stained SDS PAGE 
gel showing full length hDot1L purified from insect cells. (c) 3H-SAM 
methyltransferase assays were performed on MNs (visualized by Sybr Gold, top 
panel) using full-length hDot1L. 3H-methyl incorporation was visualized by 
fluorography (bottom panel). (d) H2B-Ub and H2B-uLL containing octamers were 
reconstituted into a chromatinized plasmid and 3H-SAM methyltransferase assays 
with full-length hDot1L were performed and analyzed via fluorography.  
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previous hDot1L assays using the disulfide linked H2BssuLL (Figure 4.6a lane 2 
compared to lane 3). Since this experiment employed the catalytic domain of 
hDot1L, we were keen to see whether the results held true using the full-length 
hDot1L. Accordingly, a flag tagged full-length hDot1L was expressed in insect 
cells and purified (see section 8.4.11 for details) (Figure 4.6b). As with the 
catalytic domain of hDot1L, the full-length enzyme had greatly reduced 
methyltransferase activity against H2B-uLL MNs compared to H2B-Ub containing 
MNs (Figure 4.6c). Moreover, we observed the same behavior in the context of a 
chromatinized plasmid template. Specifically, H2B, H2B-Ub and H2B-uLL 
containing octamers were individually reconstituted into a plasmid containing 23 
copies of the 601 positioning sequence and full-length hDot1L methyltransferase 
assays were performed (Figure 4.6d). H2B and H2B-uLL were unable to 
stimulate hDot1L activity to the same extent as H2B-Ub in these substrates 
(Figure 4.6d, lane 2 compared to lane 3). Taken together, our biochemical data 
clearly indicates that the region of the Ub surface centered on L71-L73 is 
essential for stimulation of hDot1L methyltransferase activity.  
 
While it is tempting to conclude that this region is directly involved in the 
stimulation by, for example, acting as a binding hotspot, it is conceivable that 
mutation of these two leucine residues leads to a misfolding of Ub and, hence, 
the disruption of a bonafide hotspot elsewhere on protein surface. Thus, it was 
important to examine the structural integrity of the uLL mutant. For this we chose  
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Figure 4.7. HSQC spectrum of Ub and uLL. (a) 1H-15N HSQC spectrum of uniformly 
15N labeled uLL was compared to an HSQC spectrum of uniformly 15N labeled Ub. All 
peaks were annotated from the BMRB databank (accession code 6457). (b) Chemical 
shift perturbation analysis of annotated peaks assigned in both the Ub and uLL 
spectra. The averaged, weighted CSP larger than the 10% trimmed mean + 2 
standard deviations (red line) was used as a cutoff to identify significant CSPs.  The 
average, weighted CSP was calculated according to CSP = (ΔδH2 + (ΔδN*0.2)2)1/2, 
where Δδ is the difference in resonance position between Ub and uLL. Note 0.2 is a 
weighting factor used to compare 1H and 15N chemical shifts. (c) Visual representation 
of CSP analysis. Ub is shown as a grey surface representation (PBD 1UBQ3). 
Residues for which CSPs were calculated are shown as green spheres. Significantly 
perturbed amino acid residues are labeled and shown in red. Amino acid residues 
annotated in the Ub spectra and not found in uLL are shown in blue. L71 and L73 are 




solution NMR spectroscopy since Ub has been extensively studied using this 
method.183 Indeed, the presence or absence of the Ub fold can be easily 
ascertained by comparing the amide fingerprint region in the [15N, 1H] 
heteronuclear single quantum coherence (HSQC) spectrum of the uLL mutant 
with that of native Ub.  
 
A uniform 15N labeled version of Ub and uLL (both containing a C-terminal 
carboxylic acid) were prepared for HSQC spectroscopy using established E. coli 
expression methods (see section 8.4.4 for more details). Analysis of the 
fingerprint region in  [15N, 1H] HSQC spectrum of uLL in comparison to Ub 
revealed that the majority of chemical resonances were conserved between Ub 
and uLL (we were unable to assign 8 resonances between Ub and uLL) (Figure 
4.7a). Further, the majority of the annotated peaks (37 of 41) were similar 
between both proteins (Figure 4.7a and b). Out of the four residues that were 
shown to be perturbed, two (K6 and E34) were included in the Ub alanine scan 
employed in Chapter 3 and did not affect hDot1L activity (Figure 3.4, lanes 5 and 
8). All four of these amino acid residues are proximal to L71 and L73 (Figure 
4.7c, colored red). Analogously, chemical resonances unidentified in the uLL 
spectrum, due to lack of proximal chemical resonance, were localized to the 
vicinity of the L71 and L73 mutations (Figure 4.7c, colored blue). This is 
indicative that uLL retains a native ubiquitin fold, ruling out the possibility that uLL 
lacks activity through indirect means by globally disrupting the Ub tertiary 
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structure. Collectively, these data indicate that stimulation of hDot1L activity is 
directly mediated by this hydrophobic surface-patch on Ub. 
 
4.5. A  Hub1-Ub chimera containing L71/73 is unable to recover hDot1L 
activity toward H2BssHub1 MNs 
 
Figure 4.8. hDot1L methyltransferase assays on a H2BssHub1-Ub chimera.  (a) 
The Hub1ub chimera is shown along side of both Ub and Hub1. As Hub1 and Hub1ub 
are identical in residues 1-50 these residues are not shown in Hub1ub for simplicity. 
The last 7 residues of Hub1ub are identical to Ub (bolded green) and include L71 and 
L73 (bolded red). The Ub7 mutated patch in Ub is shown (bolded yellow). (b) 3H-SAM 
methyltransferase assays were performed on MNs (visualized by Sybr Gold, top 
panel). 3H-methyl incorporation was visualized by fluorography (middle panel). 
Quantification of methylation was performed by filter binding assays followed by liquid 
scintillation counting (bottom panel). Error bars, s.e.m (n = 3). 
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Lastly, we wondered whether we could use the information derived from our SAR 
studies on Ub, namely the identification of the L71-L73 hotspot, to reverse 
engineer an ubiquitin-like protein that is normally incapable to stimulating hDot1L. 
For this we chose Hub1, which, in line with our hypothesis, differs from Ub at its 
C-terminus and is specifically the missing an LR in the LRLR motif (Figure 4.8a). 
Further, the construct employed in the original Hub1 study (note the endogenous 
Hub1 does not contain and amino acid residues RGG (Figure 3.1 compared to 
Figure 4.8a)) is one amino acid residue short of a homologous C-terminal Ub tail 
and contains bulky tyrosine residues adjacent to the LRGG motif (Figure 4.8a).  
 
We designed a chimeric protein (Hub1ub) in which the last 7 residues from the 
C-terminus of Hub1 (residues 69-76) were replaced with that of Ub (Figure 4.8a). 
The corresponding H2BssHub1ub construct was synthesized, reconstituted into 
MNs and methyltransferase assays were performed using the catalytic domain of 
hDot1L (Figure 4.8b). H2BssHub1ub MNs failed to stimulate hDot1L, as its 
activity was comparable to that of unmodified H2B and H2BssHub1 MNs. 
Conceivably, our inability to “ubiquitinize” Hub1 through this simple sequence 
switch might relate to a requirement for additional ‘second shell’ residues that 
would place the leucine hotspot in the proper structural context. Indeed, 
examination of the Ub and Hub1 sequences reveals sequence differences in 
regions that are proximal to the location of the hotspot, for example in the PPD 
patch that reduced the ability of Ub7 to stimulate hDot1L activity by 50% when 
mutated to alanine (Figure 3.5 and Figure 4.8a). Thus, installing the hDot1L 
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hotspot into Hub1 is likely to require much more sophisticated protein-
engineering strategy than the somewhat simple one attempted herein. 
 
4.6.  Summary and conclusions 
An alanine scan of the Ub surface in regard to hDot1L activity from Chapter 3 led 
to the identification of a contiguous surface patch on Ub critical for hDot1L 
stimulation. This chapter expanded upon this initial finding and explored Ub12 
through mutagenesis to determine the critical components governing the 
regulation of hDot1L activity. We elucidated that L71 and L73 within Ub were 
necessary for hDot1L-mediated H3K79 methylation. This was further confirmed 
in multiple different types of homogenously prepared chromatin substrates and 
reproduced using the full-length hDot1L polypeptide. This led to the conclusion 
that H2B-uLL is unable to stimulate hDot1L activity in chromatin contexts beyond 
our initial simplified system. Moreover, uLL did not show any appreciable affect 
on the global tertiary structure of Ub. This was directly investigated by NMR and 
additionally inferred by the ability of uLL-SH to ligate to the act-MN comparably to 
Ub-SH.   
 
It is interesting that Ub12 could be segregated into either an Ub-SH ligation 
incompetent (i.e. uRR) or hDot1L stimulation incompetent activity (i.e. uLL) 
mutant. As uRR involves the mutation of two arginine amino acid resides to 
alanine in the amino acid sequence LVLRLRGG, we hypothesize that this results 
in a highly non-polar patch at the C-terminus of Ub that is structurally dissimilar to 
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that of native Ub (or uLL). This hydrophobic patch could in some way be 
occluded as to prevent Ub12-SH/uRR-SH ligation to the act-MN. It would be 
interesting to investigate this further especially considering it is able to stimulate 
hDot1L mediated H3K79 methylation.  Potentially, this region could be ‘mis’-
folded when uRR/Ub12-SH is re-folded in solution to prevent ligation to the act-
MN, however the ‘correct’ conformation could be selected for by hDot1L and/or 
the MN in order to stimulate H3K79 methylation through the recognition of L71/73 
in the context of the H2B-Ub MN.  
 
It would also be valuable to examine the structural ramifications of uLL more 
closely. From our HSQC experiments, we observed local perturbations 
surrounding L71 and L73 in uLL compared to Ub. However, as our experiments 
detected chemical shifts primarily in the polypeptide backbone, we do not know 
what role these leucine to alanine mutations play in side chain dynamics 
surrounding the L71 and L73 sites. Thus it would be interesting to characterize 
uLL using multi-dimensional NMR experiments to determine side chain dynamics 
using residual dipolar coupling experiments that have previously been employed 
to study Ub.183 Analogously, for the Hub1ub chimera, it would be worthwhile to 
compare the local dynamics of L71 and L73 in this mutant to that of UbL71/L73. 
This could differentiate between the hypotheses that Hub1ub is unable to 
promote H3K79 methylation due to incorrect positioning (or dynamics) of L71/73 
or potentially other additional factors, such as an additional global 
steric/interaction requirement. The validity of comparisons using Hub1 will be 
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discussed further in section 7.3.2. Although the H2B-uLL MN clearly disrupts 
hDot1L activity we have not tested whether the Ub7 mutant disrupts hDot1L 
activity by disrupting the confirmation L71/73 or through independent means, 
which would be another potential reason why our attempt to ‘ubiquitinize’ Hub1 
was unsuccessful.  
 
Although, the NMR experiments suggested herein would be powerful approaches 
to systemically characterize the findings throughout this chapter, we were 
interested in the broader consequences of Ub (specifically L71 and L73) in the 
context of chromatin structure. In Chapter 5 we will take biophysical approaches 
to investigate the structural ramifications of Ub in the context of H2B-Ub MNs as 
well as H2B-uLL in the context of chromatin arrays to gain further insight into the 
role of H2B-Ub in the stimulation of hDot1L activity.  
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Chapter 5. The biophysical characterization of Ub and uLL in 
MNs and nucleosomal arrays 
 
5.1. Introduction 
Certain histone PTMs can affect chromatin function through the direct alteration 
of chromatin structure.30, 117, 138, 187, 188 This has been demonstrated in the context 
of the MN,138 as well as in the context of the 30-nm fiber.187, 188 Specifically, 
histone PTMs such as lysine methylation and lysine acetylation modulate inter 
and intra-nucleosomal dynamics through the disruption of histone-DNA and 
 
Figure 5.1. Localization of L71 and L73 in relation to the H2A-H2B dimer interface 
in the MN. The H2B-Ub nucleosome is modeled as a composite of Ub and MN 
structures (PDB 1UBQ3 and 3LZ0). Histones H2A (yellow), H2B (red), H3 (blue), H4 
(green), Ub (light green) are shown. Inset: The L71/73 patch (black) is located near the 




histone-histone contacts. In this chapter we set out to investigate, using 
biophysical approaches, whether H2B ubiquitylation alters chromatin structure 
and, if so, whether the functional hotspot identified in the preceding chapters (i.e. 
L71 and L73) is involved. As the L71 and L73 hydrophobic side chains are 
solvent exposed in the Ub structure, we expect these residues to form direct 
contacts with either the MN surface in the vicinity of H2BK120 or hDot1L to 
facilitate H3K79 methylation (Figure 5.1). We hypothesized that, given their 
proximity to the hydrophobic interface between H2A and H2B, L71/73 may orient 
Ub on the MN surface through histone contacts (Figure 5.1). Moreover, if Ub is 
indeed interacting with the MN surface, this interaction could be responsible for a 
myriad of associated H2B-Ub biochemical functions, extending beyond H3K79 
methylation.  
 
We were specifically interested in the impact of the L71/73 hydrophobic patch on 
H2B-Ub chromatin structure in order to gain mechanistic insight into the 
regulation of hDot1L and to see whether this epitope was conserved in H2B-Ub-
mediated chromatin decompaction. This was addressed by: (i) Probing the 
solvent accessibility of H3K79 in H2B and H2B-Ub containing MNs; (ii) An NMR 
approach, that specifically detects the isoleucine, leucine, and valine methyl 
groups of Ub in the context of the MN, and; (iii) Comparison of the compaction 
properties of H2BssuLL to H2BssUb containing nucleosomal arrays. These 
experimental approaches suggest that L71 and L73 do not have any appreciable 
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effect on H2B-Ub chromatin structure in the context of either the MN or 
nucleosomal arrays.  
 




                  
Figure 5.2. Effect of H3K79me2 on the MN structure. The structure of the region 
surrounding H3K79 in MNs with and without H3K79me2 are compared (PDB code 
3C1C and 1KX5 respectively). H4 is shown as a cartoon colored green (Forest dark 
for H3 MN, green for H3K79me2 MN). H3 is shown as a cartoon colored red (Maroon 
for H3 MN, red for H3K79me2 MN). Residues H3L82, H4V81, H3K79 (yellow) and 
H3K79me2 (blue) are shown as stick representations. Dashed circle indicates 
hydrophobic surface exposed upon local rearrangement of H3K79 when dimethylated. 
This results in a solvent accessible small hydrophobic cavity surrounding the H3L82 




There are several different mechanisms by which ubiquitylation of H2B might 
stimulate methylation of H3K79. One possibility involves an allosteric-type 
mechanism in which the presence of H2B-Ub changes the local structure around 
H3K79 making it more accessible to the hDot1L. Indeed, comparison of the x-ray 
crystal structures of MNs containing unmodified H3K79 and H3K79me2, reveals 
that the region surrounding H3K79 undergoes a local structural rearrangement 
upon methylation (discussed further in section 1.3.2) (Figure 5.2).138 Specifically, 
H3K79 assumes a different rotameric structure upon methylation that leads to the 
exposure of a hydrophobic cavity. Given this structural plasticity, we designed an 
experiment to determine whether H2B-Ub causes a change in H3K79 solvent 
accessibility in the context of the MN.  
 
We prepared a H3K79C mutant histone (also containing a H3C110A mutation) in 
order to test the accessibility of H3K79C towards a cysteine reactive probe. 
Specifically, a maleimide polyethylene glycol (mPEG) molecule was utilized to 
react with cysteine resulting in a stable thioether linkage between the sulfhydryl 
group of cysteine and the maleimide of mPEG. The mPEG used had a molecular 
weight of 6 kDa so that, in the context of the H3K79C MN, this reaction could be 
monitored via gel shift upon native PAGE followed by silver staining. MN 
substrates were prepared containing H3K79C, and either H2B or H2B-Ub 
histones. Cysteine-free MNs that were not ubiquitylated were reconstituted and 
were used as a control to detect any non-specific mPEG modifications.  
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A time course of the mPEG reactions with all three MNs species (H3, H3K79C, 
and H2B-Ub H3K79C) were performed over the course of 10 minutes and 
quenched with dithiolthreitol (DTT) (Figure 5.3a).  As expected, the cysteine-less 
MN (H3 MN) showed no gel shift upon mPEG addition and thus mPEG did not 
non-specifically modify MN substrates under the conditions tested (Figure 5.3a, 
lower panel). H2B or H2B-Ub MNs containing H3K79C showed multiple mPEG 
 
Figure 5.3. The mPEG modification of H3K79C and H3K79 MNs containing H2B 
or H2B-Ub. (a) A silver stained Native PAGE gel showing a time course of mPEG 
modified MNs. MNs are indicated in the lower left corner of each panel, and mPEG 
modification is obsered via gel shift from the unmodifed band at Time = 0. (b) SDS-
PAGE (left panel) and western blot analysis (right panel) of H3K79C modified with 
mPEG. H3K79C was reacted with mPEG similar to MNs and visulized via Coomassie 
staining subsequent to SDS-PAGE as well as western blot analysis with an antibody 
directed to H3. A band runing at the molecular weight of H3 (15kDa) is observed, as 
well as higher MW bands (mPEG modifications) that contain H3 (left panel western 
blot analysis). (c) The percentage of mPEG modification was analyzed via 
densitometry of the silver stained naitve PAGE mPEG modification time course (panel 
a).  H2B-Ub MNs (grey line) containing H3K79C showed simlar mPEG modification to 
that of H3K79C MNs (green line), whereas H3 MN (gray dashed line) were not 
modified.  Error bars, s.e.m (n = 3).  
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modification states (Figure 5.3a, upper and middle panels). The majority of the 
mPEG modification species were mono- or di- modified and the reaction 
proceeded primarily in an additive fashion, i.e. MNs were modified with mono-
mPEG at earlier time points in the reaction, followed by the formation of di-
mPEG. Based on the lack of modification of the H3 MNs, we believe the 
modification states observed beyond di-mPEG (as each H3K79C containing MNs 
has two cysteine residues) were the result of heterogeneities in the mPEG 
reagent. This was supported by western blot analysis of the free H3K79C histone 
subjected to mPEG modification (Figure 5.3b).  
 
Given the uncertainties of the higher mPEG modification states, we quantified the 
non-modified MN bands by densitometry and calculated the percentage of MNs 
labeled (the unmodified MN band at Time = 0 correspond to 0% labeled) (Figure 
5.3c). By this measure, we observed that H3K79C together with either H2B or 
H2B-Ub MNs showed a similar degree of mPEG modification at all time points 
tested (Figure 5.3c). Further, the degree of labeling neared 70% in both contexts, 
suggesting that H3K79 is quite solvent exposed regardless of the ubiquitylation 
state. This data argues against the role of H2B-Ub in hDot1L stimulation being 







5.3. Nuclear magnetic resonance spectroscopy reveals little ubiquitin-
specific structural perturbations of the H2B-Ub MN2  
As previous attempts to crystallize H2B-Ub MNs have proven unsuccessful,189 
we took a solution NMR approach to gain structural insights into this system. The 
approach we took was inspired by a recently reported NMR study that elucidated 
the interaction of the High mobility group nucleosomal 2 (HMGN2) protein with 
the MN surface.190 This study was performed on MN containing wild-type 
histones from Drosophila melanogaster (abbreviated as dH2B for example, as 
opposed to Xenopus laevis histones which will be labeled as xH2B, etc.) utilizing 
transverse relaxation-optimized NMR spectroscopy (TROSY). TROSY is a 
technique for the NMR analysis of large supra-molecular systems, as 
conventional solution NMR techniques are limited to a molecular size of less than 
~50 kDa (the MN is ~200kDa in size) (Figure 5.4).191 This size constraint results 
because the transverse relaxation time (T2) is inversely proportional to the 
rotational correlational time (τc) of the molecule. As T2 determines the linewidth of 
the NMR signals, a long τc (short T2) can result in broad, un-interpretable NMR 
spectra (Figure 5.4b). TROSY exploits destructive interference between T2 
mechanisms to generate spectra with greater signal-to-noise (Figure 5.4c).  
 
                                            
 
2	  Methyl-TROSY experiments were performed in collaboration with Dr. Julianne 





Figure 5.4. The molecular size of a protein molecule influences the NMR signal. 
This figure is reproduced from Fernadex et al (2003).192 (a) For a protein below 
~50kDa, a short correlational time (τc) results in a long T2 and thus narrow line widths 
(Δv) of the NMR signal upon Fourier transformation (FT). (b) For larger molecules, e.g 
the proteasome, the very long τc (small T2) results in the rapid decay of the NMR 
signal and broad line widths (Δv). (c) With TROSY, the signal can be partially 
recovered, although sample deuteration is usually required.  
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The so-called methyl-TROSY variation of the experiment additionally improves 
the sensitivity by selecting for the slow relaxation coherences of isotopically 
labeled methyl groups (Figure 5.4c).193-195 These methyl probes [13C, 1H] are 
incorporated into fully deuterated protein samples through the metabolic labeling 
of isoleucine, leucine, and valine (ILV) methyl groups (see section 8.4.5 for more 
details).196 In the context of the nucleosome, each histone was ILV labeled 
separately and incorporated into a MN where the other three histones were 
deuterated which allowed for better cross-peak resolution. Additionally to 
annotate ILV methyl resonances, 58 single-point mutant ILV labeled histone 
constructs were incorporated into MNs and analyzed by Methyl-TROSY.190 
Considering the significant amount of effort that went into assignment of the ILV 
labeled Drosophila histone resonances, we planned to test the effect of H2B-Ub 
in the context of the Drosophila MN.  
 
To elucidate whether Ub was interacting with the MN surface (potentially through 
the L71/L73 patch), we set out to prepare an ILV-labeled Ub and incorporate it 
into an H2BssUb MN NMR sample. However, as the preparation of fully 
deuterated histones and the subsequent ligation of an ILV labeled Ub-SH (UbILV-
SH) is non-trivial, we first wanted to determine whether structural insights gained 
from the dH2B-Ub MN would be relevant for hDot1L-mediated H3K79 
methylation. We did not attempt to express and purify the Drosophila Dot1 
homologue, Grappa, as this is a poorly characterized 1848 amino acid residue  
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Figure 5.5. hDot1L methyltransferase assays with xH2B and xH2BssUb MNs 
compared to dH2B and dH2BssUb MNs. 3H-SAM methyltransferase assays were 
performed on xH2B, xH2BssUb, dH2B, and dH2BssUb MNs. MNs were visualized by 
native-PAGE followed by ethidium staining (top panel), and 3H-methyl incorporation 
was probed by fluorography (middle panel). Quantification of methylation was 
performed by filter binding assays followed by liquid scintillation counting (bottom 
panel), Error S.E.M (n = 3).  
 
polypeptide. However, as Grappa and hDot1L are have 42% sequence identity 
(57.1% sequence identity in the conserved structured catalytic core hDot1(1-
330)) and d- and x- histones show greater than 71% sequence identity, we 
hypothesized hDot1L would be stimulated by dH2B-Ub MNs and thus any 
structurally related insights we gained from the dH2B-Ub MN could be 
rationalized toward hDot1L and xH2B-Ub MN biochemical results. Ligation of this 





























Figure 5.6. Characterization of UbILV-SH prepared via a Ub-NPU-6xHis construct. 
(a) C18 analytical RP-HPLC chromatogram of purified UbILV-SH. (b) ESI-MS of 
purified UbILV-SH.  
 
incorporated into Drosophila MNs. We employed the same reconstitution and 
purification protocols for Drosophila MNs as for Xenopus MNs and the former 
behaved similarly to the latter. 3H-SAM hDot1L methyltransferase assays were 
performed on both the Xenopus and Drosphila MNs (Figure 5.5). As expected, 
no 3H-methyl incorporation was observed for the non-ubiquitylated MN 
substrates, whereas hDot1L activity was strongly stimulated upon ubiquitylation 
of H2B, for both the Xenopus and Drosophila MNs (Figure 5.5). Based on this 
result, we reasoned that any structural effects observed for Ub in the context of 
the Drosophila MN could be extended to our previous biochemical analysis of 
hDot1L-mediated H3K79 stimulation. 
 
We next sought to express and purify a deuterated UbILV-SH. As recombinant 
expression yields in deuterated media are typically far less than in LB media, 
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recombinant expression in deuterated media of the Ub-NPU-6xHis construct was 
extensively optimized. The generation of Ub-SH was achieved by thiolysis of the 
Ub-NPU-6xHis construct subsequent to affinity purification. After intein thiolysis 
and HPLC purification, we were able to obtain a yield of ~7mgs/liter of pure 
UbILV-SH (Figure 5.6). These yields are suitable for the preparation of an NMR 
sample however, as this was pursued in parallel with alternative ligation 
































Figure 5.7. Comparasion of H2BssUb ligation and H2BssUbG76C ligation 
junctions. (a) Ligation of Ub-SH to dH2BK118C results in a  ligation junction that is 1 
atom longer than the native isopeptide junction (see  Figure 1.10 for more details). (b) 
The recombinant expression of UbG76C and subsequent ligation to H2BK118C, 
results in a ligation junction similar to Ub-SH with an additional carboxylate group 















































Figure 5.8. Methyl-TROSY of dH2BssUbG76CILV MNs and CSP analysis. (a) Methyl-
TROSY spectra of UbG76CILV incoprorated in MNs (Ub-MN, purple) compared to free 
UbG76CILV in solution (Ub, black). Methyl probes for the respective amino acid residues 
are labeled and include chirality (R or S configuration) when necessary.  (b) (1H, 13C) 
chemical shift perturbation analysis of all residues in UbG76CILV MNs compared to 
UbG76CILV free in solution. Red line indicates the 10% trimmed mean + 2 standard 
deviations (see section 8.10.3 for analysis details). (c) Visual representation of UbILV 
methyl groups mapped onto the Ub structure (PDB 1UBQ3) as spheres. Methyl groups 
that displayed chemical shifts similar to UbILVG76C free in solution (purple), and 
significantly perturbed methyl groups (blue) are shown. Significantly perturbed amino 
acid residues and L71 and L73 are labeled.  
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Alternatively, an UbILV construct containing a G76C mutation was prepared for 
ligation to dH2BK118C. UbILVG76C was ligated to dH2BK118C and a fully 
deuterated H2BssUb mononucleosome was reconstituted. The integrity of this 
ligation junction, which contains an additional carboxylate has yet to be validated 
with respect to H2B-Ub-related functions (Figure 5.7). Methyl-TROSY 
experiments were performed using dH2BssUbILVG76C MNs. The cross peaks 
observed from UbILVG76C, incorporated within MNs, was compared with 
UbILVG76C free in solution (Figure 5.8a, purple peaks compared to black 
resonances). Chemical shift perturbations (CSP) were calculated and 2 residues 
(I30 and I61) were shown to have significantly different chemical shifts 
(significant being greater that 2 standard deviations from the 10% trimmed mean) 
(Figure 5.8b). These residues did not co-localize to a specific region of Ub and 
instead were dispersed throughout the hydrophobic core of Ub (Figure 5.8b). 
Additionally, it is clear from these studies that UbILV is not interacting with the 
Drosophila MN as to significantly affect the chemical shifts of the annotated L71 
and L73 methyl groups (Figure 5.8b). Although these experiments are still in their 
initial stages, we hypothesize that L71 and L73 do not interact with the MN in any 
significant way. Indeed, the NMR data are more consistent with the idea that Ub 
‘hangs off’ the MN from its H2B attachment site, as opposed to the modification 





5.4. L71 and L73 are not involved in H2B-Ub-induced impairment of 
chromatin fiber compaction 
 
The biochemical and spectroscopic studies in the preceding sections suggest 
that attachment of Ub to H2B in the nucleosome does not lead to a major 
structural perturbation of Ub or the MN, at least around H3K79. However, these 
studies were, by experimental necessity, performed on a MN. Thus, we were 
keen to see whether the L71/L73 ‘hotspot’ played any role in the known ability of 
H2B-Ub to impede chromatin compaction.117 Interestingly, while our laboratory 
showed that H2B-Ub disrupts higher-order chromatin structure, attachment of 
Hub1 to the same site did not.117 This suggests that a specific surface of Ub, 
rather than its size per se, is required for this physical effect. We of course 
wondered whether the L71/L73 surface required for hDot1L stimulation might 
also be required for this structural property of H2B-Ub.  
 
We decided to test this idea using a previously developed homo-fluorescence 
resonance energy transfer (homo-FRET) steady-state anisotropy approach 
(SSA) (Figure 5.9).117 We prepared 12-mer nucleosome arrays containing H2B, 
H2BssUb or H2BssuLL octamers (Figure 5.9), where the H2A variant used was a 
H2AN110C histone labeled with fluorescein maleimide (fH2A). Fluorescein was 
the spectroscopic probe necessary for Homo-FRET.  Arrays were formed with a 
DNA template containing 12 copies of the 177bp ‘601’ positioning sequence 





Figure 5.9. Schematic of the Homo-FRET assay used to probe chromatin 
compaction. (a) 12-mer nucleosome arrays containing fH2A (indicated by orange 
star) compact upon addition of Mg2+. Compaction correlates with a lower steady-
state anisotropy (SSA) signal due to homo-FRET (right panel). (b) 12-mer 
nucleosome arrays containing H2B-Ub (Ub in green) compact upon addition of Mg2+. 
Schematic illustrates the fact that the presence of H2B-Ub is known to impede 
compaction compared to unmodified arrays. This results in a smaller change in SSA 
for H2B-Ub containing arrays compared to unmodified arrays readout by a smaller 





Figure 5.10. Reconstitution of unmodified, H2BssUb, and H2BssuLL fluorescently 
labeled chromatin arrays. (a) Sybr gold stained native 1% agarose, 1% 
polyacrylamide gel electrophoresis (APAGE) analysis of reconstituted H2B (lane 1), 
H2BssUb (lane 2), and H2BssuLL (lane 3) nucleosome arrays. (b) Sybr Gold stained 
native PAGE gel following micrococcal nuclease (MNase) digestion of reconstituted 
H2B (lane 1), H2BssUb (lane 2), and H2BssuLL (lane 3) nucleosome arrays. (c) Sybr 
Gold stained native-PAGE gel showing ScaI restriction enzyme digests of 
reconstituted H2B (lane 1), H2BssUb (lane 2), and H2BssuLL (lane 3) nucleosome 
arrays. The nucleosome band is observed at ~500 bp and a small amount of free 601 











Nucleosome arrays were formed using a semi-gradual dialysis method similar to 
MN formation, in the presence of the 155 bp ‘low affinity’ Mouse mammary tumor  
virus (MMTV) DNA.117 The addition of MMTV DNA prevents the formation of 
oversaturated, and biophysically unsuitable, arrays. H2B, H2BssUb, and 
H2BssuLL arrays were formed in parallel and were analyzed through native 1%, 
agarose, 1% polyacrylamide gel electrophoresis (APAGE) followed by staining 
with Sybr Gold (Figure 5.10a). All arrays showed the expected single band 
running near the molecular weight of 3000 bp. Micrococcal nuclease (MNase) 
digests were performed to determine the positioning of the octamers on the 
12x601 DNA template. After MNase digests DNA was extracted and PAGE was 
performed followed by Sybr Gold staining. 12 distinct DNA bands were observed 
for all NAs, indicative of 12 well-positioned octamers on the DNA template 
(Figure 5.10b). Complementary to the MNase digests, Sca1 digests were 
performed to assess the full occupancy of histone octamers at the 601 sites. ScaI 
digests were executed in the presence of increased DTT (10mM) to reduce Ub-
SH from H2BK120C. This was done in order to simplify the analysis by native 
PAGE (Figure 5.10c). All nucleosome arrays showed a predominant MN band at 
the molecular weight of an unmodified H2B MN. Collectively, these analyses are 
indicative of well-formed, completely octamer-saturated, H2B, H2BssUb, and 
H2BssuLL nucleosome arrays.  
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Homo-FRET SSA was employed to elucidate the Mg2+-induced chromatin 
compaction behavior of H2B, H2BssUb and H2BssuLL nucleosome arrays (Figure 
5.11a). As expected, the presence of H2BssUb impeded Mg2+ induced 
compaction of the 12-mer array compared to the H2B (i.e. unmodified) array 
(Figure 5.11a, green line compared to grey line). Remarkably, given the profound 
effect on hDot1L methyltransferase activity, mutation of the L71/73 surface had 
no impact on array compaction (Figure 5.11a, red dashed line). The H2BssUb 
and H2BssuLL arrays behaved identically upon Mg2+ induced compaction, both 
 
Figure 5.11. Mg2+-induced compaction of H2B, H2BssUb, and H2BssuLL 
nucleosome arrays. (a) SSA as a function of Mg2+ for H2B (grey line), H2BssUb (red 
dashed line), and H2BssuLL (green line) arrays. Error bars, s.e.m (n = 3). (b) 
Fluorescence emission of H2B (grey diamonds), H2BssUb (green triangles), and 
H2BssuLL (red circles) arrasys as a function of added Mg2+ to the sample. Graph 
shows vertically polarized fluorescence emission of each sample excited with 
vertically polarized light.  
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compacting less than H2B arrays (Figure 5.11a, green line compared toward 
dashed red line). As a control to ensure the arrays did not precipitate out of 
solution during the experiments, the fluorescence emission of the samples was 
also recorded (Figure 5.11b). All samples showed a similar absolute 
fluorescence, across all Mg2+ concentrations tested, ruling out any complicating 
effects such as precipitation (Figure 5.11b). This result indicates that the L71/L73 
surface in Ub is not required for chromatin decompaction.  
 
5.5.  Summary and conclusions 
In this chapter we investigated the structural ramifications of the Ub post-
translational modification in the context of H2B-Ub chromatin. In the first part of 
the chapter, the solvent accessibility of H3K79C was probed in H2B and H2B-Ub 
MNs. We were unable to detect a difference in mPEG labeling leading to the 
conclusion that H2B-Ub does not drastically alter the local surface surrounding 
H3K79 in a way that leads to enhanced solvent accessibility. We next took a 
spectroscopic approach to investigate the Ub structure in the context of the MN. 
Surprisingly, we observed little difference in methyl-TROSY spectrum of Ub when 
attached to the MN surface at its canonical site on H2B as compared to the Ub 
free in solution. While this argues against an intimate interaction between Ub and 
the MN surface, we caution that these preliminary experiments employed a 
conjugation strategy (i.e. an UbG76C mutant instead of Ub-SH) different from 
that used in the biochemical experiments described in the preceding chapters. 
Although, previous studies in our laboratory indicate a significant tolerance in this 
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junction region with respect to hDot1L stimulation,121, 152 it is conceivable that this 
new structure, particularly the presence of the carboxyl group, disrupts the 
normal stimulatory behavior of Ub when attached to H2B. Future studies will 
need to address this possibility. Lastly, we demonstrated that the L71/L73 
hydrophobic patch on Ub is not required for the ability of H2B-Ub to disrupt 
chromatin compaction. Specifically, when incorporated into nucleosome arrays, 
the uLL mutant did not compact any different from that of Ub.  
 
Collectively, this chapter suggests that when attached to position 120 of H2B, Ub 
does not dramatically alter the MN structure and, more specifically, that the 
L71/73 functional ‘hotspot’ is not involved in modulating higher-order chromatin 
structure. Since this ‘hotspot’ is clearly required for stimulation of hDot1L activity 
(Chapters 3 and 4), we speculate that Ub may be directly interacting with the 
enzyme itself. It is interesting to note, however, that hDot1L binds to 
mononucleosomes in both the presence and absence of H2B-Ub.152 Indeed, 
ChIP-Seq data indicates that hDot1L does not co-localize with H2B-Ub 
containing chromatin, but rather is spread throughout euchromatin regions.121, 130, 
145 Thus, we suspect that hDot1L directly binds to H2B-Ub through the surface 
centered on L71/L73 and that this interaction activates the enzyme, either 
through a direct allosteric process and/or by repositioning the protein on the 
nucleosome surface such that a productive (for H3K79 methylation) enzyme-
substrate complex is generated. This hypothesis will be discussed further in 
section 7.4.  
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Finally, this chapter indicates that Ub, in the context of H2B-Ub, is read out 
differentially in regard to H2B-Ub functions. As the L71/L73 surface on Ub does 
not contribute to the effect that H2B-Ub has on chromatin compaction, yet is 
responsible for the stimulation of hDot1L activity, we can conclude that different 
surface features of Ub are required for separate H2B-Ub functions. Because of 
this, we wondered whether L71/73 ‘hotspot’ was specific only to the regulation of 
hDot1L or a general feature required for stimulation of all H3 methyltransferases 
regulated by H2B-Ub. This will be addressed in the following chapter through the 
analysis of the critical determinants in Ub required for both yDot1 and ySet1C 
methylation.  
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Chapter 6. Characterization of the yeast Dot1 and Set1 
methyltransferases towards H2B-Ub in vivo and in vitro3 
 
6.1. Introduction 
The ubiquitylation of histone H2B is conserved from the budding yeast 
Saccharomyces cerevisiae (referred herein as ‘yeast’) to humans, as is its 
involvement in the regulation of both H3K4 and H3K79 methylation through the 
direct stimulation of the relevant H3 methyltransferases. In the previous chapters, 
we have shown that the hydrophobic patch comprising L71/73 of Ub is essential 
for stimulation of the hDot1L enzyme. This raises the question of whether this 
same motif is involved in stimulating the yeast version of the methyltransferase, 
yDot1. On the one hand this might seem likely given the high degree of 
homology within the catalytic domains of the two enzymes (29.6% identity). 
However, we note that the two enzymes differ markedly in size and organization 
outside the catalytic domain (see section 1.3.3.2). In particular, the location of the 
basic patch responsible for DNA-binding is inverted between the yeast and 
human enzymes and the yeast enzyme contains a putative ubiquitin interaction 
domain within its N-terminal region that is not present in hDot1L.148 Thus, it was 
far from clear whether the molecular details of the stimulation by H2B-Ub would 
be the same for the yeast and human Dot1 homologs.145, 148   
                                            
 
3	  The in vivo experiments were done in collaboration with Dr. Jung Ae Kim in Professor 
David Allis’s lab at Rockefeller University. Further, yDot1 and ySet1C constructs were 
prepared by Dr. Jaehoon Kim in Professor Robert Roeder’s lab at Rockefeller University	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In addition to yDot1, we also wanted to see if the L71/73 hotspot on Ub was 
critical for H3K4 methylation. As H3K4 methylation in humans is catalyzed by 
multiple Set1/MLL family histone methyltransferases, which exist in multi-subunit 
complexes and play non-redundant, conditionally Ub-independent roles (see 
section 1.3.3.1 for a further discussion),197 we sought to use ySet1C to 
investigate the effect of uLL on H3K4 methylation. In vivo, ySet1C has been 
shown to require amino acid residues in the C-terminus of H2B (H2BR119 and 
H2BT122), which are spatially adjacent to the H2B-Ub site (H2BK123 in yeast) 
and function in the recruitment of ySet1C to chromatin.198 Conceivably, the 
proximity of L71/73 in Ub to these C-terminal H2B residues (which are solvent 
exposed on an α-helix) could form a composite recognition surface between H2B 
and Ub necessary for ySet1C-mediated H3K4 methylation. 
 
In the following, we explore whether the L71/73 hotspot on Ub is important for H3 
methyltransferase activity in yeast. We reasoned that studying the yDot1 
methyltransferase would not only complement the work on the human enzyme 
but would also provide a potential avenue for in vivo studies, as yeast offers a 
more genetically tractable system than mammalian cells. Specifically, we were 
interested in the development of a genetic system to study the effect of the uLL 
mutations on yDot1-mediated H3K79me2 in vivo. Further, we were keen to 
investigate whether the same L71/L73 surface on Ub is required for the other 
histone methylation regulation by H2B-Ub, ySet1C-mediated H3K4 methylation.86 
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Surprisingly, this chapter concludes with the finding that L71/73 surface is critical 
for ySet1C activity but dispensable for yDot1 stimulation.  
 
6.2.  An in vivo system to investigate Ub surface features in H2B-Ub 
We set out to devise a genetic system that would allow us to ask whether the 
L71/L73 hydrophobic hotspot on Ub is important for ubiquitin-methylation 
crosstalk in vivo. Ubiquitin is a highly conserved protein, abundant in cells and 
essential in a range of activities such as protein degradation, localization, and 
signaling.53 An alanine scan of ubiquitin in yeast identified all non-viable ubiquitin 
mutants, including both L71 and L73 residues,8 obviously complicating the 
design of a cell-based experiment. In principle, such lethality might be by-passed 
if the Ub mutant were selectively targeted to chromatin. In thinking of this 
possibility we were inspired by two observations, namely; (i) that Ub can be 
moved to position 20 on the N-terminal tail of histone H2A, which is juxtaposed to 
the native ubiquitylation site in H2B in the nucleosome structure, without 
disrupting Dot1 activation152 and, (ii) that deletion of the first 20 residues of H2A 
in yeast does not abrogate H3K4 and H3K79 methylation.199 We reasoned that 
an Ub fusion near the N-terminus of H2A might be able to recover yDot1 activity 
in yeast when the sole H2B-Ub E2 ligase, Rad6, is deleted and thus no native 
H2B-Ub or H3K79me2/3 is observed. Specifically, we chose to engineer an Ub-
H2A(20-116) chimera to test if we could recover H3K79 methylation in a Rad6 





Figure 6.1. The positioning of H2BK120 Ub in the MN structure enables an N-
terminal Ub fusion to H2A as a H2B-Ub mimic. (a) Structural model of the H2B-Ub 
MN, (this model is a composite of the Ub structure, PDB 1UBQ3, and the wild-type 
MN structure, PDB 3LZ0). Ub (light green), H2A (yellow), H2B (red), H3 (blue), H4 
(green), are shown as both cartoon and surface representations. L71 and L73 of Ub 
are shown as black sticks, and H2BK120 and H2AG20 as spheres. Inset, a close up 
view of the Ub ligation junction. (b) The primary sequence of a linear Ub-H2A fusion 
surrounding the Ub-H2A fusion site. L71 and L73 are colored red. (c) All fusions 
employed in this chapter. Fusions are identical in amino acid sequence except for the 
residues depicted. Ub-yH2A was utlized to prevent de-ubiquitylation of the N-




Initial attempts to incorporate the N-terminally ubiquitylated H2A (n-yH2A) into 
chromatin were unsuccessful in that only a truncated version H2A was observed 
in histones extracted from yeast chromatin (Figure 6.2b lane 3). We reasoned 
that this is most likely due to the action of ubiquitin C-terminal hydrolases (or 
possibly DUBs), which are known to remove Ub from linear fusions in this case 
the Ub-H2A(20-116) fusion. To prevent this, we mutated the chimera to remove 
known hydrolase recognition elements in the C-terminus of Ub.200 Specifically, 
we replaced R74 with alanine and deleted G75; note, the resulting fusion is 
referred to as simply Ub-yH2A (Figure 6.1c and Figure 6.2a). Further, as these 
amino acid residues were dispensable in our analysis of hDot1L-mediated 
H3K79 methylation, we expected them to have little impact on yDot1 activity. 
Analysis of yeast expressing Ub-yH2A indicated this strategy was successful in 
that an H2A-containing protein was detected by western blotting at the expected 
MW of the fusions (~18 kDa) (Figure 6.2a and b, lane 4). Critically, ΔRad6 yeast 
expressing this optimized Ub-yH2A construct exhibited partial recovery of H3K79 
methylation (Figure 6.2a and b, lane 4), thereby creating a selective assay 
system to test the role of uLL in vivo. To our knowledge, this is the first instance 
of an in vivo system amenable to mutagenesis of Ub targeted to one specific 
ubiquitylation mark.  
 
Having established this system, we incorporated L71A and L73A into the Ub-
yH2A fusion (uLL-yH2A) and tested for H3K79 di-methylation (Figure 6.2b, lane 





Figure 6.2. An in vivo system to test yDot1 activity. (a) The in vivo analysis of the 
effect of Ub fusion mutants on H3 methylation. Western blot analysis of indicated 
histones as well as the H3 histone modifications, H3K79me2 and H3K4me3,  isolated 
from yeast lysates. Asterisk denotes a non-specfic band. (b) The in vivo analysis of 
the effect of an uLL-yH2A fusion mutant on H3K79me2. Western blot analysis of 
indicated histones and H3K79me2 isolated from yeast lysates. Asterisk denotes a 
non-specfic band. 
 
upper panel lane 4 compared to lane 5). Surprisingly, given the in vitro studies 
employing hDot1L, H3K79me2 levels in yeast were rescued equally by the Ub-
yH2A and uLL-yH2A (Figure 6.2b, lane 4 compared to lane 5). Thus, the Ub 
surface centered on L71/L73 appears not be involved the stimulation of yDot1 in 
vivo, at least in the context of our Ub-H2A fusion system.  
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Expression of Ub-yH2A in yeast was unable to recover H3K4me3 by ySet1C 
(Figure 6.2a, lane 4). This could be due to; (1) additional factors needed for 
efficient H3K4 methylation, (2) the inability for ySet1C to methylate H3K4 where 
H2A-Ub has been incorporated into chromatin at non-specific genomic locations, 
or (3) that the Ub-H2A fusion is not a substrate for ySet1C-mediated H3K4 
methylation. In vitro experiments with ySet1C and Ub-H2A will be discussed 
further in section 6.5.  
 
6.3. The L71/L73 surface in not involved in the stimulation of yDot1 
activity in vitro 
Surprised by the ability of the uLL-yH2A chimera to stimulate yDot1-mediated 
H3K79 methylation in yeast, we next asked whether these findings could be 
recapitulated in a biochemically-defined system. Accordingly, we set out to 
reconstitute MNs in vitro with the same H2A ubiquitin fusions employed in vivo. 
Unmodified yeast histones (yH2A, yH2B, yH3, and yH4) and histones containing 
Ub fusions (n-yH2A, Ub-yH2A, and uLL-yH2A) were expressed in E. coli, purified 
and incorporated into MNs using the appropriate 601 nucleosomal DNA. In 
parallel, a flag-tagged full-length yDot1 was affinity purified from Sf9 cells 
expressing this construct (Figure 6.3a).  3H-SAM methyltransferase assays were 
performed on the various yeast MNs containing the various Ub fusions with both 
yDot1 and hDot1L (Figure 6.3 b and c). To gauge the integrity of the MNs after 
methylation, the reaction products were separated by native PAGE followed by 




Figure 6.3. hDot1L and yDot1 methyltransferase assays on Ub-yH2A fusion 
containing MNs. (a) Coomassie stained SDS PAGE gel showing yDot1 purified from 
Sf9 cells. (b) 3H-SAM hDot1L methyltransferase assays on yeast MNs containing 
yH2A, n-yH2A, Ub-yH2A and uLL-yH2A histones. MNs were visualized by native 
PAGE followed by Sybr gold staining (top panel), and 3H-methyl incorporation was 
probed by fluorography (middle panel). Quantification of methylation was performed 
by filter binding assays followed by liquid scintillation counting (bottom panel). Error 
bars, s.e.m (n = 3). (c) 3H-SAM yDot1 methyltransferase assays on yeast MNs 
containing yH2A, n-yH2A, Ub-yH2A and uLL-yH2A histones. MNs were visualized by 
native PAGE followed by Sybr gold staining (top panel), and 3H-methyl incorporation 
was probed by fluorography (middle panel). Quantification of methylation was 
performed by filter binding assays followed by liquid scintillation counting (bottom 
panel). Error bars, s.e.m (n = 3). (d) H3K79me2 western blot analysis of ‘cold’ SAM 
yDot1 methyltransferase assays on yeast MNs containing yH2A, n-yH2A, Ub-yH2A 
and uLL-yH2A histones. MNs were seperated via SDS-PAGE followed by transfer to a 
PVDF membrane. H3 was blotted to ensure equal loading of MNs (top panel), and 
H3K79me2  was probed  using a H3K79me2 specfic antibody (middle panel). The 
ratio of H3K79me2 to H3 was quantificated by densitometry (bottom panel). 
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panels). The extent of bulk methylation was assessed by filter binding assays 
followed by scintillation counting (Figure 6.3 b and c, lower panel). hDot1L 
methyltransferase activity was stimulated by both n-yH2A and Ub-yH2A fusions 
MNs compared to yH2A MNs (Figure 6.3b, lanes 2 and 3 compared to lane 1). 
Consistent with previous SAR studies, uLL-yH2A MNs were unable to stimulate 
hDot1L activity to the same degree as Ub-yH2A MNs (Figure 6.3b, lane 3 
compared to lane 4). In contrast, yDot1 methyltransferase activity was observed 
for MNs containing all Ub fusion histones (n-yH2A, Ub-yH2A and uLL-yH2A) 
(Figure 6.3c, lanes 2, 3 and 4). To further confirm that yDot1 activity on uLL-
yH2A MNs was comparable to Ub-yH2A MNs, yDot1 methyltransferase assays 
were performed using cold SAM and the extent of H3K79me2 incorporation was 
probed via western blot analysis (Figure 6.3d). Consistent with both the in vivo 
and 3H-SAM methyltransferase assays, a comparable degree of H3K79me2 was 
detected in MNs containing Ub-yH2A and uLL-yH2A MNs (Figure 6.3c and d, 
lanes 3 and 4). The difference in the degree of stimulation of yDot1 activity 
between n-yH2A and Ub-yH2A in the 3H-SAM methyltransferase assay versus 
western blot analysis is most likely a result of the read-out (Figure 6.3, c versus 
d): the radioactive experiment follows bulk methylation, i.e. all three H3K79 
methylation states (H3K79me1/2/3), whereas the Western blot analysis allows for 




Figure 6.4. A time course analysis of yDot1 activity toward xH2B, xH2B-Ub, and 
xH2B-uLL MNs.  3H-SAM yDot1 methyltransferase assays were performed on xH2B, 
xH2B-Ub, and xH2B-uLL MNs over the course of one hour. Quantification of the 
extent of methylation was performed by filter binding assays followed by liquid 
scintillation counting. 
 
Lastly, to further show that the L71/L73 surface on Ub was not critical for yDot1 
stimulation, we tested yDot1 activity on EPL-generated xH2B-uLL MNs, which 
were used to probe hDot1L activity in Chapter 4 (Figure 6.4). 3H-methyl 
incorporation into MNs mediated by yDot1 was followed in a time-dependent 
fashion using xH2B, xH2B-Ub and xH2B-uLL MNs substrates (Figure 6.4). 
Quantification was performed by scintillation counting as described (Figure 6.4). 
Within the time course tested, the yDot1 activity toward xH2B-Ub MNs mirrored 
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that of xH2B-uLL MNs, demonstrating that the L71/L73 surface is not necessary 
for stimulation of yDot1 methyltransferase activity (Figure 6.4, green squares 
compared to red triangles at all time points). Remarkably, although H2B-Ub 
stimulates yDot1 and hDot1L activity, these methyltransferases diverge in their 
requirement of the L71/L73 amino acid residues within Ub to function. 
 
 
6.4. A Ub alanine scan reveals mutants centered on the canonical 
hydrophobic patch of Ub critical for yDot1 stimulation 
Having confirmed that the Ub surface critical for H3K79 methylation is not 
conserved between yDot1 and hDot1L, we wanted to test the activity of yDot1 
toward the Ub-SH act-MN library to identify the surface features of Ub governing 
yDot1-mediated H3K79 methylation. A library of Ub-SH act-MNs (using xenopus 
laevis histones) was prepared as previously described in Chapter 3. However, 
we did not test the Ub12 mutant, and instead opted to investigate uLL instead as 
uLL-SH ligated more efficiently to the act-MN. Ubmut-SH ligations to act-MNs 
were visualized by native PAGE followed by Sybr Gold DNA staining, and 
quantified using densitometry (Figure 6.5). All Ubmut-SH ligations proceeded to a 
comparable extent as Ub-SH with the exception of Ub2-SH, which resulted in a 
reduced absolute abundance relative to Ub-SH (Figure 6.5, lower panel lane 4). 
The lower ligation level observed for Ub2-SH is consistent with previous ligation 
results (see section 3.2). 3H-SAM yDot1 methyltransferase assays were 




    
 
Figure 6.5. Analysis of Ub-SH and Ubmut-SH ligation efficiency to act-MNs. MNs 
were visualized by native PAGE followed by ethidium bromide DNA staining (top 
panel). Quantification of the on-nucleosome ligation was performed by densitometry 
and adjusted relative to Ub-SH act-MNs. Non (grey box), mono (yellow box), and di 
ubiquitylated MNs (blue box) are plotted for each Ubmut-SH. 
 
account the relative abundance of Ubmut-SH act-MNs and Ubstim was calculated 
as in section 3.3 (Figure 6.5a). Interestingly, no single Ub mutant completely 
abrogated yDot1 activity – this should be contrasted with the results for hDot1L 
where Ub12 (represented in this experiment by uLL) had a profound effect on 
methylation activity. Rather, multiple Ubmut-SH act-MNs partially disrupted yDot1L 
activity, namely; Ub1, Ub3, Ub7, and Ub13 (Figure 6.6a). 
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The only Ubmut that partially reduced stimulation of both hDot1L and yDot1 
activity was Ub7 (Figure 6.6a, lane 9). Interestingly, the mutations in Ub1, Ub3, 
and Ub13 constitute a contiguous surface on Ub (Figure 6.6b). Importantly, this 
surface is well known to play a role in Ub-protein interactions (i.e. the canonical 
 
Figure 6.6.  Surface features on ubiquitin critical for yDot1 stimulation. (a) yDot1 
activity with respect to each Ubmut 1-13 (note that uLL has been subsituted for Ub12). 
MNs were visualized by native-PAGE followed by Sybr Gold DNA staining (top panel), 
and 3H-methyl incorporation was probed by fluorography (middle panel). 
Quantification of methylation was performed by filter binding assays followed by liquid 
scintillation counting and adjusted to include the extent of Ub-SH ligation, termed 
Ubstim (bottom panel, see section 3.3). Error bars, s.e.m (n = 3). Ub1 (dark blue box), 
Ub3 (turquoise box), Ub7 (yellow box)  and Ub13 (orange box) mutants led to a partial 
reduction in yDot1 stimulation. (b) Summary of alanine scanning results. Residues 
colored in grey did not have an effect on hDot1L stimulation, those colored in white 
were not tested. Ub1 (dark blue), Ub3 (turquoise), Ub7 (yellow)  and Ub13 (orange) 
are shown. With the exception of Ub7, these mutations are centered around the 
canional hydrophobic patch on Ub (Ub13). 
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hydrophobic Ub surface discussed in section 3.1). Thus, an important avenue for 
future experiments will be to further validate this finding through additional 
biochemical experiments (e.g. using fully reconstituted mutant H2B-Ub MNs) as 
well as in vivo studies using the yeast Ub-H2A chimera system described earlier 
in this chapter. 
 
6.5. The L71/L73 surface of Ub is required for ySet1C stimulation 
We next investigated the broader role of the L71/L73 surface patch on Ub by 
focusing on H3K4 methylation by ySet1C in vitro.  Our decision to use the 8 
subunit yeast complex was driven by several considerations the most important 
of which was its availability in highly pure form from an insect cell over-
expression system. Indeed, this recombinant system has proven extremely 
powerful for dissecting aspects of the H2B-Ub crosstalk with H3K4me – in 
particular the role of the various ySet1C subunits in sensing H2B-Ub.201  We first 
wanted to test whether yeast MNs containing Ub-yH2A were able to upregulate 
ySet1C methyltransferase activity in vitro, particularly since the Ub-yH2A chimera 
was unable to stimulate H3K4 methylation in vivo. ySet1C was affinity purified 
from Sf9 cells co-infected with baculoviruses that express FLAG-Set1 and the 




Figure 6.7. ySet1C methyltransferase assays with Ub-yH2A and H2B-Ub MNs. 
(a) Coomassie stained SDS PAGE gel showing ySet1C purified from Sf9 cells. All 
subunits are labeled. (b) 3H-SAM ySet1C methyltransferase assays were performed 
on xH2B-Ub and Ub-yH2A containing MNs (DNA visualized by Sybr Gold, top panel) 
using ySet1C. 3H-methyl incorporation was detected by fluorography (bottom panel). 
(c) 3H-SAM methyltransferase assays were performed on xH2B, xH2B-Ub and xH2B-
uLL MNs (DNA visualized by Sybr Gold, top panel) using ySet1C. 3H-methyl 
incorporation was detected by fluorography (middle panel) and quantified using 







Ub-yH2A MNs could stimulate ySet1C activity in a 3H-SAM methyltransferase 
assay using xH2B-Ub MNs as a positive control (Figure 6.7b). Consistent with 
previous studies86, 201, unmodified MNs were unable to stimulate ySet1C 
methyltransferase activity, whereas xH2B-Ub containing MNs supported robust 
methylation (Figure 6.7b, lanes 1 and lane 3 compared to 2). No detectable 
stimulation of ySet1C was observed using Ub-yH2A MNs under the same 
conditions (Figure 6.7b, lane 2 compared to lane 4). These results explain why 
we were unable to rescue H3K4me3 using the Ub-yH2A fusion in vivo (Figure 
6.2), i.e. the Ub-H2A fusion does not seem to be recognized by ySet1C as an 
H2B-Ub mimic, whereas this is the case for yDot1. 
 
We next wanted to test whether the L71/L73 surface on Ub was required for the 
stimulation of ySet1C activity, analogous to hDot1L. 3H-SAM methyltransferase 
assays were performed on xH2B, xH2B-Ub, and xH2B-uLL MNs (Figure 6.7c). 
As before, ySet1C was stimulated by xH2B-Ub MNs and showed no activity 
towards xH2B MNs (Figure 6.7c, lane 1 compared to lane 2). Surprisingly, and 
analogous to hDot1L, ySet1C was not stimulated by xH2B-uLL MNs (Figure 6.7c, 
lane 3). Thus, the requirement of UbL71/L73 in H3 methyltransferases activity is 
conserved between ySet1C and hDot1L, highlighting the importance of this 






6.6. Summary and conclusions 
As H2B-Ub is conserved between yeast and humans and is a prerequisite in both 
organisms for H3K4 and H3K79 methylations, we explored the surface features 
of Ub in the H2B-Ub stimulation of yDot1 and ySet1C activity. We designed an in 
vivo system to test the affect the uLL mutant had on yDot1 in yeast. This was 
done through the generation of an N-terminally fused Ub to a truncated H2A, 
creating a genetically tractable construct that mimicked the MNs positioning of 
H2B-Ub. Using this system we were able to partially recover H3K79me2 
methylation and elucidate that yDot1 activity was stimulated by Ub-yH2A and 
uLL-yH2A similarly in an in vivo context.  Unfortunately, we did not detect H3K4 
methylation leading us to conclude, and later confirm in vitro, that Ub-yH2A does 
not upregulate ySet1C activity. 
 
 
This most surprising finding in this chapter is that the yeast Dot1 enzyme was 
unaffected by mutation of the L71/L73 surface on Ub, both in vivo and in vitro. 
Rather our preliminary SAR data indicates that the yeast enzyme senses a 
different surface of Ub, one that localizes to the canonical hydrophobic patch on 
the protein (i.e. centered on residues L8 and I44) that is known to engage a wide-
range of target proteins through typically helical ubiquitin interaction domains.53, 
184 As demonstrated in Chapter 3, the hDot1L does not require the canonical 
hydrophobic patch on Ub for stimulation, but rather senses L71/L73. Thus, there 
is a clear divergence in how the yeast and human versions of this 
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methyltransferase readout H2B-Ub. This remarkable finding speaks to 
information-rich nature of the Ub protein itself; the large size of the modification 
(say compared to methylation or acetylation) means that it can engage trans-
acting factors through different non-overlapping surfaces, perhaps even 
mediating multiple biochemical processes simultaneously. With respect to this, 
we note that the L71/L73 surface is not required for H2B-Ub mediated structural 
changes on the chromatin fiber (see Chapter 5) – in other words H2B-Ub 
appears to be able to simultaneously decompact chromatin and stimulate 
hDot1L.117 
 
We can only speculate as to why the yeast and human versions of Dot1 sense 
different surfaces of Ub, despite the fact that both enzymes share a highly 
homologous catalytic core. As noted at the beginning of this chapter, the overall 
size and domain organization of the enzymes differ markedly. The human 
enzyme contains 1739 amino acids, as opposed to 582 for the yeast enzyme. 
The former contains a DNA-binding motif on the C-terminal side of the catalytic 
domain, whereas the latter contains this motif N-terminal the catalytic domain. 
Thus, there may be geometric differences in the way these two enzymes engage 
the nucleosome. Further to this point, biochemical studies have identified a short 
ubiquitin-binding domain in yDot1 that in not conserved in the human enzyme. It 
is likely relevant to consider that histone ubiquitylations underwent a rapid 
expansion from yeast to humans, with only 2 (H2BK123-Ub, and H3-Ub) in yeast, 
to 36 Ub sites annotated across the 4 histones in mammalian cells.58 Thus, the 
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business of discriminating between stimulatory and non-stimulatory histone 
ubiquitylation sites would seem to be a much more challenging task for hDot1L 
than its yeast counterpart. Conceivably, this readout may be more selective when 
the L71/L73 surface of Ub is employed due its spatial proximity to the histone 
attachment site – this would allow for a composite recognition epitope involving 
both Ub and the local histone surface. Additional biochemical analyses will be 
needed to test this idea. 
 
In the last part of this chapter, we asked whether the L71/L73 surface patch on 
Ub is required for stimulation of the ySet1C H4K4 methyltransferase. We found 
that Ub fused to an N-terminally truncated version of H2A (Δ1-20) was unable to 
stimulate H3K4 methylation. Previously studies have shown that the H2A tail is 
dispensable for H2B-Ub stimulation of ySet1C199. Thus, it is likely that the 
inability of Ub-yH2A to activate ySet1C results from this being an imperfect mimic 
of H2B-Ub, presumably this enzyme complex is intolerant of the changes in 
positioning and attachment site associated with the Ub-H2A fusion. Indeed, it is 
known ySet1C-mediated H3K4 methylation is sensitive to mutation of residues 
immediately around the Ub attachment site on H2B; a H2B-R119A/T122D 
construct reduced global levels of chromatin bound ySet1C in vivo even in the 
presence of high levels of H2B-Ub.198 This finding combined with the results of 
this chapter, that ySet1C requires UbL71/L73 for H3K4 methylation, suggests 
that a composite surface between H2B and Ub is required for ySet1C function.  
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Chapter 7. Discussion and outlook 
7.1. Introduction 
The ubiquitylation of H2B at lysine 120 is intimately involved in transcription 
elongation, acting as both a positive regulator of H3K4 and H3K79 methylation, 
as well as contributing to the maintenance of a less compact local chromatin 
state.64, 86, 117, 118 This is achieved through specific properties of the ubiquitin 
modification, and is not simply due to the steric bulk of adding an 8.5 kDa protein 
to the nucleosomal surface. The work presented in this thesis describes the 
biochemical characterization of the surface features of Ub that are sensed by the 
enzymes responsible for H3K4 and H3K79 methylation, Set1 and Dot1, 
respectively. Additionally, the structural implication of H2B-Ub was assessed and 
provided insight into H2B-Ub chromatin structure in regard to H2B-Ub function.  
Collectively, this work is indicative of Ub as an information rich modification able 
to orchestrate distinct biochemical functions on chromatin by using non-
overlapping surface epitopes. A synthesis of the impact of this work in regard to 
H2B-Ub function and a conceptual framework for the advancement of histone 
PTM biology will be addressed below.    
 
 
7.2. The post-translational modification of pre-assembled nucleosomes. 
Several methods for the preparation of Ub substrates have been described, 
making the biochemical reconstitution of homogenous ubiquitylated histone 
containing chromatin accessible.118, 121, 152 A caveat to these existing methods is 
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the need to prepare H2B-Ub prior to its incorporation into chromatin, resulting in 
a multi-step process that is both time-consuming and sample intensive. Herein, 
we greatly simplify the process by showing that Ub can be chemically introduced 
in a site-specific fashion to a pre-assembled MN. This approach involves an 
asymmetric disulfide formation reaction, compatible with nucleosomal 
reconstitution protocols, and achieves regioselectivity by exploiting the ability to 
introduce a unique cysteine residue into recombinant chromatin. As this method 
relies on the late stage diversification of the ubiquitin substrate, systematic 
structure-activity analysis of the system becomes tractable, as demonstrated in 
Chapter 2.   
 
This approach will be of use to study other histone ubiquitylations and their 
associated functions in a high throughput manner. Moreover, through 
combination with the ubiquitin alanine mutant library from Chapter 3, the 
elucidation of SARs in other ubiquitylated histone contexts becomes feasible. 
Additionally, the disulfide attachment chemistry employed has the attractive 
feature that the modification can be removed through simple reduction, thereby 
offering the potential to study, in a time-resolved way, the functional and 
structural consequences of PTM removal.  
  
7.2.1. The application of cysteine chemistry to other histone PTMs 
It may be possible to adapt our on-nucleosomal ligation strategy to give non-
reducible thioether linkages through use of alternate thiol-directed chemistries, 
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such as the conversion of cysteine into dehydroalanine or via thiol-ene 
chemistry.202, 203 Alternatively, analogs of other PTMs can, in principle, be 
introduced chemically into pre-assembled chromatin using known cysteine 
derivatization routes, for example, lysine methylation,138 and acetylation.176 
Conceivably, other chemical functionalities utilized in bio-orthogonal reactions 
(e.g. an azide functionality) could be used instead of cysteine, thereby further 
expanding the palette of chemistries that can be exploited to install PTMs into 
pre-assembled chromatin.204 This could be achieved through the preparation of 
histones with bio-orthogonal amino acid residues via unnatural amino acid 
mutagenesis and EPL.159, 172 Additionally, thiol-directed chemistries could be 
used in combination with these chemistries, enabling the chemical multi-
modification of pre-assembled chromatin. 
 
7.2.2. The application of split inteins to histone PTMs 
Alternatively, split inteins could be utilized for the incorporation of histone PTMs 
into a pre-assembled MN. Split inteins are naturally occurring inteins that are split 
into two fragments (N-intein and C-intein) and direct protein splicing in trans.165 
This results in the polypeptide N-terminal to the N-intein being spliced to the 
polypeptide C-terminal to the C-intein (Figure 7.1a). Histone peptides, containing 
PTMs, can be synthesized through SPPS, and subsequently incorporated into 
either the N- or C- intein fragment construct using EPL.164 As discussed in 





Figure 7.1. The application of split inteins to generate histone PTMs within the 
nucleosome (a) Split inteins are naturally occuring inteins that splice proteins in 
trans. Fragment A (green box) is ligated to Fragment B (pink box) through trans 
splicing subsequent to the association of the N-intein (labled N-Int) and C-intein 
(labeled C-Int). Trans splicing requires a cysteine which remains in the final A-B 
construct (right panel). (b)  Through the synthesis of a PTM containing histone peptide 
construct N-terminal to the N-intein fragment, histone PTMs can be introduced into 




necessary for ligation. This is a requirement for split intein function and we 
suspect, based on mutations made in nucleosomes in the preceding chapters, 
that the introduction of a cysteine mutation into the nucleosome will not 
significantly impact nucleosome structure or function. However, it may also be 
possible to desulfurize pre-assembled nucleosomes by adapting currently 
employed histone desulfurization methods to be amendable to non-denaturing 
conditions.121  
 
We envision, much like the ubiquitylation of activated MNs, split inteins could be 
utilized to install PTMs into pre-assembled chromatin containing histones fusions 
to either an N or C-intein fragment. The advantage of this approach would be to 
expedite the incorporation of histone PTMs into the MN, as histone PTM peptides 
would need only to be ligated to either an N- or C-intein fragment, which then 
could be directly incorporated into chromatin. Moreover, with the newly 
discovered ultrafast split inteins these reactions could be performed at extremely 
low reactant concentrations (the intein fragments have picomolar affinity) and 
would be complete in a matter of seconds.165 This would enable the streamlined 
synthesis of modified MNs and substantially reduce the amount of histone PTM 
peptide needed (typically yields from octamer reconstitution to nucleosome 
formation are ~10-20%)180. This approach could be utilized to titrate the amount 
of a histone PTM (or modification state, e.g. me1, me2, and me3) into chromatin, 
through combination with differentially modified histone tail-intein fragments. 
Adding an additional layer of complexity, orthogonal split intein fragments could 
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be incorporated into chromatin, creating a template for the generation of multi-
PTM containing MNs.205  
 
The use of split inteins may additionally facilitate the investigation of histone 
PTMs in vivo, as the modulation of enzyme activity or mutation of histone PTM 
sites often have multiple biological outcomes (i.e. chromatin modifiers often have 
multiple targets and histone modification sites often are modified with multiple 
types of PTMs).47 Our lab has recently begun to pursue in vivo chromatin 
modification with engineered split inteins applied to the study of H2B-Ub in 
mammalian cells.4 Specifically, this was achieved through the in vivo expression 
of an H2B(1-116)-N-intein fragment and the subsequent addition of a 
complementary K120 ubiquitylated C-intein-H2B(117-125)-Ub fragment. Through 
this technique, we envision that SAR studies, much like the in vitro mutagenesis 
of the Ub surface, can be elucidated in an in vivo context similar to the 
techniques introduced in Chapter 6. Further, the use of split inteins in vivo 
enables the incorporation of biophysical probes and bio-orthogonal handles into 
native chromatin which will be of great use in a variety of applications such as 
monitoring chromatin dynamics.164 
                                            
 
4	  This is the work of Dr. Miquel Vila-Perello and Dr. Yael David Shternberg in 
Professor Tom Muir’s lab at Princeton University.	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7.2.3. The post-translational modification of histones within pre-assembled MNs 
in high throughput systems 
The post-translational modification of pre-assembled MNs, activated for 
ubiquitylation or through the establishment of methodologies previously 
discussed (collectively referred to as Post-translationally modified after 
reconstitution (PAR-)), may be of use in combination with methodologies that 
take advantage of high-throughput DNA sequencing and mass spectrometry. The 
Muir laboratory has recently developed a high throughput chromatin biochemistry 
platform based on the generation and subsequent ChIP-Seq analysis of DNA-
barcoded MN libraries containing user-defined DNA and/or histone 
modifications.5 Using multiplexed next generation sequencing, it possible to 
perform thousands of biochemical assays in parallel and deduce, in a 
quantitative fashion, the binding preferences or substrates preferences of 
chromatin modifiers. We envision that encoded PAR-MNs could add to the 
flexibility of this approach. In this strategy, a library of PAR-MNs (containing 
either single cysteine mutations or split intein fusions) would be uniquely 
encoded. Depending on the type of library needed, these PAR-MNs could be 
diversified and pooled. The advantage of this would be that the library could be 
tailored to the biochemical question and easily adapted, which is not possible 
with current methodologies. For instance, encoded PAR-MNs could be 
                                            
 
5	  This is the work of Dr. Uyen Nguyen in Professor Tom Muir’s lab at Princeton 
University.	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ubiquitylated, with either wild-type Ub or Ub mutants, and high-throughput assays 
could be performed as an alternative way to test both enzyme activity, i.e. pull 
downs directed towards a chromatin modification (e.g. H3K79me2), or relative 
binding affinity (e.g. hDot1L), i.e. pull downs directed towards the chromatin 
binder. Accordingly, PAR-MNs have the potential to greatly expedite powerful 
approaches to study histone PTMs in well-defined systems.  
 
7.2.4. The application of PAR-MNs to investigate ‘H2B-Ub-like’ ubiquitylations  
‘H2B-Ub-like’ ubiquitylations that can recapitulate specific H2B-Ub functions have 
been identified and suggested. 22, 157, 206 Specifically, H2BK34 ubiquitylation is 
able to stimulate H3K4 and H3K79 methylation. This was observed both in vivo 
and in vitro in the absence of H2BK120-Ub.157 Recently, this remarkable finding 
has been extended to H4K31 ubiquitylation.206 As these ubiquitylation sites 
localize to distinct regions within the nucleosome, it is unclear how these histone 
ubiquitylations perform similar functions (Figure 7.2). Further, the transcription 
factor NY-F has been structurally characterized in complex with DNA and shown 
to be homologues to a H2A/H2B dimer containing two histone folds through a tri-
meric complex (comprised of NY-y, NY-b, and NY-a).22 Interestingly, NY-F is 
ubiquitylated at K138 of the subunit NY-y, which corresponds to that of H2BK120 
based on structural alignment (Figure 7.2).22 Collectively, these studies suggest 





chromatin factors may be functionally redundant for H2B-Ub associated 
functions. Further work is necessary to explore these ubiquitylations and the 
alanine mutant library employed in Chapter 3 could be employed to test whether 
the specificity of hDot1L for L71 and L73 is conserved between the different 
histone ubiquitylation sites. 
 
 Recent proteomic studies have identified numerous histone ubiquitylation sites 
(i.e. in addition to those noted above) whose epigenetic functions are completely 














Figure 7.2. Ubiquitylations that recapitulate H2BK120 ubiquitylation functions. 
Multipe histone ubiquitylation sites (in black) and the transcription factor NY-F, a H2B-Ub 
PTM mimic, could potentially regulate H3K79 methylation similar to H2BK120-Ub. The 
MN is shown (PDB 1KX5), H2A (yellow), H2B (red), H3 (blue), H4 (green). All potential 
ubiquitylation sites that have been shown to regulate hDot1L are labeled. Inset: NY-F in 
complex with DNA (PDB 4AWL) is shown. The H2BK120 ubiquitylation site analog NY-y 
K138 is labeled. 
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are capable of stimulating H3 methyltransferases (and potentially other chromatin 
modifiers). This could serve to focus in vivo studies on the relevance of such 
marks. Testing this would be feasible through the expression of histone cysteine 
mutants and incorporation into MNs using optimized MN reconstitution 
procedures. Furthermore, these MNs could be encoded and pooled to create a 
comprehensive library of ubiquitylated nucleosomes, where these nucleosomes 
could be studied in a competitive fashion. Specifically, methyltransferase assays 
in high-throughput systems could reveal whether hDot1L is stimulated equally by 
identified ubiquitylation sites.  
 
7.3. H2BK120 ubiquitylation in chromatin structure 
 
7.3.1. H2B-Ub nucleosomal structure 
Understanding the intrinsic structural implications of H2B-Ub as a histone PTM is 
crucial to elucidate its associated processes. In Chapter 5 we took multiple 
approaches to determine what effect Ub had on chromatin structure and 
specifically tested whether any observed structural change was mediated by the 
L71/73 hotspot necessary for H3 methyltransferase regulation. Although much of 
this work is in its infancy, we have not been unable to detect a significant 
structural change in the nucleosome caused by Ub or uLL. We hypothesize that 
ubiquitin does not significantly affect the nucleosome structure and, furthermore, 
that hDot1L regulation by H2B-Ub is not dependent on a change in nucleosome 
conformation. This is based on: (i) that only minor perturbations of ILV residues  
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within Ub are observed via methyl-TROSY in H2B-Ub nucleosomes; (ii) mPEG 
assays failed to detect a difference in H3K79C solvent accessibility; (iii) all 12 
permissive alanine Ub mutants (which contain the majority of Ub surface 
residues) stimulate hDot1L-mediated H3K79 methylation, and; (iv) uLL, which 
does not stimulate hDot1L activity, was directly observed in the methyl-TROSY 
analysis. The hypothesis most consistent with the findings of this thesis is that Ub 
merely ‘hangs off’ of the H2BK120 surface and does not maintain any specific 
Ub-nucleosome contacts (Figure 7.3a). This is further substantiated as the effect 
of H2B-Ub on nucleosomal stability is modest116 and that H2B-Ub functions are 
recapitulated by multiple distinct histone ubiquitylations, and thus the spatial 




Figure 7.3. The contribution of ubiquitin to nucleosomal and array structure.  (a) 
Little, if any, structural change is observed in the nculeosome upon H2B 
ubiquitylation.  (b) In the context of nucleosomal arrays, ubiquitin could interact inter-




Future investigation of Ub in the context of the H2B-Ub nucleosome is warranted 
and is being further investigated using the methyl-TROSY approach presented in 
Chapter 5.6 Additionally, paramagnetic relaxation enhancement (PRE) 
experiments in the context of the ILV labeled nucleosomes may be of use to 
obtain Ub-position sampling information on H2BK120-Ub nucleosomes. PRE 
experiments detect long-range distance information (~5-30nm) and thus a 
paramagnetic spin label attached to Ub could reveal how Ub is positioned within 
the nucleosome.190, 207 Specifically, Ub-SH could be engineered to contain S-
Methanethiosulfonylcysteaminyl-EDTA–Mn2+ (a paramagnetic spin label) distal to 
the Ub ligation junction. Proximity of this spin label on ubiquitin to different 
regions of the nucleosome, would reveal which, if any, specific orientation was 
favored as the presence of the paramagnetic spin label reduces the peak 
intensities in the nucleosome in a distance-dependent manner.190 
 
7.3.2. H2B-Ub in chromatin compaction 
Since the mutation of the L71/73 epitope has no impact on the ability of H2B-Ub 
to inhibit chromatin compaction, it is still unclear how this is achieved by ubiquitin. 
Conversely, as the compaction properties of a nucleosomal array is intimately 
intertwined with chromatin structure, we can infer that the structure of H2B-uLL 
containing arrays is similar to that of H2B-Ub arrays. However, as Hub1ylated 
nucleosomal arrays show no such alteration in array compaction properties 
                                            
 
6	  This is the work of Dr. Julianne Kitveski in Professor Lewis Kay’s lab at the 
University of Toronto.	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(compared to unmodified arrays), the regulation of chromatin structure by H2B-
Ub appears to be sequence specific. Collectively, as H2B-Ub has little, if any, 
structural effect on the nucleosome, a specific, i.e. not exclusively steric, H2B-Ub 
inter-nucleosomal interaction in the context of nucleosomal arrays could 
potentially mediate this effect (Figure 7.3b). The positioning of the H2BK120 site 
in the context of the tetra-nucleosome x-ray crystal structure and chromatin array 
models indicates that this may indeed be the case.117, 208  
 
We propose that the library of alanine Ub mutants developed in Chapter 3, in 
combination of pre-assembled activated chromatin arrays could be employed to 
determine whether a discrete epitope on the Ub surface is responsible for the 
inhibition of array compaction. Specifically, H2BK120C could be incorporated in 
octamers, activated with DTNB, and incorporated into 12-mer nucleosomal 
arrays. Prior to array precipitation (a crucial step in the purification of 
nucleosomal arrays), these pre-assembled arrays could be ubiquitylated with Ub-
SH and the library of Ubmut-SHs. Homo-FRET assays followed by SDS-PAGE 
analysis of the arrays (to determine the extent of ubiquitylation) could be 
performed to normalize for the extent of ubiquitylation as it is additive in the 
context of chromatin compaction.117 Further, if specific Ub mutants are found that 
do not alter the chromatin compaction behavior of these arrays, crosslinking 




We must be cautious as to attribute too much significance to results using Hub1, 
however, as Hub1ylated chromatin is neither native nor shown to function in an 
‘H2B-Ub-like’ manner. More work to confirm that Hub1 is well folded and able to 
recapitulate the sterics of Ub, in the context of H2B-Ub chromatin, is needed. 
Given the inability of a Hub1-Ub chimera to stimulate hDot1L, it is also possible 
that Hub1 may not be a ‘passive’ Ub-like molecule in the context of the 
nucleosome but may intrinsically disrupt H2B-Ub processes through other 
undefined means. 
 
7.4. H2B-Ub regulation of H3 methyltransferase activity 
Our structure-activity studies establish a hydrophobic surface on ubiquitin, 
comprising L71 and L73, that is required for the stimulation of hDot1L-mediated 
H3K79 methylation as well as ySet1C-mediated H3K4 methylation. Surprisingly, 
these amino acid residues were not required for yDot1-mediated H3K79 
methylation, and in Chapter 6, we were able to identify (although follow up 
studies are on going) that the canonical hydrophobic surface (L8/I44) on Ub 
promoted this methylation instead. Taken together, H2B-Ub is able to regulate 
these three H3 methyltransferases through either the L8/I44 or L71/L73 
hydrophobic patches. As these patches are spatially adjacent in the Ub tertiary 
structure it is surprising –in the case of hDot1L and yDot1- that each patch 
regulates these enzymes separately (Figure 7.4). Taken together, as hDot1L is 
not homologous to ySet1C, but is homologous to yDot1, a conserved Ub  
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recognition element or allosteric mechanism within these proteins is unlikely.121, 
201, 209 
 
7.4.1. Insights into the mechanism of hDot1L regulation by H2B-Ub 
The three non-mutually exclusive hypotheses, in section 1.3.3.2, for the 
regulation of hDot1L activity by H2B-Ub were predicated upon the fact that this 
regulation occurs intra-nucleosomally (Figure 1.7).118, 121 We can now readjust 
our hypothesis to integrate the information contained herein. As we have been 
unable to detect a significant structural change in the nucleosome upon H2B 
ubiquitylation (specifically in the L71/73 patch that is required hDot1L activity) we 
posit that hDot1L forms direct hDot1L-Ub contacts mediated by L71 and L73 
               
Figure 7.4. The proxmity of the L8/I44 and L71/L73 hydrophobic patches. Both 
L8/I44 (orange) and L71/L73 (red) hydrophobic patches are adjacent in the tertiary 
structure of ubiquitin.  
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within Ub (Figure 1.7 b and c). We note that that hDot1L binds to the nucleosome 
in the presence of absence of Ub.152 Thus, the putative hDot1L-Ub interaction 
would either have to allosterically activate the enzyme and/or simply lead to a re-
positioning of hDot1L on the nucleosome surface to facilitate K79 methylation. 
 
Crosslinking studies to detect whether hDot1L interacts directly with the L71/73 
surface are underway.7 Photo-leucine, a diazirine containing cross-linking mimic 
of leucine, was incorporated in ubiquitin at position L73 and ligated to H2B via an 
asymmetric disulfide approach. This construct can further be incorporated into 
MNs, and then cross-linking can be carried out in the presence of hDot1L upon 
UV radiation. Upon reduction of Ub-SH from the nucleosomes we expect, based 
on our model, to detect an Ub-hDot1L cross-linked species. Further, if a cross-
link between hDot1L is demonstrated, the identification of the interaction site 
within hDot1L would be crucial to understand the consequences of this 
recognition.  
 
The modulation of hDot1L binding affinity to the nucleosome by Ub could be 
elucidated through the determination of binding constants of hDot1L to the H2B 
and H2B-Ub nucleosomes. Potentially, the contribution of Ub to hDot1L binding 
the nucleosome could be minor as hDot1L is reported to interact with the 
unmodified nucleosome similar to the H2B-Ub nucleosome in low resolution gel 
                                            
 
7	  This is the work of Catlin Zhou in Professor Tom Muir’s lab at Princeton 
University.	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shift assays (presumably through the H4 basic patch and nucleosomal DNA).121, 
145, 147 Detecting a binding difference, if any, would provide much needed insight 
into how hDot1L engages the nucleosome. Further, the specific contributions of 
each nucleosomal recognition element could be investigated through 
mutagenesis. Although, an hDot1L-H2B-Ub MN co-crystal structure would be the 
most informative to how hDot1L engages the H2B-Ub nucleosome, this is 
potentially the most challenging undertaking.  
 
7.4.2. Future avenues in the investigation of hDot1L  
Many facets of hDot1L regulation remain to be explored and are highlighted 
below as possible areas of investigation: 
 
(i) hDot1L has been shown to interact with long non-coding RNAs (lncRNA) 
(Figure 7.5).210 Specifically, the lncRNA PRNCR1 was found to bind to the 
androgen receptor protein within DNA enhancer elements where its association 
with hDot1L led to the methylation of the androgen receptor. An hDot1L-
PRNCR1 interaction was identified by a mass spectrometry pull down with the in 
vitro transcribed PRNCR1. It would be interesting to investigate the mechanism 
by which hDot1L is recruited by PRNCR1, and use hDot1L to pull down and 
identify other hDot1L interacting lncRNAs. Additionally, methylation of the 
androgen receptor led to the recruitment of another lncRNA, PCGEM1. As 















Figure 7.5. The many facets of hDot1L regulation. hDot1L (i) interacts with 
lncRNAs (green), (ii) methylates the androgen receptor (labeled AR, pink), (iii) is 
heavily post-translationally modified (Dot1 in blue, P denotes a phosphoylation site), 
(iv) and interacts with RNA Pol II (black). The catalytic domain of hDot1L is shown in 
blue (PDB 1NW3) along with the rest of hDot1L (blue oval) which structure has not 
been determined. Nucleosomes containing histone PTMs are shown as these are 
chromatin-templated processes. 
 
interesting to investigate whether any lncRNAs interact with the H3K79 
methylated nucleosome.210 
 
(ii) Additionally, it would be worthwhile to investigate the ability of hDot1L to 
methylate non-histone substrates (Figure 7.5). Currently, the androgen receptor 
protein is methylated by hDot1L at K349 and is the only identified non-H3K79 
methylation attributed to hDot1L.210 Genome-wide chromatin methylation profiling 
in the presence or absence of hDot1L could reveal additional hDot1L 
substrates.211 Additionally, it would be interesting to investigate whether the 
methylation of the androgen receptor, (or additional methylations attributed to 
hDot1L) is Ub-dependent. As this is presumably a chromatin-templated process, 
either H2B-Ub or the ubiquitylation of the androgen receptor itself may be 
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required for this methylation. Interestingly, Ub-proteomic screens have identified 
multiple ubiquitylation sites within the androgen receptor.58  
 
(iii) hDot1L is heavily acetylated and phosphorylated (Figure 7.5).212 These PTMs 
have been annotated in the catalytic core of hDot1L, in the region directly C-
terminal to the catalytic core of hDot1L required for binding MNs, and near the 
identified site of hDot1L-RNA Pol II interaction (this is a RNA Pol II CTD S2ph 
and S5ph based interaction).130, 212 It would be fascinating to test the effect of 
these modifications on the modulation of hDot1L-protein and hDot1L-chromatin 
interactions as well as H3K79 methylation activity. As these modification sites are 
localized towards the C-terminus of the catalytic domain, a post-translationally 
modified hDot1L is an ideal candidate for EPL. 
 
(iv) Lastly, given the recently identified RNA Pol II-hDot1L interaction130 and the 
ability to reconstitute transcriptional systems with semi-synthetic H2B-Ub (or 
H2B-uLL), it would be interesting to test what impact the L71/73 surface has in a 
broader in vitro chromatin context i.e. whether this surface is conditionally or 
absolutely required (Figure 7.5). Interestingly, hSet1C-mediated methylated can 
be stimulated through the co-activator P300 combined with the transcription 
factor p53 with methyltransferase activity being indistinguishable in the presence 
or absence of H2B-Ub.197 It would be interesting to elucidate whether hDot1L can 
be activated in the absence of H2B-Ub mimicry, which could be potentially 




The ubiquitylation of H2B at K120 is an information rich post-translational 
modification implicated in both trans-histone pathways and the alteration of 
chromatin structure through discrete epitopes of the ubiquitin surface. Herein, we 
gained much insight into the many facets of H2B-Ub regulated chromatin 
processes. However, much remains to be explored in this complex system. The 
experimental approaches proposed above will enhance our understanding of 
H2B-Ub functions as well as allow for the investigation of the regulation of 
hDot1L in a greater detail.  
 
The biochemical analysis of chromatin-templated processes is integral to the 
understanding the complexity of chromatin functions at the molecular level. 
Accordingly, the strategies developed within this thesis and discussed herein will 
serve to expedite the reconstitution of chromatin containing histone PTMs. We 
anticipate that, in combination with the substantially improved epigenomic 
methods that quantitatively discern the contribution of these epigenetic marks 
within the nucleus, the further biochemical analysis of modified chromatin has the 
potential to substantially expand our knowledge of the underlying mechanisms of 
chromatin function. 
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Chapter 8 Materials and Methods 
8.1 Materials 
Amino acid derivatives, coupling reagents and resins were purchased from 
Novabiochem (Merck, NJ). The thiol activating reagents 2,2'-dithiobis(5-
nitropyridine) (DTNP), 5, 5’-Dithiobis(2-nitrobenzoic acid) (DTNB), and cystamine 
dihydrochloride were purchased from Sigma-Aldrich Chemical Company 
(Milwaukee, WI). [3H]-S-adenosyl methionine (3H-SAM), Amplify solution and 
Sephacryl S-200 resin were obtained from GE Healthcare (Waukesha, WI). S-
adenosyl methionine was obtained from New England Biolabs (Ipswich, MA). 15N 
labeled ammonium chloride and deuterium oxide (99.9%) were purchased from 
Cambridge Isotopes. All other commonly used chemical reagents and solvents 
were purchased from Sigma-Aldrich Chemical Company (Milwaukee, WI) or 
Fischer Scientific (Pittsburgh, PA). Chemically competent DH5alpha, BL21(DE3), 
and BL21(DE3)pLysS cells were purchased from Novagen (Madison, WI). The 
pTXB1 vector, restriction enzymes, T4 DNA ligase, chitin resin, and NiNTA resin 
were obtained from New England BioLabs (Ipswitch, MA). Primer synthesis and 
gene sequencing were performed by Integrated DNA Technologies (Coralville, 
IA) and Genewiz (South Plainfeld, NJ), respectively. Criterion 15% Tris-HCl and 
5% TBE gels were purchased from BioRad (Hercules, CA). Centricons were from 
Sartorius (Goettingen, Germany) and dialysis cassettes were from Pierce 
(Rockford, IL). PCR purification and gel extraction kits were purchased from 
Qiagen (Valencia, CA).  
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Table 7.1. List of antibodies used in this thesis. 
Antigen Supplier Identifier  
H3  Abcam  Ab1791 
H3K79me2  Abcam  Ab3594 
H3K4me3  Abcam  Ab7766 
yH2A  Active Motif  39235 
yH2B  Active Motif  39237 
 
 
8.2 Equipment  
Size-exclusion and ion-exchange chromatography were performed on an AKTA 
FPLC system from GE Healthcare equipped with a P-920 pump and UPC-900 
monitor. Analytical reversed-phase HPLC (RP-HPLC) was performed on a 
Hewlett-Packard 1100 series instrument with a Vydac C18 column (5 micron, 4 x 
150 mm), employing 0.1% TFA in water (A), and 90% CH3CN, 0.1% TFA in 
water (B), as the mobile phases. Typical analytical gradients were 0-73% B over 
30 min at a flow rate of 1 mL/min. Preparative HPLC was carried out on a Waters 
prep LC system comprised of a Waters 2545 Binary Gradient Module and a 
Waters 2489 UV detector. A Vydac C18 process column (15-20 micron, 50 x 250 
mm) or a semi-preparative column (12 micron, 10 mm x 250 mm) was employed 
at a flow rate of 30 mL/min, or, 4 mL/min, respectively. ESI-MS analysis was 
conducted on a Sciex API-100 single quadrupole spectrometer or Bruker 
Daltonics MicrOTOF-Q II mass spectrometer. All protein starting materials and 
ligation products were analyzed by C18 analytical RP- HPLC and ESI-MS. 
Scintillation counting was performed on a LKB Wallac 1209 RackBeta Primo 
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Liquid scintillation counter. All fluorescent measurements were done on a 
Fluorolog-3 fluorescence spectrometer (HORIBA Jobin Yvon, Edison NJ). 
 
8.3 Cloning 
All plasmids were prepared by either site directed mutagenesis or restriction 
enzyme-free cloning of the construct into a suitable plasmid.213 Synthetic 
constructs were purchased directly from Integrated DNA technologies.  All 
previously unreported constructs used throughout this thesis will be discussed. 
 
8.3.1 Ubiquitin  
Ubiquitin mutants were prepared using either an ubiquitin GyrA-intein Chitin 
Binding Domain fusion (Ub-GyrA-CBD) or an ubiquitin NPU intein 6xHis-tag 





8.3.1.1 Mutagenesis of pUb-GyrA-CBD: 
All ubiquitin library mutants were made by site-directed mutagenesis using a pUb 
plasmid template previously engineered with ubiquitin(1-75) in a pTXB1 vector 
and mutagenic primers as follows 118: 
 
pUb1. Forward primer (Ub T9A/G10A/K11A/T12A)  5’-CAT ATG CAG ATC TTC 
GTG AAG ACT CTG GCT GCT GCG GCC ATC ACT CTC GAA GTG GAG 
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CCG-3’ and reverse primer (Ub T9A/G10A/K11A/T12A)  5’- CTC GGC TCC ACT 
TCG AGA GTG ATG GCC GCA GCA GC C AGA GTC TTC ACG AAG ATC TGC 
ATA TG-3’.  
 
pUb2. Forward primer (Ub Q2A)  5’- CTTTAAGAAGGAGATATACAT ATG GCG 
ATC TTC GTG AAG ACT CTG AC -3’ and reverse primer (Ub Q2A)  5’ -GT CAG 
AGT CTT CAC GAA GAT CGC CAT ATG TAT ATC TCC TTC TTA AAG-3’ and 
forward primer (UbL15A/E16A) 5’- CT CTG ACT GGT AAG ACC ATC ACT GCC 
GCA GTG GAG CCG AGT GAC ACC ATT GAG -3’ and reverse primer 
(UbL15A/E16A) 5’ - CTC AAT GGT GTC ACT CGG CTC CAC TGC GGC AGT 
GAT GGT CTT ACC AGT CAG AG-3’ and forward primer (Ub K29A) 5’- C ACC 
ATT GAG AAT GTC AAG GCA GCG ATC CAA GAC AAG GAA GGC ATC CC-3’ 
and reverse primer (Ub K29A) 5’- GGG ATG CCT TCC TTG TCT TGG ATC GCT 
GCC TTG ACA TTC TCA ATG GTG -3’ 
 
pUb3. Forward primer (Ub K6A) 5’- GATATACAT ATG CAG ATC TTC GTG 
GCG ACT CTG ACT GGT AAG ACC ATC AC-3’ and reverse primer (Ub K6A) 5’- 
GTG ATG GTC TTA CCA GTC AGA GTC GCC ACG AAG ATC TGC ATA TGT 
ATA TC-3’ and forward primer (Ub T66A/H68A) 5’- GAC TAC AAC ATC CAG 
AAA GAG TCC GCC CTG GCC CTG GTA CTC CGT CTC AGA GGT TG-3’ and 
reverse primer (Ub T66A/H68A) 5’-CAA CCT CTG AGA CGG AGT ACC AGG 
GCC AGG GCG GAC TCT TTC TGG ATG TTG TAG TC-3’. 
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pUb4. Forward primer (Ub E18A/P19A/S20A/D21A) 5’- GGT AAG ACC ATC 
ACT CTC GAA GTG GCG GCG GCT GCC ACC ATT GAG AAT GTC AAG GCA 
AAG-3’ and reverse primer (Ub E18A/P19A/S20A/D21A) 5’-CTT TGC CTT GAC 
ATT CTC AAT GGT GGC AGC CGC CGC CAC TTC GAG AGT GAT GGT CTT 
ACC-3’. 
 
pUb5. Forward primer (Ub T22A/E24A/N25A) 5’-CT CTC GAA GTG GAG CCG 
AGT GAC GCC ATT GCG GCT GTC AAG GCA AAG ATC CAA GAC AAG -3’ 
and reverse primer (Ub T22A/E24A/N25A) 5’-CTT GTC TTG GAT CTT TGC CTT 
GAC AGC CGC AAT GGC GTC ACT CGG CTC CAC TTC GAG AGT G-3’. 
 
pUb6. Forward primer (Ub Q31A/D32A/K33A/E34A) 5’- C ATT GAG AAT GTC 
AAG GCA AAG ATC GCA GCC GCG GCA GGC ATC CCT CCT GAC CAG 
CAG AG -3’ and reverse primer (Ub Q31A/D32A/K33A/E34A) 5’- CCT CTG CTG 
GTC AGG AGG GAT GCC TGC CGC GGC TGC GAT CTT  TGC CTT GAC ATT 
CTC AAT G-3’. 
 
pUb7. Forward primer (Ub P37A/P38A/D39A) 5’- GCA AAG ATC CAA GAC AAG 
GAA GGC ATC GCT GCT GCC CAG CAG AGG TTG ATC TTT GCT GGG-3’ 
and reverse primer (Ub P37A/P38A/D39A) 5’- CCC AGC AAA GAT CAA CCT 
CTG CTG GGC AGC AGC GAT GCC TTC CTT GTC TTG GAT CTT TGC-3’. 
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pUb8. Forward primer (Ub G47A/K48A/Q49A) 5’- GAC CAG CAG AGG TTG 
ATC TTT GCT GCG GCA GCG CTG GAA GAT GGA CGC ACC CTG TCT G-3’ 
and reverse primer (Ub G47A/K48A/Q49A) 5’-CAG ACA GGG TGC GTC CAT 
CTT CCA GCG CTG CCG CAG CAA AGA TCA ACC TCT GCT GGT C-3’. 
 
pUb9. Forward primer (Ub E51A/D52A/G53A/R54A) 5’- G TTG ATC TTT GCT 
GGG AAA CAG CTG GCA GCT GCA GCC ACC CTG TCT GAC TAC AAC ATC 
C-3’ and reverse primer (Ub E51A/D52A/G53A/R54A) 5’- CTG GAT GTT GTA 
GTC AGA CAG GGT GGC TGC AGC TGC CAG CTG TTT CCC AGC AAA GAT 
CAA C-3’. 
 
pUb10. Forward primer (Ub D58A/Y59A/N60A) 5’- G CTG GAA GAT GGA CGC 
ACC CTG TCT GCC GCC GCC ATC CAG AAA GAG TCC ACC CTG CAC C-3’ 
and reverse primer (Ub D58A/Y59A/N60A) 5’- GGT GCA GGG TGG ACT CTT 
TCT GGA TGG CGG CGG CAG ACA GGG TGC GTC CAT CTT CCA GC-3’. 
 
pUb11. Forward primer (Ub Q62A/K63A/E64A) 5’- CGC ACC CTG TCT GAC 
TAC AAC ATC GCG GCA GCG TCC ACC CTG CAC CTG GTA CTC CGT C-3’ 
and reverse primer (Ub Q62A/K63A/E64A) 5’- GAC GGA GTA CCA GGT GCA 
GGG TGG ACG CTG CCG CGA TGT TGT AGT CAG ACA GGG TGC G-3’. 
 
pUb12. Forward primer (UbL71/R72/L73/R74A) 5’- G AAA GAG TCC ACC CTG 
CAC CTG GTA GCC GCT GCC GCA GGT TGC ATC ACG GGA GAT GCA CTA 
 156 
G-3’ and reverse primer (UbL71/R72/L73/R74A) 5’ CTA GTG CAT CTC CCG 
TGA TGC AAC CTG CGG CAG CGG CTA CCA GGT GCA GGG TGG ACT CTT 
TC-3’. 
 
8.3.1.2 Mutagenesis of ubiquitin in NPU intein 6XHis tagged vector:  
Selected ubiquitin mutants were generated by site-directed mutagenesis using a 
previously described pUb-NPU-6xHis plasmid template165 and mutagenic primers 
as follows: 
 
pUb13. Forward primer (UbL8A)  5’-GCA GAT CTT CGT GAA GAC TGC GAC 
TGG TAA GAC CAT CAC T-3’ and reverse primer (Ub L8A) 5’- AGT GAT GGT 
CTT ACC AGT CGC AGT CTT CAC GAA GAT CTG C  -3’ and forward primer 
(UbI44A) 5’-CTG ACC AGC AGA GGT TGG CCT TTG CTG GGA AAC AGC-3’ 
and reverse primer (UbI44A) 5’- GCT GTT TCC CAG CAA AGG CCA ACC TCT 
GCT GGT CAG-3’. 
 
pULL. Forward primer (UbL71/73A) 5’-C CTG CAC CTG GTA GCC CGT GCC 
AGA GGT GGT TGT TTA AGC TAT GAA ACG GAA ATA TTG AC-3’ and 
reverse primer (UbL71/73A) 5’-GT CAA TAT TTC CGT TTC ATA GCT TAA ACA 
ACC ACC TCT GGC ACG GGC TAC CAG GTG CAG G-3’. 
 
pURR. Forward primer (UbR72/74A) 5’- GAG TCC ACC CTG CAC CTG GTA 
CTC GCT CTC GCA GGT GGT TGT TTA AGC TAT GAA ACG G -3’ and 
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reverse primer (R72/74A) 5’ C CGT TTC ATA GCT TAA ACA ACC ACC TGC GAG 
AGC GAG TAC CAG GTG CAG GGT GGA CTC -3’. 
 
8.3.2 Preparation of Hub1 containing plasmid 
A Hub1ub mutant construct was prepared using a Hub1ub-NPU-6xHis protein 





8.3.2.1 Construction of pHub1ub-NPU-6xhis vector: 
 
pHub1ub. Hub1ub was cloned into a the Ub-NPU-6xHis vector via ligation-
independent cloning of the Hubub1 mini-gene ordered from IDT with the 
sequence: 
 
5’-ATGATTGAAG TCGTCGTTAA TGATCGCCTT GGGAAAAAGG 
TGCGTGTAAA ATCCTTAGCG GAAGATAGTG TTGGTGATTT TAAAAAAGTG 
CTGTCTTTAC AGATCGGCAC CCAGCCAAAC AAAATTGTGC TGCAGAAAGG 
CGGTAGTGTG CTGAAAGATC ACATTTCACT TGAAGACTAC GAAGTTCATG 
ATCAAACTAA CCTTGAACTG GTACTGCGTC TGCGGGGCGG G-3’ 
 
To anneal the N-terminal and C-terminal sequence of the mini-gene to the a 
linearized Ub-NPU-6xHis pTXB1 vector, PCR was utilized with the following 
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primers: Forward primer (N-terminus of Hub1ub): 5’-GTT TAA CTT TAA GAA 
GGA GAT ATA  CAT ATG ATC GAA GTT GTT GTG AAT GAT CGC-3’, Reverse 
primer (C-terminus of Hub1ub):  5’-GGT TCA TGA CCA GAC AAA TTT AGA 
ACT TTA TTA TCT G GGT TCA TGA CCA GAC AAA TTT AGA ACT TGTA CTC 
AGA CTG AGA GGT GGT TG-3’. 
 
8.3.3 Histones 
8.3.3.1 Mutagenesis of histone H3 
H3C110S was prepared using the previously described xenopus laevis H3.1 
construct in a pET3a plasmid as a template118 using the mutagenic primers: 
Forward primer (H3C110S) 5’-GCT CTC TTT GAG GAC ACC AAC CTG AGC 
GCC ATC CAC GCC AAG AGG GTC ACC ATC ATG C-3’ and reverse 
(H3C110S) 5’ G CTA GAT GGT GAC CCT CTT GGC GTG GAT GGC GCT CAG 
GTT GGT GTC CTC AAA GAG TGC-3’. 
 
8.3.3.2 Mutagenesis of Ub-H2A yeast constructs  
Ub-H2A fusions were prepared using a wt yH2A construct in a pET3a vector as a 
template protein and the ubiquitin sequence from the Ub-NPU-6xHis vector 








8.3.3.3 Construction of n-yH2A vector: 
The following primers were utilized to PCR amplify an linear H2A(20-123)-pET3a 
vector for the insertion of Ub: Forward primer (directed toward the H2A(20-28) 5’- 
TTA ACA TTC CCA GTT GGT AGA GTG C-3’ Reverse primer (directed toward 
the 5’ end of vector construct): 5’-GGA GAT ATA CAT ATG-3’ 
 
Primers to create the Ub(1-76) product: Forward primer (directed toward the N-
terminus of Ub) 5’ CTT TAA GAA GGA GAT ATA CAT ATG CAG ATC TTC GTG 
AAG ACT CT-3’ Reverse primer (directed toward the C-terminus of Ub and 
H2A(20-26)): 5’- GCA CTC TAC CAA CTG GGA ATG TTA AAC CCG CGG CAC 
GGG CTA CCA GGT GCA GGG-3’ 
 
pUb-yH2A Forward primer (L71/L73A): 5’- CC CTG CAC CTG GTA CTG CGT 
CTG GCG GGT TTA ACA TTC CCA GTT GG-3’ and reverse primer (L71/L73A): 
5’- CC AAC TGG GAA TGT TAA ACC CGC CAG ACG CAG TAC CAG GTG 
CAG GG-3’ 
 
pULL-yH2A Forward primer (L71/L73A): 5’- CC CTG CAC CTG GTA GCC CGT 
GCC GCG GGT TTA ACA TTC CCA GTT GG-3’ and reverse primer (L71/L73A): 




8.3.4 Mutagenesis of hDot1L(1-416)  











A 6xHis-Sumo tagged cysteine-less hDot1L(1-416) construct was prepared and 
cloned into a pET30 vector prepared via sequence and ligation-independent 
cloning using  a 6XHis-SUMO PCR product and a PCR product prepared from 
the previously reported hDot1L(1-416) construct 118 where all cysteine residues 
(C44S/C74S/C178S) were mutated to serine. The mutagenic primers used 
prepare a cysteine-less hDot1L(1-416): 
 
Forward primer (C44S) 5'- ACC ATC CGA TGG GTC AGT GAA GAA ATC CCG 
G -3' and reverse, 5'- CCG GGA TTT CTT CAC TGA CCC ATC GGA TGG T -3'. 
Forward primer (C74S) 5'- AGC ATG CAG AGG CTC AGC GAC AAG TAC AAC 
C -3' and reverse, 5'- GGT TGT ACT TGT CGC TGA GCC TCT GCA TGC T -3'. 
Forward primer (C178S) 5'- TGC TGC TGC CAC CAA CAG CAA ACA TCA CTA 
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TGG -3' and reverse, 5'-CCA TAG TGA TGT TTG CTG TTG GTG GCA GCA 
GCA-3'.  
 
Primers to create hDot1L(1-416) PCR product: Forward primer (directed toward 
Sumo-hDot1) 5’-GCT CAC AGA GAA CAG ATT GGT GGT ATG GGG GAG AAG 
CTG GAG CTG -3’ Reverse primer (Directed toward hDot1L–pET30 vector) 5’-
CCG CAA GCG CGG GCG CCC CAA GAA GTA GGA ATT CGA GCT CCG 
TCG ACA AGC TTG CGG C-3’ 
 
8.4 Protein preparation 
8.4.1 Preparation of ubiquitin aminoethanethiol analogs by thiolysis of GyrA 
intein fusions 
 
Ubiquitin aminoethanethiol analogs were prepared as described.152 E. coli 
BL21(DE3) cells were transformed with plasmids containing the Ubiquitin-GyrA-
Chitin Binding Domain (CBD) fusion or ubiquitin mutant-GyrA-CBD fusions and 
grown in 6L of Luria-Bertani (LB) media (100ug/L ampicillin) at 37oC until an 
OD600 of 0.6. Overexpression of the desired proteins was induced by the 
addition of 0.5 mM IPTG and the cells were grown for an additional 5 h at 30 °C. 
The cells were then harvested by centrifugation at 10k x g for 15 min and the 
cell-pellet was resuspended in buffer A (50 mM Tris, 200 mM NaCl, 1 mM EDTA, 
pH 7.2). The cells were lysed by passage through a French Press and the 
soluble fraction separated from insoluble cellular debris by centrifugation at 18.5-
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20k x g for 20 min. After filtration through a 0.45 µm filter, supernatants were 
bound to a 50 mL chitin column, pre-equilibrated with ten column volumes of 
buffer A, for 2 h at 4 °C. The resin was washed with 20 column volumes of buffer 
A, followed by 3 column volumes of column buffer B (50 mM Tris, 200 mM NaCl, 
and 1 mM EDTA, pH 7.5). Ubiquitin and Ub mutants were cleaved from the 
respective intein-CBD fusions by incubation with 1.5 column volumes of buffer B 
containing 50 mM of cystamine-dihydrochloride, and 50 mM of Tris(2-
carboxyethyl) phosphine, pH 7.75 for 48 h. The eluted proteins, bearing the 
desired C-terminal aminoethanethiol linker, were subsequently purified by C18 
process RP-HPLC employing a gradient of 25-55% B, over 60 min, followed by a 
second purification by C18 semi-preparative HPLC with a gradient of 25-55% B 
over 60 min to remove residual cystamine. Typical yields were 4-6mg for each 
protein. The purest fractions were pooled and analyzed by analytical HPLC, and 
mass spectrometry. 
 
8.4.2 Preparation of ubiquitin and Hub1 aminoethanethiol analogs by thiolysis of 
NPU intein 6xHis fusions 
 
E. coli BL21(DE3) cells were transformed with plasmids containing the Ubiquitin-
NPU-6XHis fusion or ubiquitin mutant-NPU-His tag fusions and grown in 6L of 
Luria-Bertani (LB) media (100 ug/L ampicillin) at 37 °C until an OD600 of 0.6. 
Overexpression of the desired proteins was induced by the addition of 0.5 mM 
IPTG and the cells were grown for an additional 5 h at 30 °C. The cells were then 
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harvested by centrifugation at 10k x g for 15 min and the cell-pellet was 
resuspended in buffer B (50 mM Sodium Phosphate, 200 mM NaCl, 1 mM EDTA, 
pH 6.0). The cells were lysed by passage through a French Press and the 
soluble fraction separated from insoluble cellular debris by centrifugation at 18.5-
20k x g for 20 min. After filtration through a 0.45 µm filter, supernatants were 
bound to a 5 mL Ni-NTA column, pre-equilibrated with ten column volumes of 
buffer B, for 30 min at 4 °C. The resin was washed with 10 column volumes of 
buffer B, followed by 10 column volumes of column buffer B containing 20 mM 
imidazole, and eluted with 10 column volumes of buffer B containing 250 mM 
imidazole. Following dialysis into buffer B (containing no imidazole), Ub and Ub 
mutants were cleaved from the respective NPU-6XHis fusions by incubation with 
10 column volumes of buffer B containing 50 mM of cystamine dihydrochloride, 
and 50 mM of Tris(2-carboxyethyl) phosphine, pH 7.2 for 10 h. The eluted 
proteins, bearing the desired C-terminal aminoethanethiol appendage, were 
subsequently purified by C18 process RP-HPLC employing a gradient of 25-55% 
B, over 60 min, followed by a second purification by C18 semi-preparative HPLC 
with a gradient of 25-55% B over 60 min to remove residual cystamine. Typical 
yields were 10-30 mgs per liter for each protein. The purest fractions were pooled 
and analyzed by analytical HPLC, and mass spectrometry. 
 
8.4.3 Preparation of ubiquitin α-thioesters 
All constructs were expressed, purified and dialyzed into Buffer B similar to Ub 
aminoethanethiol constructs and then thiolyzed with mercaptoethane sulfonate 
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(MES) as referenced in McGinty et al. 2008.165 Briefly, ubiquitin and Ub mutants 
were cleaved from the respective NPU intein fusions, after a dialysis step into 
buffer B, by incubation with 10 column volumes of buffer B containing 80 mM 
MES and 10 mM of Tris(2-carboxyethyl) phosphine, pH 7.2 for 18 h. The eluted 
proteins, bearing the desired C-terminal MES a-thioester, were subsequently 
purified by C18 process RP-HPLC employing a gradient of 25-55% B, over 60 
min, and the purest fractions were pooled and analyzed by analytical HPLC, and 
mass spectrometry. Typical yields were 10-30 mgs per liter per protein.  
 
8.4.4 Preparation of 15N labeled Ub and uLL  
E. coli BL21(DE3) cells were transformed with a plasmid encoding the ubiquitin 
mutant-NPU-His tag fusion and grown in 1L of M9 minimal media containing 15N 
labeled ammonium chloride  (100ug/L ampicillin) at 37 °C until an OD600 of 0.6. 
Overexpression of the desired proteins was induced by the addition of 0.5 mM 
IPTG and the cells were grown for an additional 4 h at 37 °C. The Ub-NPU-His 
fusion was prepared exactly as the aminoethanethiol constructs but then 
thiolyzed with Dithiothreitol (DTT).  Briefly, uLL was cleaved from the respective 
NPU intein fusion, resulting in a free carboxyl group, after a dialysis step into 
buffer B, by incubation with 10 column volumes of buffer B containing 80 mM 
DTT, pH 8.5 for 10 h. The eluted protein was subsequently purified by C18 
process RP-HPLC employing a gradient of 25-55% B, over 60 min, and the 
purest fractions were pooled and analyzed by analytical HPLC, and mass 
spectrometry. Typical yields were 5 -10mgs per liter per protein.  
 165 
 
8.4.5 Preparation of deuterated UbILV-SH 
E. coli Codon plus cells were transformed with a plasmid encoding the ubiquitin-
NPU-6xHis tag fusion and grown in 1L of deuterated M9 minimal media 
containing 60mg α-ketobutyric acid and 80mg α-keto-3-methylbutyric acid 
necessary for ILV labeling, and 100ug/L ampicillin at 37 °C until an OD600 of 0.6. 
Overexpression of the desired proteins was induced by the addition of 0.5 mM 
IPTG and the cells were grown for an additional 4 h at 37 °C. The UbILV-NPU-
6xHis fusion was prepared exactly as the aminoethanethiol constructs. The 
eluted protein was subsequently purified by C18 process RP-HPLC employing a 
gradient of 25-55% B, over 60 min, and the purest fractions were pooled and 
analyzed by analytical HPLC, and mass spectrometry. Typical yields were 5-7 
mgs per liter per protein.  
 
8.4.6 Expression of recombinant histones  
All histones (including the Ub-yH2A fusions) were prepared as previously 
reported.118 Untagged histone constructs and Ub-H2A fusions were grown in LB 
media (100ug/L ampicillin) at 37 °C until an OD600 of 0.6. Overexpression of the 
desired protein was induced by the addition of 0.5 mM IPTG and the cells were 
grown for an additional 3 h at 37 °C. The cells were then harvested by 
centrifugation at 10k x g for 15 min and the cell-pellet was resuspended in buffer 
B (50 mM Sodium Phosphate, 200 mM NaCl, 1 mM EDTA, pH 8.0). The cells 
were lysed by passage through a French Press and the insoluble fraction was 
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washed 3 times with buffer B containing 1% triton x and centrifuged at 18.5-20k x 
g for 20 min. Histones were extracted with through the addition of 1 ml DMSO 
followed by 20 ml of buffer B containing 6M guanidinium hydrochloride (Gn-HCl). 
Size exclusion chromatography was utilized for the purification under denaturing 
conditions using an S200 preparatory column. Histone containing fractions from 
SEC were dialyzed into H2O further HPLC purified on 30 to 70% B gradient. The 
purest fractions from HPLC purification were pooled and analyzed by analytical 
HPLC and mass spectrometry. 
 
8.4.7 Fluorescent labeling of H2A(N110C) 
H2AN110C was labeled with fluorescein as previously reported.117 Briefly, 4 mgs 
of H2AN110C was dissolved in 2 mL labeling buffer (20 mM Tris, pH 7.8, 6 M 
Gn-HCl, 200 uM TCEP) and 0.4 mg fluorescein-5-maleimide (0.8 umol, 2.7 
equivalents) was added in 50 ul N,N-dimethylformamide (DMF) in the dark. The 
mixture was stirred for 1 h and quenched by addition of 1 mM 2-
mercaptoethanol. fH2A was purified through a 30-70% B HPLC gradient over the 
course of 1 hour. The purest HPLC fractions were pooled and analyzed by 
analytical HPLC, and mass spectrometry. 
 
8.4.8 Synthesis of ubiquitylated H2BssUb constructs 
H2BssUb and H2BssUb mutants were prepared according to published 
protocols.152 In a typical reaction, 2 mgs of DTNP (6.45 mmol) was dissolved in 
500 mL of a 3:1 (v/v) acetic acid:water mixture and added to 2mgs H2BK120C 
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(0.15 µmol, ~20 equivalents). The reaction was allowed to proceed for 12 h at 25 
°C, prior to purification by C18 semi-preparative RP-HPLC with a 42-48% B 
gradient at 50 °C over 45 min. The purest HPLC fractions were pooled and 
analyzed by analytical HPLC, and mass spectrometry. 
 
For Ub-SH conjugation, 1.5 mg of H2BK120C-TNP (0.108 umol) and 2.0 mgs of 
Ub-SH or Ubmut-SH (0.232 umol, 2 equivalents) were dissolved in 625 uL of 
reaction buffer consisting of 1M HEPES, 6 M Gn-HCl, pH 6.93. The reaction was 
allowed for 1 h at 25°C with continuous shaking. The reaction was purified by 
C18 semi-preparative RP-HPLC with a 30-70% B gradient at 25 °C over 60 min. 
The purest HPLC fractions were pooled and analyzed by analytical HPLC, and 
mass spectrometry. 
 
8.4.9 Preparation of H2B-Ub conjugates by expressed protein ligation 
H2B-Ub and H2B-uLL were prepared by an optimized sequential expressed 
protein ligation procedure described in McGinty et al 2009.121 Note the ubiquitin 
in these semisynthetic constructs harbored a G76A mutation.  
 
The sequence corresponding to residues 117–125 of xH2B with an A117Thz 
replacement and a cysteine conjugated to K120 was synthesized as described 
previously, with some exceptions.118 Briefly, on pre-loaded Wang resin using 
manual solid-phase peptide synthesis with an Fmoc Nα protection strategy and 
using 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate 
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(HBTU) for amino-acid activation. Standard tbutyl side-chain protection was used 
throughout with the following exceptions: the ϵ-amino group of K120 was 
protected with the Alloc group, and the thiol group of the C117 synthon was 
protected as Boc-Thz. The ligation auxiliary (cysteine conjugated to K120) was 
installed on the solid phase as follows: (i) the Alloc group on K120 was 
deprotected by two successive incubations of the peptidyl-resin in DCM with 24 
eq. PhSiH3 and 0.25 eq. Pd(PPh3)4 for 30 min each; (ii) dry, alloc deprotected 
peptidyl-resin was re-swelled in DMF and Boc-Cys(Trt)-OH was coupled using 
standard Fmoc coupling conditions.  After cleavage from the resin with 
TFA:TIS:H2O (95:2.5:2.5) for 3  h, H2B(117—125)A117Thz,CysK120 was purified 
by RP-HPLC on a semi-preparative scale using a 5–35% B gradient over 60 min.  
 
The ligation reaction between H2B(117-125)A117Thz,CysK120 and Ub(1–75)-
MES or uLL(1-75)-MES was performed using conditions similar to those 
previously employed.161 8mM purified H2B peptide and 1.5mM Ub(1-75)-MES or 
uLL(1-75)-MES was dissolved in 140  µl of buffer containing 6M Gn-HCl, 200  mM 
sodium phosphate pH 7.0, 25  mM TCEP, 100mM MESNa and incubated at room 
temperature for  4 hours. The Thz moiety on each H2B peptide was then 
deprotected by adding 140uL 1:1 solvent A:solvent B, 40uL 3M methoxylamine-
HCl, then increasing the pH to 4.0 using 5N NaOH before flushing with argon and 
letting sit at room temperature overnight. The ligation products were purified 
using semi-preparative HPLC with a 20–45% B gradient over 60  min, yielding 
approximately 4.0  mg of pure, lyophilized protein each.  
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100uL of 6M Gn-HCl, 200mM sodium phosphate pH 7.9, 25mM TCEP, 100mM 
MESNa was added to 2.5mM Thz deprotected uH2B(117-125) or uLLH2B(117-
125) and 2.1mM H2B(1–116)-MES. The pH was adjusted to 7.8 using 2N NaOH 
before flushing with argon and letting sit at room temperature overnight. 15mM 
TCEP was then added to the ligation mixtures, respectively, and the exogenous 
thiol was diluted 625x using a 5000 MWCO spin concentrator and argon-sparged 
6M Gn-HCl, 0.2M Pi, pH 7.0 solution (Gua buffer) over a period of several hours. 
After spinning each solution down to a final concentration of 150uL, 50uL of 
750mM TCEP in Gua buffer, 20uL 400mM reduced glutathione, and 16uL 0.2M 
VA-061 radical initiator in MeOH was added to each. The desulfurization 
solutions were flushed with argon, and placed at 37o C overnight. H2B-Ub and 
H2B-uLL were then purified out of the solutions by diluting each 5x with 30%B 
before performing semi-preparative purification on a 40-60%B in 60min gradient.  
The purest fractions from HPLC purification were pooled and analyzed by 
analytical HPLC, and mass spectrometry, yielding approximately 1mg of final 
product each. 
 
8.4.10 hDot1L(1-416) preparation 
E. coli BL21(DE3) cells were transformed with plasmids containing the 6XHis-
SUMO-hDot1L(1-416) fusion and grown in 6L of Luria-Bertani (LB) media (50 
ug/L kanamycin) at 37 °C until an OD600 of 0.6. Overexpression of the desired 
protein was induced by the addition of 0.5 mM IPTG and the cells were grown for 
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an additional 18 h at 18 °C. The cells were then harvested by centrifugation at 
10k x g for 15 min and the cell-pellet was resuspended in buffer C (50 mM Tris, 
200 mM NaCl, 1 mM EDTA, pH 7.5 at 4 °C). The cells were lysed by passage 
through a French Press and the soluble fraction separated from insoluble cellular 
debris by centrifugation at 18.5-20k x g for 20 min. After filtration through a 0.45 
µm filter, supernatants were bound to a 5 mL Ni-NTA column, pre-equilibrated 
with ten column volumes of buffer C, for 12 h at 4 °C. The resin was washed with 
10 column volumes of buffer C, followed by 10 column volumes each of column 
buffer C containing 25mM, 50mM, and 100mM imidazole. His-SUMO-hDot1L(1-
416) was eluted with 10 column volumes of buffer B containing 250mM imidazole 
by collecting 1 column volume fractions which were analyzed by SDS-PAGE and 
the purest fractions were pooled. The His-SUMO tag was cleaved from 
hDot1L(1-416) at 4 °C by the addition of SUMO protease. Cleavage was 
monitored by SDS-PAGE, and upon 100% cleavage hDot1L(1-416) was purified 
by cation exchange chromatography using a High Trap SP FF 5ml column 
(gradient is 100mM NaCl to 1M NaCl over 10 column volumes). Fractions were 
analyzed by SDS-PAGE, and the purest fractions were pooled, concentrated and 
purified further using gel filtration. Fractions were analyzed by analytical SEC 
FPLC, pooled and stored at -80 °C in 50% glycerol. 
 
8.4.11 Preparation of full-length hDot1L, yDot1, and ySet1C  
These enzymes were purified from baculovirus expression system as previously 
described. 118, 121 Briefly, all enzymes contained a FLAG tag on the N-terminus of 
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the Dot1 or Set1 methyltransferase. The baculovirus was generated according to 
the manufacturer’s instructions. Sf9 cells were infected with the baculovirus and 
the resulting cell extracts were subjected to standard purification procedures as 
described below. Sf9 cells (700 mL at a density of 1 million cells per mL) were 
infected with fresh virus (7.5 mL) three days prior to collection by centrifugation at 
430 g for 5 min. Cells were washed with phosphate buffered saline and 
centrifuged again. Washed cells were resuspended in 18 mL lysis buffer (20 mM 
Tris HCl, 500 mM NaCl, 4 mM MgCl2, 0.4 mM EDTA, 20% glycerol, 1 mM PMSF, 
2 mM DTT, pH 7.9), and disrupted with 3x10 strokes with a dounce homogenizer 
with a 10 min break between sets of 10. After removal of cell debris by 
centrifugation at 22.5 kg for 15 min, the supernatant was adjusted to 0.1% NP-40 
and 300 mM NaCl, by dilution with 20 mM Tris HCl containing 10% glycerol,and 
the resulting solution was incubated with 400 µL M2-agarose for 3.5 h at 4°C. 
The agarose was washed four times with 10 mL wash buffer (20 mM Tris HCl, 
150 mM NaCl, 2 mM MgCl2, 0.2 mM EDTA, 15% glycerol, 0.1% NP-40, 1 mM 
PMSF, 1mM DTT (this was omitted for hDot1L), pH 7.9). Each wash was 
followed by centrifugation at 400 g for 1 min. The third wash was left on a rotator 
for 10 min at 4 °C. Bound methyltrasnferase was eluted with 3x100 µL wash 
buffer containing 0.5 mg/mL 3x FLAG peptide (Sigma). These enzyme 
preparations were stored at -80 °C in 50% glycerol. 
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8.5 Nucleosome reconstitution  
8.5.1 Histone octamer formation 
Histone octamers were formed as previously described.117 Briefly, lyophilized 
histones were resuspended in unfolding buffer (20 mM Tris, pH 7.5, 7 M Gn-
HCl), combined in equimolar amounts and dialyzed into refolding buffer (10 mM 
Tris, pH 7.5, 2 M NaCl, 1 mM ETDA) for 3 x 2 h. The refolded histone octamers 
were concentrated and purified by size-exclusion chromatography (Superdex 200 
10/300). Fractions were analyzed by SDS-PAGE and the fractions containing 
equivalent amount of all histones were pooled, concentrated, and stored at -20 
°C after the addition of 50% glycerol (v/v).  
 
8.5.2 DNA preparation 
A 153bp segment containing the 601 DNA sequence was prepared as previously 
described with slight alterations.180 A plasmid containing 30 copies of the 147 
base pair 601 DNA flanked by EcoRV sites (153 bp in total length) was 
assembled following according to a general DNA plasmid isolation protocol.180 
The plasmid was prepared via alkaline lysis, digested with EcoRV, and purified 
from the vector with 10% polyethylene glycol-3500 precipitation on ice followed 
by centrifugation at 26,00 g for 30 min. The 153bp construct was further purified 
by isopropanol and ethanol precipitation, centrifuged, resuspended in TE buffer 
(10 mM Tris pH 7.5, and 1 mM EDTA), and quantified by UV spectroscopy and 
stored in aliquots at -20 oC. 
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For array formation, a plasmid containing 12 copies of a 177 base pair repeat of 
the 601 nucleosome positioning sequence (12-177-601) flanked by EcoRV sites 
was purified from a 6 L culture of DH5alpha cells as previously described 180. The 
12-177-601 sequence was obtained by preparative digestion of the plasmid 
followed by selective precipitation of the fragment with 6% polyethylene glycol-
6000 on ice followed by centrifugation at 26,000 g for 30 min. After phenol 
extraction and ethanol precipitation the DNA was redissolved in TE buffer (10 
mM Tris pH 7.5, 1 mM EDTA), quantified by UV spectroscopy and stored in 
aliquots at -20 °C. 
 
8.5.3 Mononucleosome reconstitution  
1) Small-scale nucleosome reconstitution by dilution. Mononucleosomes were 
formed using a previously described step-wise dilution procedure with slight 
modifications.152, 214 Briefly, octamers and 601 DNA were combined in 10 µL high 
salt (2M NaCl) refolding buffer to a final concentration of 3 µM. After incubation at 
37 °C for 15 min, 3.3 µL of dilution buffer 1 (10 mM HEPES, 1 mM EDTA, 0.5 
mM PMSF, pH7.9) was added and the temperature was dropped to 30 °C. 
Further dilutions of 6.7, 5, 3.6, 4.7, 6.7, 10, 30, and 20 µL, respectively, were 
then performed every 15 min. A final dilution with 100 µL of dilution buffer 2 (10 
mM Tris HCl, 1 mM EDTA, 0.1% NP-40, 0.5 mM PMSF, 20% glycerol, pH 7.5) 
was carried out. After an additional 15 min, the nucleosomes were concentrated 
using Vivaspin 500 centricons (3-10 kDa MWCO) at 4 °C. Nucleosome formation 
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was verified by separation on a Criterion 5% TBE gel run in 0.5x TBE, followed 
by ethidium bromide staining. 
 
2) Large-scale nucleosome reconstitution by dialysis. For act-MNs, large-scale 
nucleosome reconstitution was performed following procedures similar to those 
previously reported.180 Briefly, octamers were mixed with 601 DNA in ratios 
optimized using the small scale reconstitution protocol described above, at 5 µM 
DNA concentration, and the NaCl concentration was adjusted to 2 M. The 
mixture was dialyzed against 200 mL initial buffer (1.4 M KCl, 10 mM Tris HCl, 
0.1 mM EDTA, pH 7.5) at 4 °C for 60 min. Semi-gradual dialysis was performed 
at a flow rate of 1 mL/min diluting with final buffer (10 mM KCl, 10 mM Tris 
HCl,0.1 mM EDTA) over 12 hours. 1 subsequent dialysis step of at least 2 h in 
final buffer was performed to ensure that the nucleosomes were fully dialyzed. 
 
8.5.4 Yeast Nucleosome formation 
Yeast nucleosomes were formed via the small-scale dilution method but were 
additionally heat shifted at 55oC for 1 hour subsequent to MN formation to heat 
shift DNA relative to the octamer core. Nucleosome formation was verified by 






8.5.5 Nucleosomal array formation 
Nucleosomal arrays were prepared by the large scale dialysis method used to 
make nucleosomes however a 12x601 DNA template was used instead of the 
153bp 601 DNA.117 Upon formation, nucleosomal arrays were precipitated from 
solution with MgCl2 (concentrations were empirically determined) and 
resuspended in nucleosome array buffer (10 mM KCl, 10 mM Tris HCl, , pH 7.5).   
Array formation was verified by separation on a APAGE (1% agarose, 1% 
polyacrylamide) gel run in 0.5x TBE, followed by Sybr Gold staining. Partial 
micrococcal nuclease digestion and restriction enzyme digests were utilized to 
assess array quality.117  
 
8.5.6 Recombinant chromatin formation 
Chromatinized plasmids were assembled using a previously described 
procedure215 and plasmid216. Micrococcal nuclease digestion was employed to 
verify equivalent chromatin reconstitution with H2B, H2B-Ub and H2B-uLL. 
 
8.6 Preparation of H2BssUb nucleosomes via direct ligation of ubiquitin. 
In a typical reaction, reconstituted H2BK120C containing octamers (5 nmol, 50 
uL) in octamer formation buffer (10 mM Tris, 2 M NaCl, 1 mM EDTA, pH 7.5) 
were mixed 1:1 with octamer formation buffer containing 5,5'-dithiobis-(2-
nitrobenzoic acid) (DTNB) (50 mmol, 50 uL) and nutated at RT for 10 min. to 
yield activated (H2B-TNB) octamers. Act-MNs were formed via dialysis (also 
removing all free DTNB) as described above (see mononucleosome/nucleosome 
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array reconstitution). The quality of the reconstitution was assessed by 
separation on a Criterion 5% TBE gel run in 0.5x TBE buffer, followed by staining 
with ethidium bromide or Sybr Gold.  
 
Ub-SH or Ub-SH mutants (4.25 mg, 0.5 nmol) were added to 50 pmol of act-MNs 
in a final reaction volume of 10 uL and incubated at 55 °C for 1 hour. The degree 
of Ub-SH ligation was determine by separation on a Criterion 5% TBE gel run in 
0.5x TBE buffer, followed by staining with ethidium bromide. These Ub-SH act-
MNs were used in methyltransferase assays without subsequent purification. 
 
8.7 Methyltransferase assays 
8.7.1  hDot1L methyltransferase assays  
Methyltransferase assays were performed using an optimized protocol as 
previously described 118. 1.5 pmol of nucleosomes and 0.2 pmol of hDot1L or 0.3 
pmol full-length hDot1L were equilibrated in 20 mL of assay buffer (20 mM Tris 
7.9, 140 mM NaCl, 2 mM MgCl2, 1 mM PMSF). 250 nCi of [3H]-S-adenosyl 
methionine was added and the reaction was incubated at 30 °C for 15 minutes. 
15 mL of the reaction mixture was run on a Criterion 5% TBE gel in 0.5x TBE 
buffer, followed by staining with ethiduim bromide, or Sybr Gold. The gel was 
incubated in Amplify solution for 15 min. and then dried and visualized by 
fluorography. The remaining 5 mL of the reaction mixture was spotted on 
Whatman p81 filter paper and washed three times with NaHCO3 solution (pH 9) 
and air-dried. Econo F Liquid Scintillation Cocktail (GE healthcare) was then 
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added, and the samples were counted with a LKB Wallac 1209 RackBeta Primo 
Liquid scintillation counter. Data presented is the average of 3 to 6 independent 
experiments ± s.e.m.  
 
8.7.2 yDot1 methyltransferase assays  
Methyltransferase assays were performed using an optimized protocol as 
previously described.118 1.5 pmol of nucleosomes and 0.2 pmol of yDot1 was 
equilibrated in 20 mL of assay buffer (20 mM Tris 7.9, 140 mM NaCl, 2 mM 
MgCl2, 1 mM PMSF). 250 nCi of [3H]-S-adenosyl methionine was added and the 
reaction was incubated at 30 °C for 15 minutes. 15 uL of the reaction mixture 
was run on a Criterion 5% TBE gel in 0.5x TBE buffer, followed by staining with 
ethiduim bromide, or Sybr Gold. The gel was incubated in Amplify solution for 15 
min. and then dried and visualized by fluorography. The remaining 5 uL of the 
reaction mixture was spotted on Whatman p81 filter paper and washed three 
times with NaHCO3 solution (pH 9) and air-dried. Econo F Liquid Scintillation 
Cocktail (GE healthcare) was then added, and the samples were counted with a 
LKB Wallac 1209 RackBeta Primo Liquid scintillation counter. Data presented is 
the average of 3 independent experiments ± s.e.m.  
 
8.7.3 Western blot analysis of yDot1 methyltransferase assays  
Methyltransferase assays were performed identical to yDot1 assays using [3H]-S-
adenosyl methionine except 0.8 mM of ‘cold’ [1H]-S-adenosyl methionine was 
utilized. 20uL of the reaction mixture was run on a 15% Tris-HCl gel in 1.0x Tris-
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Glycine buffer, followed by semi-dry transfer to a PVDF membrane and blotting 
with an antibody directed to H3K79me2. This was read out by chemo-
luminescence   
 
8.7.4 ySet1 methyltransferase assays 
Methyltransferase assays were performed using a slightly altered protocol from 
previous reports.201 3 pmol of nucleosomes and ySet1C (containing 50 ng of 
Bre2) were equilibrated in 40 mL of HEG buffer (25 mM HEPES pH 7.6, 0.1 mM 
EDTA, 10% Glycerol). 0.7 mCi of [3H]-S-adenosyl methionine was added and the 
reaction was incubated at 30 °C for 2 h. 40 uL of the reaction was run on a 
Criterion 5% TBE gel in 0.5x TBE buffer, followed by staining with Sybr Gold 
stain. The gel was incubated in Amplify solution for 15 min. and then dried and 
visualized by fluorography. 
 
8.8 In vivo analysis of H3K79me2 
Yeast experiments were performed using the wild-type yeast strain BY4742 and 
a strain that contained a Rad6 deletion in the BY4742 background 
(CDAY23). Plasmids were constructed through insertion of the Ub-H2A 
constructs into the pQQ18 plasmid that contained all H2B, H3, H4 histones. 
These plasmids contained Leu2 auxotropic markers and CEN sequences.  
 
Plasmids (H2A, n-yH2A, Ub-yH2A, or uLL-yH2A) were transformed into BY4742 
(for H2A) and CDAY23 (for H2A, n-yH2A, Ub-yH2A, or uLL-yH2A) and plated 
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on –Leu dropout plates. Colonies for each type of yeast were selected for and 
grown in –Leu dropout media overnight to reach confluence.  Cells were diluted 
to an OD600 of 0.2 and grown for an additional ~6 hours until they reached an 
OD600 of 0.8. Cells were spun down for 20 min at 4oC and lysed by TCA 
precipitation and bead beating.  The TCA protein precipitate was resuspended 
Laemmli SB buffer heated at 100oC for 10 min and run on a 15% Tris-HCl 
criterion gel. Western blot analysis was performed using standard protocols and 
the antibodies indicated in Table 1.  
 
8.9 mPEG assays  
Nucleosomes were subjected to mPEGylation according to the following protocol. 
Nuclesomes (4.5pmol), in small-scale nucleosome reconstitution buffer (see 
section 8.5.3) were combined 1:1 with mPEG buffer (1mM mPEG 10 mM KCl, 10 
mM Tris HCl, pH 7.5 ) and incubated at 30oC. To quench the reaction, at the 
indicated times, 30 ul of the reaction was added to 2.5 ul of DTT (10mM) on ice. 
The reactions were run on a Criterion 5% TBE gel in 0.5x TBE buffer, followed by 
silver staining to visualize the mPEGylated nucleosomes.  
 
8.10 Biophysical analysis of Ub and H2B-Ub chromatin 
8.10.1 NMR Analysis of Ub and uLL 
NMR spectra of Ub and uLL in 20 mM Tris, pH 7.5, 10 mM KCl, and 1 mM EDTA 
concentrated to ~1 mM was recorded at 30°C on either a Varian Inova 800-MHz 
spectrometer or an A800 Avance III 800MHz spectrometer. All recorded data 
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were processed using NMRPipe and analyzed using Sparky 
(http://www.cgl.ucsf.edu/home/sparky/). 
 
8.10.2 Methyl-TROSY of UbILV containing nucleosomes 
Reconstituted H2BssUbILVG76C MNs with deuterated histones were exchanged 
into NMR buffer (99% D2O, 20mM sodium phosphate, pD 6.0) following 
reconstitution. MNs were concentrated to 100uM. NMR experiments were carried 
out on an 11.7-T (500 MHz 1H frequency) spectrometer equipped with a room-
temperature probe head or a 14.1-T (600 MHz) spectrometer with a cryoprobe at 
45oC. Methyl-TROSY spectra were recorded with acquisition times t1 and t2 of 30 
and 64 ms, respectively. All data were processed using NMRPipe and analyzed 
with Sparky (http://www.cgl.ucsf.edu/home/sparky/). 
 
8.10.3 Chemical Shift Perturbation analysis 
Chemical shift perturbation analysis was conducted similar to the analysis in Kato 
et al. 2011 and Lee et al. 2014 for methyl-TROSY data and ubiquitin analysis 
respectively.190, 217 Briefly, for comparasion of Ub and uLL, HSQC annotated 
chemical resonances were identified and the chemical shift perturbation (CSP) 
was calculated according to:  
 
CSP = (ΔδH2 + (ΔδN*wi)2)1/2, 
where Δδx is the difference in peak position between Ub and uLL 
wi = weighting factor to compare chemical shifts (0.2 for 15N) 
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Spectra were referenced to minimize the 20% trimmed mean of the chemical 
shift perturbations.  The 10% trimmed mean and the standard deviation of this 
mean was calculated so that the 10% trimmed mean + 2 standard deviations 
could be used as a cut off to determine whether the chemical shift perturbation of 
each amino acid residue was significant.  
 
For comparison of Ub and H2B-Ub MN via methyl-TROSY annotated chemical 
resonances were identified and the chemical shift perturbation of each methyl 
group was calculated according to:  
 
CSP = (ΔδH2 + (Δδc*wi)2)1/2, 
where Δδx is the difference in peak position 
wi = weighting factor to compare chemical shifts (0.16 for 13C) 
 
Spectra were referenced to minimize the 20% trimmed mean of the chemical 
shift perturbations.  In the case of amino acid residues with 2 annotated methyl 
groups (for L and V residues) the CSP of each methyl group was averaged to 
calculate the total CSP for each amino acid residue.190 The 10% trimmed mean 
and the standard deviation of this mean was calculated for the amino acid 
residue CSPs so that the 10% trimmed mean + 2 standard deviations could be 
used as a cut off to determine whether the chemical shift perturbation of each 
amino acid residue was significant.  
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8.10.4 Fluorescence–based chromatin compaction assay 
Fluorescence measurements were performed in measurement buffer (10 mM 
Tris, pH 7.8, 10 mM KCl) containing appropriate amounts of MgCl2 as previously 
described.117 For measurements in the absence of Mg2+, the buffer contained 0.1 
mM EDTA. All buffers were degassed before use by sonication. Nucleosomal 
array concentrations were 50 nM (per nucleosome, measured by abs at 260nm) 
for all measurements. Samples containing different Mg2+ concentrations were 
prepared fresh by mixing an equivalent volume of array stock (100 nM per 
nucleosome) with measurement buffer containing twice the final amount of MgCl2 
and equilibrating for 15 min at RT before measurement. Measurements were 
performed on a Fluorolog-3 instrument (HORIBA Jobin Yvon) equipped with 
automated dual polarizers and using a Sub-Micro Fluorometer cell (Starna Cells) 
with 10-mm path length. The excitation wavelength was 480 nm with a bandwidth 
of 5 nm, and emission was recorded at 520 nM with 5 nm bandwidth. Six to eight 
measurements were taken per sample with an integration time of 5 sec for V/V, 
V/H, H/H and H/V polarizer settings (excitation/emission, V: vertical polarization, 
H: horizontal polarization). The final anisotropy was calculated by the formula 
SSA = (IVV – G × IVH)/(IVV + 2 × G × IVH), with G = IHV/IHH.  Vertically polarized 
emission intensity was monitored as a function of [Mg2+] for all samples to ensure 





8.11 Analytical data for proteins and peptides 
 



























































































































Figure 8.1 RP-HPLC analysis of proteins from Chapter 2. Proteins were run on a 
analytical C18 column at the indicated gradient and time. (a) Purified H2A (b) Purified 
H2B (c) Purified H3C110S (d) purified H4 (e) purified H2BK120C (f) purified Ub-SH 
(g) Purified H2BK120-DTNP (h) Purified H2BssUb (i) Purified H2AK119C (j) Purified 










Table 8.2. Masses of purfied proteins from Chapter 2 
Protein Expected Mass (Da) Observed Mass (Da) 
H2A 13951.17 13953.81 
H2B 13818 13820 
H3C110S 15240.75 15240.71 
H4 11237 11238 
H2BK120C 13791.94 13791.8 
Ub-SH 8567.94 8567.47 
H2B-DTNP 13947 13946.03 
H2BssUb 22414.9 22413.78 
H2AK119C 13925.4 13924.735 
H2BK108C 13793 13794 
H2BK116C 13793 13794 




























































































































































Figure 8.2  RP-HPLC analysis of proteins from Chapter 3.  Proteins were run on a  
analytical  C18 column at the indicated gradient and time. (a) Purified Ub1-SH (b)  
Purified Ub2-SH (c)  Purified Ub3-SH (d)  Purified Ub4-SH (e)  Purified Ub5-SH (f)  
Purified Ub6-SH (g)  Purified Ub7-SH (h)  Purified Ub8-SH (i)  Purified Ub9-SH (j)  
Purified Ub10-SH (k)  Purified Ub11-SH (l)  Purified Ub12-SH (m)  Purified Ub13-SH 




Table 8.2. Masses of purfied proteins from Chapter 3 
Protein Expected Mass (Da) Observed Mass (Da) 
Ub1-SH 8464.85 8463.86 
Ub2-SH 8222.47 8224.14 
Ub3-SH 8414.75 8414.9 
Ub4-SH 8423.85 8424.06 
Ub5-SH 8436.85 8437.31 
Ub6-SH 8351.75 8350.62 
Ub7-SH 8471.85 8469.51 
Ub8-SH 8467.85 8465.49 
Ub9-SH 8394.85 8394.59 
Ub10-SH 8388.85 8388.1 
Ub11-SH 8395.85 8394.29 
Ub12-SH 8313.55 8313.41 
Ub13-SH 8482.76 8482.34 
H2BssUb7 22263.76 22262.51 































































































Figure 8.3.  RP-HPLC analysis of proteins from Chapter 4.  Proteins were run on a 
analytical C18 column at the indicated gradient and time. (a) Purified uRR-SH (b)  
Purified uLL-SH (c)  Purified H2B-Ub (d)  Purified H2B-uLL (e)  Purified 15N uLL (f)  



















Table 8.4. Masses of purfied proteins/peptides from Chapter 4 
Protein/Peptide Expected Mass (Da) Observed Mass (Da) 
uRR-SH 8397.71 8400.71 
uLL-SH 8483.76 8483.06 
H2B(1-116)-Mes 12990.9 12990.3 
H2B(117-125) 1116.1 1115.5 
Ub75-Mes 8632 8632 
uLL-Mes 8547.82 8547.64 
H2B(117-125)-Ub 8631.7 8631.7 
H2B-Ub 22378 22377.68 
H2B(117-125)-uLL 8547.6 8547.5 
H2B-uLL 22293.7 22293.75 
(15N, 1H) uLL 8584.67 8584.35 
Hub1-SH 8586 8588 
H2BssHub1 22376 22379 
Hub1ub-SH 8627.07 8626.59 

































































































Figure 8.4. RP-HPLC analysis of proteins from Chapter 5.  Proteins were run on a  
analytical  C18 column at the indicated gradient and time. (a) Purified dH2A (b)  
Purified dH2B (c)  Purified dH3S110C (d)  Purified dH4 (e)  Purified dH2BK118C (f)  

















Table 8.5. Masses of purfied proteins from Chapter 5 
Protein Expected Mass (Da) Observed Mass (Da) 
dH2A 13232.47 13232.29 
dH2B 13809.09 13825.52 
dH3 15240.75 15240.71 
dH4 11495.51 11493.89 
dH2BK120C 13785.06 13786.78 
dH2BssUb 22352.43 22356.65 
UbILV-SH 9011.00 9004.19 
H2AN110C 13940 13939.13 















Table 8.6. Masses of purfied proteins from Chapter 6 
Protein Expected Mass (Da) Observed Mass (Da) 
yH2A 13857.94 13858.41 
yH2B 14105.01 14105.87 
yH3 15252.74 15252.36 
yH4 13989.14 13988.81 
n-yH2A 20404.60 20403.43 
Ub-yH2A 20262.44 20261.65 









































































Figure 8.5. RP-HPLC analysis of proteins from Chapter 6.  Proteins were run on a  
analytical C18 column at the indicated gradient and time. (a) Purified yH2A (b)  
Purified yH2B (c)  Purified yH3 (d)  Purified yH4 (e)  Purified n-yH2A (f)  Purified Ub-
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